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on radioim m unoassay (RIA) and gas  chrom atography-m ass
sp e c tr o m e tr y  (GC-MS) and th e  developm ent and subsequ ent
e v a lu a t io n  o f  combined h ig h  p r e s s u r e  l i q u i d  chromatography and
radioim m unoassay (HPLC-RIA) and H P L C -flu o re scen c e  methods
f o r  the d e t e c t i o n  and q u a n tif ic a tio n  o f  ca n n a b in o id s  in  body
f l u i d s .  RIA was used to  measure l e v e l s  o f  c r o s s - r e a c t i o n  in
plasm a and u r in e  sam ples o b ta in e d  from s u b j e c t s  a f t e r  th ey
9
had smoked a m oderate dose  o f  A -THC. I t  was p o s s i b l e  t o
d i s t i n g u i s h  th e s e  from b lan k  sa m p le s . The GC-MS method
9was c a p a b le  o f  q u a n t i f y in g  A -THC in  plasm a a t  c o n c e n t r a t io n s
9down to  ln g /m l .  T h is  method was used to  measure A -THC
9
c o n c e n t r a t io n s  in  plasm a sam p les o b ta in e d  from th e  A -THC
sm okers. The HPLC-RIA method was a b le  to  q u a n t i fy  s e v e r a l
i n d i v i d u a l  c r o s s - r e a c t i n g  ca n n a b in o id s  in  one a n a l y s i s  in
e i t h e r  plasm a o r  u r in e  at c o n c e n t r a t io n s  as low as 0 . l n g /m l .
9T h is  method was used t o  measure c o n c e n t r a t io n s  o f  A -THC 
and i t s  m e t a b o l i t e s  in  b oth  plasm a and u r in e  sam p les o b ta in e d
9
from th e  A -THC sm okers. The H P L C -flu o re scen c e  method c o u ld  
d e t e c t  l e s s  than ln g  o f  c a n n a b in o l  but has not been d e v e lo p e d  t o  
the s t a g e  where o th e r  ca n n a b in o id s  c o u ld  be d e t e c t e d .
F o r e n s ic  c a se  sam ples r e q u ir in g  ex am in ation  f o r  
can n ab in oid  c o n te n t  were a n a ly s e d  w ith  th e  RIA, GC-MS and 
HPLC-RIA m ethods. RIA and HPLC-RIA were found t o  be s u i t a b l e  
methods f o r  th e  r o u t in e  a n a ly s e s  o f  plasm a and u r in e  sa m p le s .
SUMMARY
This thesis describes the evaluation of methods based
SECTION 1
IN T R O D U C T IO N
methods f o r  i d e n t i f y i n g  and q u a n t i f y in g  c a n n ab in oid  compounds
in  body f l u i d s .  These were i n v e s t i g a t e d  p r i m a r i ly  f o r  use
in  F o r e n s ic  S c ie n c e  L a b o r a to r ie s  to  h e lp  f i l l  a requ irem en t
f o r  r a p id  methods which p r o v id e  an u n eq u iv o c a l r e s u l t  f o r  th e
9c o n fir m a tio n  o f  th e  p re se n ce  o f  A -te tr a h y d r o c a n n a b in o l  
9
(A -THC, th e  p s y c h o a c t iv e  c o n s t i t u e n t  o f  c a n n a b is )  and i t s  
m e t a b o l i t e s  in  p lasm a and u r in e  sam p les . Due t o  th e  g r a v i t y  
o f  th e  s i t u a t i o n  t h a t  a f o r e n s i c  s c i e n t i s t  e n c o u n te r s  when 
g iv i n g  e v id e n c e  co n c ern in g  th e  i l l e g a l  p o s s e s s io n  o f  can n ab is  
in  a co u rt  o f  law he r e q u ir e s  a d e t a i l e d  knowledge o f  many 
a s p e c ts  o f  th e  s u b j e c t .  A c c o r d in g ly  t h i s  in t r o d u c t io n  
c o n ta in s  g e n e r a l  background in fo r m a tio n  o f  r e le v a n c e  t o  
th e  f o r e n s i c  s c i e n t i s t  in v o lv e d  in  th e  a n a ly s i s  o f  
can n ab in oid  m a t e r i a l .
(A) GENERAL INTRODUCTION
This thesis describes the evaluation and development of
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(B) THE BOTANY OF CANNABIS
Cannabis i s  one o f  m an 's  o l d e s t  c u l t i v a t e d  p l a n t s ,  
i t s  f i b r e  has been used f o r  hempen c lo t h  m anufacture f o r  at  
l e a s t  6000 y e a r s  and was used f o r  t h i s  p u rpose  in  r e g io n s  
as f a r  ap art  as E a stern  Europe and China. Knowledge o f  i t s
u se  as a d r u g ' j  a l s o  e x te n d s  back from th e  p re se n t  by
s e v e r a l  m i l l e n n i a .  The S c y th ia n s  grew hemp in  th e  V o lg a  
r e g io n  3000  y e a r s  ago and b u rn t th e  can n ab is  se e d s  
(presu m ably  contam inated  w ith  r e s i n )  t o  produce an i n t o x i c a ­
t i n g  smoke. In th e  In d ian  s u b -c o n t i n e n t  m e d ic a l  w r i t in g s  
com p iled  b e fo r e  1000BC r e p o r t  th e  use o f  can n ab is  r e s i n  as a 
m e d ic in e . Hemp was in tr o d u c e d  i n t o  W estern  Europe at about  
1500BC, p o s s i b l y  by S c y th ia n  in v a d e r s ,  and was s u b se q u e n tly  
sp re a d  f u r t h e r  west by T e u to n ic  p e o p le s .
The name Cannabis g o es  back to  Roman t im e s ,  but th e  
s t a r t i n g  p o in t  f o r  i t s  b o t a n i c a l  nom enclature  ( Cannabis  
s a t i v a ) d a te s  from L in n a e u s 's  S p e c ie s  P lanatarum  o f  1 7 5 3 .  
Cannabis i s  p ro b a b ly  a m onotypic  genus (a  genus w ith  one 
s p e c i e s )  t h a t  has d i v e r s i f i e d  i n t o  a la r g e  number o f  
e c o ty p e s  and c u l t i v a t e d  r a c e s .  Cannabis i n d i c a  has been  
used t o  d en ote  a ra ce  n a t iv e  t o  In d ia  w ith  a high  c o n c e n tr a t io n  
o f  i n t o x i c a t i n g  p r i n c i p l e s ,  but t o  c a t a lo g u e  Cannabis  
s a t i v a  i n t o  i t s  d i f f e r e n t  r a c e s  i s  c o m p lic a te d  by the f a c t  
t h a t  th e  p la n t  changes in  some way t o  adapt t o  i t s  en viron m en t.  
P la n t s  grown in  England and France from se e d  im ported from  
In d ia  have changed over  s e v e r a l  g e n e r a t io n s  t o  p la n t s  
m o r p h o lo g ic a l ly  i n d i s t i n g u i s h a b l e  from v a r i e t i e s  lo n g  
a c c l i m a t i s e d  t o  European c o n d i t i o n s .  There a r e ,  however, 
c o n s id e r a b le  d i f f e r e n c e s  in  th e  h a b it  and p r o p e r t i e s  o f  th e
3
v a r i e t i e s ,  some o f  which have undoubtedly  been caused by 
s e l e c t i o n  by man f o r  a p a r t i c u l a r  p ro p e r ty  o f  th e  p l a n t .
Cannabis s a t i v a  i s  a r a p i d l y  growing e r e c t  annual 
which c om p letes  i t s  l i f e  c y c l e  w ith in  a few m onths. I t  i s  
c l a s s i f i e d  as a l l i e d  t o  Humulus, th e  genus o f  th e  hop p l a n t .
The p la n t  grows from 3 t o  15 f e e t  in  h e i g h t ,  w ith  an a n g u la r  
som etim es h o llo w  stem  and lo n g  narrow le a v e s  (F ig u r e  1 ) .
The f lo w e r s  are produced  in  g r e a t  abundance on th e  upper  
p a r t  o f  th e  p la n t  which i s  u s u a l l y  u n is e x u a l  (n o r m a lly  th e  
p la n t  b e a rs  o n ly  one k in d  o f  f lo w e r  and i s  e i t h e r  male o r  
fe m a le ,  but som etim es th e  p la n t  does have b o th  c h a r a c t e r i s t i c s ) .
The f i b r e s  o f  th e  stem  are u sed  t o  produce hemp, w h ile  o i l s  
from th e  p la n t  and se e d s  are  u sed  in  th e  p a in t  and soap  
i n d u s t r i e s  and th e  se e d  i s  u sed  t o  fe e d  p o u l t r y  and c a g e b ir d s .
The p h a r m a c o lo g ic a l  p r o p e r t i e s  o f  can n abis  a re  found in  th e  r e s i n  
produced in  g la n d u la r  h a i r s  on th e  l e a v e s ,  stem  and 
i n f l o r e s c e n c e s  o f  th e  p l a n t .  The l a r g e s t  q u a n t i t i e s  o f  
r e s i n  are found on th e . b r a c t s  (p a r t  o f  th e  f lo w e r )  o f  t h e  
fem ale  p la n t  du rin g  th e  f lo w e r in g  or  f r u i t i n g  p e r io d  o f  
developm ent. The h i s t o r y  and botany o f  Cannabis has been  
review ed  (S t e a r n ,  1970 and S c h u l t e s ^ 1 9 7 0 ) .
The p h a r m a c o lo g ic a l  e f f e c t s  o f  cannabis  are  u s u a l l y  obtained*, 
by smoking th e  p la n t  m a t e r i a l  or  an e x t r a c t ,  though th e  drug  
may a l s o  be ea ten  or  drunk ( a s  a t e a ) .  Cannabis i s  used  in  
s e v e r a l  form s. H erbal c a n n a b is  i s  norm ally  th e  d r ie d  upper  
p a r t  o f  th e  p la n t  h a r v e s te d  d u rin g  th e  f r u i t i n g  and f lo w e r in g  
p e r io d .  K i f  i s  p rep a red  by f i n e l y  chopping th e  p la n t  m a t e r i a l  
and removing l a r g e  p a r t i c l e s  w ith  a s i e v e .  T h is  p r e p a r a t io n  
may a l s o  be r e f e r e d  t o  as  h e r b a l  c a n n a b is . Cannabis r e s i n  i s
4
s e p t a l  from  
male f lo w e r
F ig u r e  1. C annabis  s a t i v a .
Drawn by D Erasm us, th e  B r i t i s h  Museum 
(N a tu r a l  H i s t o r y ) ,  London.
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o b ta in e d  by com pressin g  th e  d r ie d  p la n t  m a t e r ia l  in  gauze  
t o  e x tru d e  th e  r e s i n .  A modern form o f  th e  drug known as  
l i q u i d  c a n n a b is ,  hash o i l  o r  THC, i s  prep ared  by e x t r a c t i n g  
th e  p la n t  m a t e r ia l  w ith  an o r g a n ic  s o lv e n t  to  g iv e  a 
c o n c e n tr a te d  ca n n a b in o id  p r e p a r a t io n .  Because o f  th e  high  
c o n c e n tr a t io n  o f  THC in  t h i s  p r e p a r a t io n ,  i t  i s  one o f  th e  
most p o te n t  forms o f  th e  drug. There are many names f o r  
p r e p a r a t io n s  o f  c a n n a b is .  The d r ie d  p la n t  m a t e r ia l  may be  
termed marihuana, g r a s s  or  dagga; th e  r e s i n  may be c a l l e d  
h a s h is h ,  or  c h a r ra s  and th e r e  i s  a l s o  an e x t e n s iv e  and
changing v o c a b u la r y  r e l a t i n g  t o  can n abis  and i t s  e f f e c t s .
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(C ) THE PHARMACOLOGY OF CANNABIS
The m ajor p s y c h o a c t i v e  c o n s t i t u e n t  o f  th e  d rug, A -THC, 
a c ts  upon th e  c e n t r a l  n ervou s sy stem . I t s  e f f e c t s  are  dependent  
on th e  d o se ,  th e  p erso n  t a k in g  i t ,  h i s  c u l t u r a l  background  
and t o  some e x t e n t  th e  environm ent in  which i t  i s  ta k e n . The 
resp o n se  t o  ca n n a b is  w i l l  a l s o  vary a c c o r d in g  t o  th e  method  
by which i t  i s  ta k e n . When i t  i s  smoked th e  e f f e c t s  
norm ally  come w it h in  h a l f  an hour and l a s t  f o r  two or  t h r e e  
h ou rs . Where i t  i s  ta k en  by mouth th e  o n se t  o f  e f f e c t s  a re  
d e la y e d  som etim es up t o  two o r  th r e e  hours and may l a s t  as  
lo n g  as s i x  h o u rs . B ecause o f  th e  r e l a t i v e l y  r a p id  o n se t  
when th e  drug i s  smoked, e x p e r ie n c e d  smokers can a d ju s t  t h e i r  
dosage t o  a c h ie v e  th e  e f f e c t  th a t  they se e k .  Taking c a n n a b is  
does not n orm ally  r e s u l t  in  any ob v io u s  p h y s i c a l  e f f e c t s  
excep t th a t  o f  r e d n e s s  o f  th e  e y e s .  When th e  drug i s  
smoked t h e r e  may be some i n i t i a l  rawness o f  th e  th r o a t  and 
t i g h t n e s s  in  th e  c h e s t ,  som etim es t h i s  may be accom panied by  
nausea or a headache. The apparent e f f e c t s  o f  th e  drug in  
moderate amounts are  p re d o m in a n tly  p s y c h o l o g i c a l .  They 
g e n e r a l ly  b e g in  w ith  a s e n se  o f  ex c item en t o r  t e n s i o n ,  
sometimes w ith  a p p reh en sion  o r  h i l a r i t y ,  f o l lo w e d  by a s e n s e  
o f  h e ig h te n e d  aw aren ess ; c o lo u r ,  sounds and s o c i a l  i n t e r ­
cou rse  appear more in t e n s e  and m eaningfu l and t im e  may appear  
t o  p a ss  more s l o w l y .  A se n se  o f  w e l l  b e in g  i s  then  u s u a l  
and a f t e r  t h i s  a p h ase  o f  t r a n q u i l i t y  and o f  p a s s i v e  enjoym ent  
o f  th e  environment ( t h e  h ig h )  norm ally  f o l l o w s  u n t i l ,  a f t e r  
a few h o u rs , f a t i g u e  s e t s  in  and th e  s u b je c t  may s l e e p .  Once 
th e  e f f e c t s  o f  th e  drug have worn o f f  t h e r e  may be an 
i n c r e a s e  in  a p p e t i t e  and even ravenous hunger. The l e s s
9
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ob v io u s  p h y s i c a l  e f f e c t s  o f  th e  drug in c lu d e  a r a i s e d  p u ls e  
r a t e  and b lo o d  p r e s s u r e ,  d i l a t e d  p u p i l s  and r a p id  sh a llo w  
b r e a th in g .  C annabis a l s o  has a d e tr im e n ta l  e f f e c t  on 
m a n ip u la t iv e  a b i l i t y ,  i n c lu d in g  d r i v in g  p erfo rm a n ce . The 
p h a r m a c o lo g ic a l  p r o p e r t i e s  o f  can n ab is  have been summarised  
(W ootton C om m ittee, 1 9 6 8 ) .
I t  i s  e s t im a te d  t h a t  can n a b is  i s  consumed by between  
200 to  300 m i l l i o n  p e o p le  in  th e  w o r ld ; 26 m i l l i o n  c i t i z e n s  
o f  the USA have t r i e d  th e  drug (P e te r s e n ,  1 9 7 6 )  and can n abis  
u s e r s  in  th e  UK may number s e v e r a l  hundreds o f  thousan ds  
(W ootton C om m ittee, 1 9 6 8 ) .
I t  i s  o f  some im portance t h e r e f o r e  th a t  any lo n g  term  
e f f e c t s  produced by th e  drug sh o u ld  be i d e n t i f i e d .  The 
n atu re  and degree  o f  s e v e r i t y  o f  such e f f e c t s  are  a t  th e  
moment th e  s u b je c t  o f  some s c i e n t i f i c  c o n t r o v e r s y .  W h ile  
i t  i s  g e n e r a l ly  ag reed  t h a t  low consum ption o f  th e  drug w i l l  
p ro b a b ly  cau se  no harm ful e f f e c t s  i t  has been s u g g e s te d  
t h a t  m oderate o r  h ig h  consum ption may cau se  i r r e v e r s i b l e  
b r a in  damage, sharp p e r s o n a l i t y  ch an ges , s e v e r e  d e b i l i t a t i o n  
o f  the lu n gs and b r o n c h ia l  t r a c t ,  a f f e c t  hormone l e v e l s ,  
cause chromosome damage and produce a d is r u p t i o n  o f  c e l l u l a r  
m etabolism  in c lu d i n g  s y n t h e s i s  o f  DNA (Maugh, 1 9 7 4 ) .  As 
lo n g  as th e  p o s s i b i l i t y  o f  such e f f e c t s  e x i s t  many a u t h o r i t i e s  
reg a rd  i t  as n e c e s s a r y  to  c o n t r o l  th e  a v a i l a b i l i t y  o f  c a n n a b is .  
A r e p o r t  by th e  Wooten Committee (1 9 6 8 )  c on clu d ed  th a t  
b ecause  o f  th e  l i m i t s  o f  p r e s e n t  knowledge co n c ern in g  th e  
p h y s ic a l  e f f e c t s  and s o c i a l  consequen ces o f  can n ab is  u s e ,  i t  
was n e c e s s a r y  in  th e  i n t e r e s t  o f  p u b l i c  h e a l t h  t o  m a in ta in  
r e s t r i c t i o n s  on th e  a v a i l a b i l i t y  o f  th e  drug.
The s a l e  o f  c a n n a b is  has been s u b j e c t  t o  c o n t r o l  in  th e
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UK s in c e  th e  Dangerous Drugs Act ( 1 9 2 5 ) .  R e s t r i c t i o n s *  k 
con cern in g  th e  p o s s e s s i o n  and c u l t i v a t i o n  o f  can n abis  were 
in tr o d u c e d  in  th e  Dangerous Drugs Act 1 9 6 5 .  C o n tro l o f  
can n abin oid s  was exten d ed  in  th e  M isuse  o f  Drugs Act 1971  
t o  in c lu d e  ca n n a b in o l and i t s  d e r i v a t i v e s  ( c l a s s  A d ru g s)  as  
w e l l  as cannabis  and can n abis  r e s i n  ( c l a s s  B d r u g s ) .
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(D) THE ISOLATION AND STRUCTURAL ELUCIDATION OF NATURALLY 
OCCURRING CANNABINOIDS
D uring th e  l a s t  cen tu ry  a la r g e  p a r t  o f  ch em ica l  
r e se a rc h  was d i r e c t e d  tow ards th e  i s o l a t i o n  o f  p h a r m a c o lo g ic a l ly  
a c t i v e  n a t u r a l l y  o c c u r r in g  compounds. Three o f  th e  drugs  
which were s u c c e s s f u l l y  i s o l a t e d ,  c h a r a c t e r i s e d  and 
s u b se q u e n tly  used in  m e d ic in e  d u rin g  t h i s  p e r i o d ,  were th e  
a lk a lo id s ,  m orphine, c o c a in e  and s t r y c h n in e .  T h is  ty p e  o f  
compound was, how ever, s im p le  to  i s o l a t e  and p u r i f y  r e l a t i v e  
t o  th e  n a t u r a l l y  o c c u r r in g  t e r p e n o id s .  These were u s u a l l y  
p r e s e n t  as  com plex m fx tu r e s  o f  components whose s e p a r a t io n  was 
d i f f i c u l t  t o  a c h ie v e  w ith  th e  te c h n iq u e s  a v a i l a b l e  at th e  
t im e . The i s o l a t i o n  o f  t h e  a c t i v e  c o n s t i t u e n t s  o f  c a n n a b is  
in v o lv e d  th e  s e p a r a t io n  o f  such a m ixtu re  o f  t e r p e n e s .
The f i r s t  c h e m ists  t o  a ttem p t th e  a n a l y s i s  o f  c a n n a b is
were T s c h e e p e ( 1 8 2 1 ) , S c h le s in g e r  ( 1 8 4 0 ) ,  B o h l ig  ( 1 8 4 0 ) ,
Savory( 1 8 4 3 ) ,  R obertson  ( 1 8 4 7 ) ,  G a s t i n e l  ( 1 8 4 8 ) ,  Smith and
Smith ( 1 8 4 7 ,  1 8 4 8 )  and Smith ( 1 8 8 5 ) .  Most o f  t h i s  work
c o n s i s t e d  o f  a tte m p ts  t o  i s o l a t e  an a c t i v e  ca n n a b in o id  by
e i t h e r  th e  e x t r a c t i o n  o f  p la n t  m a t e r ia l  w ith  an o r g a n ic  s o lv e n t
or  th e  d i s t i l l a t i o n  o f  p la n t  m a t e r ia l  t o  o b t a in  th e  v o l a t i l e
o i l s .  In many c a s e s  t h e s e  workers were a b le  t o  o b ta in  a
c o n c e n tr a te d  p r e p a r a t io n  c o n ta in in g  th e  a c t i v e  c o n s t i t u e n t  o f
c a n n a b is ,  but a pure ca n n a b in o id  was not o b t a in e d .  Wood e t  a l .
( 1 8 9 6 )  a c h ie v e d  a c o n s i d e r a b le  p u r i f i c a t i o n  o f  th e  components
o f  cannabis  by f r a c t i o n a l  d i s t i l l a t i o n  o f  an e t h e r e a l
e x t r a c t  o f  th e  r e s i n .  A h ig h  b o i l i n g ,  v i s c o u s  red  o i l  was
o b ta in e d  which was assumed t o  be a s i n g l e  s u b s ta n c e  and was
named c a n n a b in o l  (CBN). The o i l  was e x tr e m e ly  a c t i v e ,  20mg b e in g  
s u f f i c i e n t  t o  ind uce i n t o x i c a t i o n ,  and was reg a rd ed  as t h e  a c t i v e
c o n s t i t u e n t  o f  th e  p l a n t .  Soon a fte r w a r d s  Dunstan and Henry
/
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homogeneous and p u r i f i e d  i t  f u r t h e r .  A f t e r  a c e t y l a t i o n  a 
c r y s t a l l i n e  a c e t a t e  was o b ta in e d  which upon h y d r o l y s i s  y i e l d e d  
a r e s in o u s  c ry p to p h en o l t h a t  a n a ly s e d  as C21 H2 6 ° 2  3 1 0 >-
The name o f  can n ab in ol was t r a n s f e r r e d  t o  t h i s  compound 
which was th e  f i r s t  c a n n a b in o id  to  be o b ta in e d  in  a pure form .  
No i n d i c a t i o n  was g iv e n  a t  t h i s  t im e w hether c a n n ab in ol was 
p h a r m a c o lo g ic a l ly  a c t i v e .
Numerous w orkers o v e r  th e  f o l l o w i n g  30 y e a r s  a ttem p ted  
t o  r e p e a t  t h i s  work w ith ou t s u c c e s s ,  u n t i l  th e  r e i n v e s t i g a t i o n  
o f  th e  s u b je c t  by Cahn ( 1 9 3 0 ,  1 9 3 1 ,  1 9 3 2 ,  1 9 3 3 ) .  U sin g  th e  
method o f  Wood e t  a l . ( 1 8 9 9 )  he o b ta in e d  c r y s t a l l i n e  a c e t y l  
can n ab in ol w ith  a m e lt in g  p o in t  i d e n t i c a l  to  th a t  o b ta in e d  
p r e v i o u s ly .  He conducted  a s e r i e s  o f  complex d e g r a d a t iv e  
r e a c t i o n s  upon ca n n a b in o l some o f  which had been used by 
Wood e t  a l . ( 1 8 9 9 ) ,  in  o r d e r  t o  i d e n t i f y  s e c t i o n s  o f  th e  
m o le c u le .  He was f i n a l l y  a b le  t o  s u g g e s t  a p a r t i a l  s t r u c t u r e  
f o r  c a n n a b in o l ,  in  which th e  p o s i t i o n s  o f  th e  p h e n o l ic  
hydroxy and p e n ty l  s i d e  ch a in  groups were not f u l l y  d eterm in ed  
(F ig u r e  2 ) . -
(1898) and Wood et al, (1899) found that the oil was not
c 5h „
OH
F igu re  2 The p a r t i a l  s t r u c t u r e  o f  c a n n a b in o l e l u c i d a t e d  by  
Cahn ( 1 9 3 3 )
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The com plete  s t r u c t u r e  o f  c a n n ab in ol was f i n a l l y  
e s t a b l i s h e d  by th e  groups o f  Todd (Jacob and Todd, 1 9 4 0 a and 
1940b , Simonsen and Todd, 1 9 4 2 ,  Leaf et a l . , 1942 and Todd 1946
in  B r i t a i n  and Adams e t  a l . ( 1 9 4 0 a , 1940b , 1 9 4 0 ° ,  1 9 4 1 ,  1 9 4 2 )  
in  th e  U n ited  S t a t e s .  They s y n t h e s i s e d  th e  iso m e rs  o f  
can n ab in ol su g g e ste d  by Cahn, compared th e s e  w ith  th e  n a tu r a l  
compound and e s t a b l i s h e d  which isom er was ca n n a b in o l  
(F ig u r e  4 ) .  They a l s o  s u g g e s te d  t h a t  th e  a c t i v e  c o n s t i t u e n t s  
o f  can n abis  were p ro b a b ly  a m ixtu re  o f  some o f  th e  iso m e r s  o f  
THC.
c5h „
Formal numbering M onoterpenoid numbering
F igu re  3. Numbering system s f o r  A^-THC (A^-THC)
C.H5 Ml
F ig u re  4 . Cannabinol and A^0a-THC (A^-THC)
T h is  work a l s o  produced a f u r t h e r  im p ortan t developm ent
in  can n ab in oid  ch em istry  when both  groups in d e p e n d e n tly
1 0 aprepared pure samples of A -THC, (Figure 4) as an
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in te r m e d ia te  in  th e  c a n n ab in ol s y n t h e s i s  ( t h e  form al numbering  
sy stem , F igu re  3 ,  has been used throughout t h i s  t h e s i s ) .  The 
compound was found t o  cause th e  c h a r a c t e r i s t i c  e f f e c t s  o f  
cannabis  and becau se  p u r e , n a t u r a l  THC was not a v a i l a b l e  f o r  
a fu r t h e r  2 0  y e a r s  i t  was su b se q u e n tly  used as a s tan d ard  f o r  
b i o l o g i c a l  work. Adams (1 9 4 0  ) a l s o  i s o l a t e d  c a n n a b id io l  
( CBD) from c a n n a b is ,  but d id  n ot determ ine i t s  s t r u c t u r e .
W o lln e r ,  e t  a l  ( 1 9 4 2 ) ,  u s in g  th e  d i s t i l l a t i o n  and 
a c e t y l a t i o n  methods employed f o r  th e  i s o l a t i o n  o f  c a n n a b in o l ,  
i s o l a t e d  a THC isom er from can n ab is  which was not i d e n t i c a l
1 D a
to  the s y n t h e s i s e d  A THC. W o lln e r ,  e t  a l . ( 1 9 4 2 )  d id  not  
however determ ine th e  e x a c t  p o s i t i o n  o f  th e  dou ble  bond.
F u rth er  can n a b in o id  s t r u c t u r a l  e l u c i d a t i o n  was not  
accom p lish ed  u n t i l  th e  te c h n iq u e s  o f  column chromatography,  
c o u n te r c u r r e n t  d i s t r i b u t i o n  and n u c le a r  m a g n e tic  resonance  
s p e c tr o s c o p y  (NMR) were e s t a b l i s h e d ,  de Ropp ( 1 9 6 0 )  s e p a r a te d  
c a n n ab in oid s  on a f l o r i s i l  column and i d e n t i f i e d  can n ab in ol  
and c a n n a b id io l  by com parison w ith  th e  a u t h e n t i c  sam ples  
from th e  work o f  Adams 20 y e a r s  e a r l i e r .  A t h i r d  
p h a r m a c o lo g ic a l ly  a c t i v e  component presumed to  be a THC 
isom er was a l s o  i s o l a t e d ,  but no s t r u c t u r a l  work on t h i s  
compound was r e p o r te d .  K o rte  and S ie p e r  ( 1 9 6 0 )  a l s o  i s o l a t e d  
c a n n a b id io l  from ca n n a b is  u s in g  c o u n te r c u r r e n t  d i s t r i b u t i o n .  
Mechoulam and Shvo ( 1 9 6 3 )  then  determ ined  th e  t o t a l  
s t r u c t u r e  o f  c a n n a b id io l  (F ig u r e  5 )  u s in g  th e  e x i s t i n g  d a ta  
and fu r t h e r  in fo r m a t io n  o b ta in e d  from i t s  NMR spectrum .
Gaoni and Mechoulam ( 1 9 6 4 )  chromatographed a hexane  
e x t r a c t  o f  can n ab is  r e s i n  on a f l o r i s i l  column and se p a r a te d  
s e v e r a l  can n ab in oid  components in c lu d in g  a THC iso m e r . The 
u l t r a - v i o l e t  spectrum  o f  t h i s  component i n d i c a t e d  th a t  th e  
double bond was not c o n ju g a te d  w ith  the a r o m a tic  r i n g .  From a
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F igu re  5 .  C an n ab id io l
stu d y  o f  th e  NMR spectrum  Gaoni and Mechoulam p ro p o sed  t h a t
g
th e  double bond was in  th e  A p o s i t i o n .  T his  was co n firm ed
9by th e  t o t a l  s y n t h e s i s  o f  A -THC by Mechoulam and Gaoni 
( 1 9 6 5 a ) .  The s y n t h e t i c  r o u te  in c lu d e d  th e  p r e p a r a t io n  o f  
c a n n a b id io l  as an in t e r m e d ia t e .  The r e l a t i v e  s t e r e o ­
c h em istry  o f  th e  two c h i r a l  c e n t r e s  o f  c a n n a b id io l  and hence
9
A -THC were e s t a b l i s h e d  as t r a n s ,  from NMR d a ta  by Mechoulam
and Shvo ( 1 9 6 3 ) .  The t o t a l  s t r u c t u r e s  o f  th e  th r e e  m ajor
components o f  can n abis  had how been d eterm in ed , and t h e s e
con firm ed  by t h e i r  s y n t h e s i s .  D e t a i l s  o f  th e  s t r u c t u r a l
9
c o n form a tion  o f  A -THC (F ig u r e  6 ) was r e p o r te d  by A rch er  
e t  a l . ( 1 9 7 0 ) .
The p o s i t i o n  o f  th e  d ou ble  bond in  a secon d  n a t u r a l l y
Q
o c c u r r in g  THC isomer, A -THC, a minor can n abis  component, was
e s t a b l i s h e d  w ith  NMR and mass s p e c t r a l  d ata  by B u d z ik ie w ic z
e t  a l . ( 1 9 6 5 ) ,  Gaoni and Mechoulam (1 9 6 6 )  and H iv e iy  ( 1 9 6 6 ) .
The s t r u c t u r e  o f  a f u r t h e r ,  o f t e n  th e  m a jo r ,  component
o f  c a n n a b is ,  A^-THC a c id  (A ) (F ig u r e  7 )  was e s t a b l i s h e d  by
K orte  et  a l . ( 1 9 6 5 ) ,  and t h a t  o f  th e  A^-THC a c id  (B ) (F ig u r e
7 )  by Mechoulam and Yagen ( 1 9 6 9 )  on th e  b a s i s  o f  t h e i r  NMR 
s p e c t r a
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9 9The A -THC a c id s  are b oth  d e c a r b o x la te d  to  A -THC by h e a t .
F ig u re  6 .  C onform ation  o f  A -THC
COOH
F ig u re  7 .  A9-THC a c id  (A ) and A9 -THC a c id  (B)
The s t r u c t u r e s  o f  c a n n a b i d i o l i c  a c id  and c a n n a b in o lic
a c id  were e s t a b l i s h e d  from NMR d a ta  by Mechoulam and Gaoni
( 1 9 6 5 k ) .  These compounds have a c a r b o x y l i c  a c id  group in
9
th e  same p o s i t i o n  ( 2 )  as th e  A -THC a c id  ( A ) .
The p r o p y l  hom ologues ( i n s t e a d  o f  p e n t y l )  o f  A9 -THC,
9
c a n n ab in ol and c a n n a b i d i o l ,  which were named A -  
te tr a h y d r o c a n n a b iv fr r o l , c a n n a b iv a r o l  and ca n n a b id iv 'a ro l  
r e s p e c t i v e l y  were i s o l a t e d  and s t r u c t u r a l l y  i d e n t i f i e d  by
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V o l ln e r  e t  a l , ( 1 9 6 9 )  V ree e t  a l . ( 1 9 7 1 )  and G i l l  ( 1 9 7 1 )  
u s in g  NMR and mass s p e c tr o m e tr y .
The s t r u c t u r e  o f  a minor cannabis  component 
c a n n a b i g e r o l , (F ig u r e  8 ) was e s t a b l i s h e d  by Gaoni and
T .
Mechoulam (1 9 6 4  , 1 9 7 1 )  w ith  UV and NMR, and con firm ed  by  
i t s  s y n t h e s i s .
OH
/ \
F ig u re  8 . C an n abigero l
Two grou p s, C la u ssen  and K orte  (1 9 6 6 )  and Gaoni and 
Mechoulam (1 9 6 6  , 1 9 7 1 )  in d e p e n d e n tly  i s o l a t e d  and e s t a b l i s h e d  
th e  s t r u c t u r e  o f  cannabichrom ene (F ig u r e  9 )  w ith  UV and NMR, 
b oth  a s s ig n in g  th e  same name to  t h i s  can n abin oid .
OH
F igu re  9 .  Cannabichromene
C a n n a b ic y c lo l , a f u r t h e r  minor can n abis  component was
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f i r s t  i s o l a t e d  by K orte  and S ie p e r  ( 1 9 6 4 ) .  Crombie and 
P o n sfo rd  ( 1 9 6 8 ,  1 9 7 1 )  p rop osed  i t s  s t r u c t u r e  from NMR d a ta  
and con firm ed  t h i s  by s y n t h e s i s  (F ig u re  1 0 ) .
F igu re  1 0 .  C a n n a b ic y c lo l
The e l u c i d a t i o n  o f  th e  s t r u c t u r e s  o f  th e  m ajor  
can n ab in oid  components in  can n abis  would now appear to  be  
e s s e n t i a l l y  c o m p lete . T h is  in fo r m a tio n  t o g e t h e r  w ith  an 
a v a i l a b i l i t y  o f  pure compounds has p e r m itte d  a stu d y  o f  
c a n n ab in oid  m etab olism .
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(E ) THE METABOLISM OF THE CANNABINOIDS
C annabinoids are  e x t e n s i v e l y  m e ta b o lis e d  in  mammals and
a knowledge o f  t h i s  t r a n s fo r m a t io n  may be o f  some h e lp  w ith
the development o f  methods f o r  t h e i r  a n a l y s i s  in  body f l u i d s .
The g e n e r a l  m e t a b o l ic  pathway p ro c eed s  v i a  an i n i t i a l
a l l y l i c  o r  p e n t y l  s i d e  c h a in  h y d r o x y la t io n , fo l lo w e d  by
o th e r  r e a c t i o n s  o f  e i t h e r  f u r t h e r  h y d r o x y la t io n  or  f u r t h e r
o x id a t io n  at  th e  carbon atom c o n ta in in g  th e  e x i s t i n g  h y d r o x y l
group. A f i n a l  s t a g e  may be c o n ju g a tio n  w ith  g lu c u r o n ic  a c i d .
The e x c r e t i o n  o f  m e t a b o l i t e s  in  humans a f t e r  th e
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a d m in is tr a t io n  o f  r a d i o l a b e l l e d  A -THC was measured by
Leraberger e t  a l . ( 1 9 7 1 ) .  T h is  group found t h a t  a low er
p r o p o r t io n  o f  m e t a b o l i t e s  were e x c r e te d  in  th e  u r in e  r e l a t i v e
t o  the f a e c e s ,  and t h a t  th e  e x te n t  o f  th e  e x c r e t i o n  in  th e
u rin e  o v e r  a seven day p e r i o d  r e p r e se n te d  a p p ro x im a te ly  25%
o f  th e  o r i g i n a l  d o se .
THC i s  a l i p i d  s o l u b l e  compound which i s  s u i t a b l e  f o r
m e ta b o lic  t r a n s fo r m a t io n  by th e  h e p a t ic  m icrosom al enzyme
sy stem . The system  r e q u i r e s  as c o - f a c t o r s , reduced ^ i c o t i n i h i i d ^ ‘
ad en in e  d i n u c l e o t i d e  p hosp hate  and m o le c u la r  oxygen and'
c a t a l y s e s  a v a r i e t y  o f  r e a c t i o n s ,  many b e in g  o x i d a t i o n s  in
which cytochrome P -4 5 0  s e r v e s  as the  te r m in a l  o x id a s e .
S e v e r a l  l a b o r a t o r i e s  th rou gh ou t th e  w orld  have examined t h e
m e ta b o lic  f a t e  o f  THC w ith  l i v e r  m icrosom al enzyme
p r e p a r a t io n s .  N i ls s o n  e t  a l . ( 1 9 7 0 )  and W a ll  e t  a l . ( 1 9 7 0 )
9in c u b a te d  r a d i o l a b e l l e d  A -THC w ith  1 0 ,0 0 0 g  l i v e r  s u p e r n a ta n t
9
from r a b b i t s  and r a t s  and i s o l a t e d  a m o n o -h y d ro x y la ted  A -THC 
m e t a b o l i t e .  T h is  was i d e n t i f i e d  by both groups u s in g  mass
9
s p e c tr o m e tr y  and NMR as 1 1 -h y d r o x y -A  -THC, (F ig u r e  1 1 ) .
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S im u lta n e o u s ly  B u r s te in  e t  a l , ( 1 9 7 0 )  and F o l t z  e t  a l . ( 1 9 7 0 )
g
c h a r a c t e r is e d  th e  s t r u c t u r e  o f  a A -THC m e t a b o l i t e ,  1 1 -
h y d ro x y -A 8 -THC. C h r is te n s e n  e t  a l . ( 1 9 7 1 )  in c u b a te d  A9 -THC
w ith  human l i v e r  p r e p a r a t io n s  o b ta in e d  p o st-m o rte m  and
9again  th e  1 1 -h y d r o x y -A  -THC m e t a b o l i t e  was i d e n t i f i e d .
F ig u re  1 1 .  l l - h y d r o x y - A 9-THC
9
Lemberger e t  a l . ( 1 9 7 1 ) ,  u s in g  r a d i o l a b e l l e d  A -THC,
9
found t h a t  in  man 1 1 -h y d r o x y -A  -THC was e x c r e te d  m ain ly  in
th e  f a e c e s  and o n ly  3% o f  th e  r a d i o a c t i v i t y  was p r e s e n t  as
t h i s  m e t a b o l i t e  in  u r in e  h y d r o ly se d  w ith  3 -g l u c u r o n i d a s e .
11 -h ydroxy-A ^-T H C  was i d e n t i f i e d  by W all e t  a l ♦ ( 1 9 7 2 )  in  a
p o o le d  plasm a sam ple ( 1 2 0 0 m l) from f i v e  s u b j e c t s  who to o k  
9A \-THC o r a l l y .  Woodhouse ( 1 9 7 2 )  examined th e  p o o le d  u r in e  o f
s e v e r a l  can n abis  smokers and i d e n t i f i e d  t h i s  m e t a b o l i t e  in
th e  u r in e  a f t e r  i t s  h y d r o ly s i s  w ith  3 -g lu c u r o n id a s e .  A GC-MS
method f o r  th e  measurement o f  t h i s  m e t a b o l i t e  in  plasm a has
been d e s c r ib e d  by W all e t  a l . ( 1 9 7 6 ) .  Plasm a c o n c e n t r a t io n s
o f  th e  o r d e r  o f  ln g /m l  were found by t h i s  method in  s e v e r a l
9s u b j e c t s  th a t  had been g iv e n  4 to  5 mg o f  A -THC in t r a v e n o u s ly .  
The m e t a b o l i t e  i s  known t o  have a s i m i l a r  p h a r m a c o lo g ic a l  
a c t i v i t y  to  A^-THC but th e s e  low c o n c e n t r a t io n s  in  plasm a c o u ld  
s u g g e s t  t h a t  th e  compound i s  not r e s p o n s i b le  f o r  th e  t o t a l
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O ther m onohydroxylated  THC m e t a b o l i t e s  have been
i s o l a t e d  from l i v e r  i n c u b a t e s .  W all e t  a l . ( 1 9 7 0 ,  1 9 7 1 )
a
i d e n t i f i e d  p h a r m a c o lo g ic a l ly  a c t i v e  8 -3 -h y d ro x y ~ A  -THC and
Q u a rles  e t  a l . ( 1 9 7 3 )  i s o l a t e d  the 8 -c t -h y d ro x y -A 9-THC
m e t a b o l i t e .  W a ll  e t  a l . ( 1 9 7 4 )  d e te c te d  both  o f  th e s e
m e t a b o l i t e s  in  human p lasm a a f t e r  th e  a d m in is tr a t io n  o f  
9r a d i o l a b e l l e d  A -THC. Maynard e t  a l . ( 1 9 7 1 )  u s in g  a dog
l i v e r  m icrosom al p r e p a r a t io n  r e p o r te d  the o c cu rren c e  o f
h y d r o x y la t io n  in  th e  1 ’ and 3 '  p o s i t i o n s  o f  th e  s id e  c h a in  o f  
8A -THC. Widman e t  a l . ( 1 9 7 5 ) ,  u s in g  an i s o l a t e d  p e r fu s e d
9dog lung t o  stu d y  A -THC m e ta b o lism , i s o l a t e d  th e  3 ' -  
h y d ro x y -A 9-THC and 4 1 -h y d r o x y -A 9-THC m e t a b o l i t e s .
9
S e v e r a l  o th e r  s im p le  o x i d a t i o n  p ro d u c ts  o f  A -THC have  
been o b serv ed  w ith  in c u b a te s  o f  m icrosom al p r e p a r a t io n s .
Jones e t  a l . ( 1 9 7 4 )  i s o l a t e d  8 - o x o - A 9-THC (F ig u r e  1 2 )  from
9
a mouse l i v e r  in c u b a te  o f  A -THC.
9effects observed with A ^THC.
F ig u re  1 2 .  8 -o x o - A 9-THC
Gurny_ et  a l . ( 1 9 7 2 )  i d e n t i f i e d  9 , 1 0 -e p o x y h e x a h y d ro -  
ca n n a b in o l in  a monkey l i v e r  in c u b a te  (F ig u r e  1 3 ) .
B e n -Z v i and B u r s te in  ( 1 9 7 4 )  o b ta in e d  a s m a ll  y i e l d  o f
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1 1 -o x o -A  -THC (F ig u r e  1 4 )  in  a r a t  l i v e r  m icrosom al in c u b a te  
Qo f  A -THC. T h is  a ld ehyd e was p o s t u l a t e d  as an in t e r m e d ia t e
9in  th e  m e t a b o l ic  c o n v e r s io n  o f  11 -h y d r o x y -A  -THC t o  th e  
c a r b o x y l i c  a c id  m e t a b o l i t e .
9
F ig u r e  1 3 .  9 , 10 -e p o x y h e x a h y d ro c a n n a b in o l
The e x i s t e n c e  o f  a THC a c id  m e t a b o l i t e  was o r i g i n a l l y
r e p o r te d  by N i ls s o n  e t  a l . ( 1 9 7 3 ) .  T h is  group i n j e c t e d
r a d i o l a b e l l e d  AS-THC i n t o  r a b b i t s  and i d e n t i f i e d  A8 -T H C -1 1 -
o i c  a c id  in  th e  u r in e .  W all e t  a l . ( 1 9 7 4 )  a d m in is te r e d  
9r a d i o l a b e l l e d  A -THC t o  v o lu n t e e r s  and o b se r v e d  t h a t  
9A - T H C - l l - o i c  a c id  (F ig u r e  15 )  was a m ajor m e t a b o l i t e ,  p r e s e n t  
in  th e  p la sm a , u r in e  and f a e c e s .
CHO
Figure 14 . ll-oxo-A9-THC
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c 5h „
F ig u re  1 5 . A ^ - T H C - l l - o i c  a c id
The compounds d e s c r ib e d  above are  c o m p a r a tiv e ly  non­
p o la r  h avin g  o n ly  one p o la r  group more than THC. They 
r e p r e s e n t  o n ly  a sm a ll  p r o p o r t io n  o f  th e  m e t a b o l i t e s  o b se r v e d  
w ith  in  v iv o  s t u d i e s  and a re  form ed as p a rt  o f  th e  i n i t i a l  
m e ta b o lic  p r o c e s s .  O ther more p o l a r  m e t a b o l i t e s  have been
o b se r v e d . For exam ple, a p h a r m a c o lo g ic a l ly  i n a c t i v e  d ih y d ro x y
q
m e t a b o l i t e  was i s o l a t e d  and i d e n t i f i e d  as 8 , l l -d i h y d r o x y -A  -
THC (F ig u r e  16 )  in  a r a t  l i v e r  homogenate by W all e t  a l . ( 1 9 7 1 ) .
W a ll  e t  a l . ( 1 9 7 4 )  d e t e c t e d  t h i s  m e t a b o l i t e  in  human plasm a
q
and fa e c e s  a f t e r  th e  a d m in i s t r a t io n  o f  r a d i o l a b e l l e d  A -THC.
C O O H
c h 2o h
F ig u re  1 6 . 8 , 11 -d ih y d ro x y -A ^ -T H C
An a c i d i c  m e t a b o l i t e  was i s o l a t e d  by B u r s te in  and 
R o s e n fe ld  (1 9 7 1 )  from r a b b i t  u r in e  a f t e r  th e  a d m in is tr a t io n  o f
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r a d i o l a b e l l e d  A9 -THC and i d e n t i f i e d  ; i t  as 2 ! -h y d r o x y ^ A ^ '-T H C -l l -  
o i c  a c id  (F ig u r e  1 7 ) .
A second a c i d i c  m e t a b o l i t e  was r e p o r te d  by B u r s te in  
e t  a l . ( 1 9 7 2 )  in  r a b b i t  u r in e  and i d e n t i f i e d  as 1 1-h y d r o x y -
9
I A - T H C - l l - o i c  a c id .  N o r d q v is t  e t  a l . ( 1 9 7 4 )  a l s o  a d m in is te r e d
9
r a d i o l a b e l l e d  A -THC t o  r a b b i t s  and r e p o r te d  th e  i d e n t i f i c a t i o n
9o f  a d i c a r b o x y l i c  a c id  m e t a b o l i t e  4 ' , 5 f- b i s n o r  A - T H C - 1 1 ,3 ’ -
d i o i c  a c id  (F ig u r e  1 8 ) .  W ith  t h i s  m e t a b o l i t e  two carbon atoms
have been removed from th e  p e n t y l  s i d e  c h a in .
A s i m i l a r  l o s s  o f  s i d e  ch ain  carbon atoms has been
o b serv ed  by M artin  e t  a l . ( 1 9 7 6 ) ,  Guinea p i g s ,  r a b b i t s  and
9m ice were g iv e n  A -THC in t r a v e n o u s ly  and th e  m e t a b o l i t e s  5 '~ n o r -
A9 -TH C-4 1 - o i c  a c i d ,  4 * , 5 1 -b isn o r r -A 9 ^THC-3x - o i c  a c id  and
93 f , 4 '  , 5 } - t r i s n o r - A  - T H C r ^ ' - o i c  a c id  were i s o l a t e d  from l i v e r
and i d e n t i f i e d  w ith  mass s p e c tr o m e tr y .  More p o la r  m e t a b o l i t e s
9p r e s e n t  in  mouse l i v e r  a f t e r  A -THC a d m in is tr a t io n  have been  
i d e n t i f i e d  u s in g  mass sp e c tr o m e tr y  by Harvey and Paton ( 1 9 7 6 ) .
9
These were 3 ' , 8 a -d ih y d r o x y -A  - T H C - l l - o i c  a c i d ,  2 ' , 8 a -d ih y d r o x y -
9 9A - T H C - l l - o i c  a c i d ,  2 ' -h y d r o x y -A  - T H C - l l - o i c  a c i d ,  3 ' - h y d r o x y -
.A9 - T H C - l l - o i c  a c id  and 8 a -h y d r o x y ~ A 9 - T H C - l l - o i e  a c id .
COOH
F ig u re  1 7 .  2 ’ -h y d r o x y ~ A 9 - T H C - l l - o i c  a c id
The m e ta b o lism  o f  CBN has a l s o  been s t u d ie d  and found t o  
resem ble  t h a t  o f  THC, Widman e t  a l . ( 1 9 7 1 )  and W a ll  e t  a l . 
( 1 9 7 1 )  examined th e  t r a n s fo r m a t io n  o f  CBN in  l i v e r  m icrosom al
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C O O H
F igu re  1 8 . 4 ’ , 5 1, -b i s n o r ~ A 9-T H C ~ l l , 3 1- d i o i c  a c id
p r e p a r a t io n s  and found th a t  11-hydroxy-C B N  was th e  m ajor  
m e t a b o l i t e .  W a ll  e t  a l . ( 1 9 7 1 )  a l s o  i d e n t i f i e d  a m e t a b o l i t e  
h y d r o x y la te d  in  th e  2 -  p o s i t i o n  o f  th e  p e n t y l  s i d e  c h a in .
W all e t  a l . ( 1 9 7 4 )  a d m in is te r e d  r a d i o l a b e l l e d  CBN (18mg)  
in t r a v e n o u s ly  t o  v o lu n t e e r s  and found th a t  th e  most 
prom inent s i n g l e  m e t a b o l i t e  in  plasm a was C B N - l l - o i c  a c id  
and th e  m ajor group o f  m e t a b o l i t e s  were p o l a r  and a c i d i c .
Low c o n c e n t r a t io n s  o f ' t h e  11 -hydroxy-C B N  m e t a b o l i t e  were a l s o  
o b serv ed  and a p p ro x im a te ly  8% o f  th e  a d m in is te r e d  dose was 
found in  th e  u r in e  and 35% in  th e  fa e c e s  a f t e r  72 h o u rs . The 
m ajor t r a n s fo r m a t io n  p r o d u c ts  in  th e  f a e c e s  were th e  
m onohydroxylated m e t a b o l i t e s  and C B N - l l - o i c  a c i d .
S e v e r a l  m e t a b o l i t e s  o f  CBN have been found a f t e r  th e
9
a d m in is tr a t io n  o f  A -THC. B e n -Z v i  e t  a l . ( 1 9 7 4 )  found CBN-
l l - o i c  a c id  in  th e  u r in e  a f t e r  th e  a d m in is tr a t io n  o f  
9r a d i o l a b e l l e d  A -THC t o  a rh esu s  monkey. B e n -Z v i  and 
B u r s te in  ( 1 9 7 5 )  i d e n t i f i e d  5" , 4 r ,3 '  , 2 f-q u a d n o r -C B N -l1 - o i c  a c i d ,  
(F ig u r e  1 9 )  a g a in  in  monkey u r in e  a f t e r  t h e  a d m i n i s t r a t i o n
a
o f  A -THC. T h is  may be th e  r e s u l t  o f  an i n i t i a l  c o n v e r s io n  
o f  e i t h e r  A9-THC or m e t a b o l i c a l l y  formed l l - h y d r o x y - A 9-THC 
to  CBN fo l lo w e d  by m etab olism  o f  th e  CBN.
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E vidence f o r  th e  fo r m a tio n  o f  g lu c u r o n id e  c o n ju g a te s  
has been r e p o r te d  by Harvey e t  a l . ( 1 9 7 7 ) .  T h is  group  
i d e n t i f i e d ,  w ith  mass s p e c tr o m e tr y ,  g lu c u r o n id e s  o f  CBN, 
11-hydroxy-CBN  and C B N - l l - o i c  a c id  in  mouse l i v e r  sa m p les .
CBD a l s o  s h a r e s  some s i m i l a r i t y  o f  m etab olism  w ith  th e  
o th e r  c a n n a b in o id s . N i ls s o n  e t  a l . ( 1 9 7 1 )  s t u d ie d  th e  
co n v e r s io n  o f  CBD by r a t  l i v e r  microsom es and i d e n t i f i e d  
11-hydroxy-C BD .
W a ll  e t  a l . ( 1 9 7 4 )  a d m in is te r e d  r a d i o l a b e l l e d  CBD 
(20mg) in t r a v e n o u s ly  t o  v o lu n t e e r s  and found 11-h ydroxy-C B D  
and C B D - l l - o i c  a c id  in  p lasm a and u r in e .  A s u b s t a n t i a l  
q u a n t i t y  o f  unchanged CBD was found in  th e  f a e c e s .
G lu c u ro n ic  a c id  c o n ju g a te s  o f  CBD and 11-h ydroxy-C B D  
have been i d e n t i f i e d  by Harvey e t  a l . ( 1 9 7 7 )  in  mouse l i v e r  
sam ples a f t e r  th e  a d m in is tr a t io n  o f  CBD.
The m etab olism  o f  th e  t h r e e  m ajor c a n n a b in o id s  has now 
been s u b s t a n t i a l l y  e l u c i d a t e d ,  but the  r e l a t i v e  p r o p o r t io n s  
o f  t h e s e  p ro d u c ts  p r e s e n t  in  body f l u i d s  has not y e t  been  
d eterm ined f u l l y .  The developm ent o f  methods w ith  s u f f i c i e n t  
s e n s i t i v i t y  and s p e c i f i c i t y  t o  p erm it the  q u a n t i t a t i o n  o f  th e  
low c o n c e n tr a t io n s  o f  t h e s e  m e t a b o l i t e s  p r e s e n t  in  body f l u i d s
Figure 19. 5 ',.4 ’,3 ' -quadnor-CBN-11 -oic acid
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should eventually proyide further information concerning 
cannabinoid metabolic pathways.
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(F) CANNABINOID DETECTION AND QUANTIFICATION IN BODY FLUIDS
Attempts to devise methods for the detection of 
cannabinoids in plasma and urine have been complicated by the 
fact that the ingestion of sufficient quantities of cannabis 
to produce its {pharmacological effects result in only low 
levels of cannabinoids and their metabolites in body fluids.
This factor requires that not only should a method have the 
sensitivity to detect these concentrations, but should also 
have the specificity to avoid interference from endogenous 
compounds present in plasma and urine. Initial efforts to 
develop such a method were based upon thin-layer chromatography 
(TLC) with Fast Blue B as a visualising agent with some 
specificity of reaction towards cannabinoids.
The first report of the detection of a cannabinoid in
body fluids was made by da Silva (1967) who used a TLC method which
was claimed to be capable of detecting cannabinol in the
blood, urine and saliva from subjects intoxicated with cannabis.
Cannabinoids have been detected in saliva from cannabis smokers
with TLC by Just et al. (1972) and Hackel (1972) but no
subsequent workers have confirmed the results obtained by
da Silva with plasma and urine. Christiansen and Rafaelson
(1969) described a TLC method for the detection of cannabinoids
in urine. The urine,'obtained from subjects after they had
ingested cannabis resin, was hydrolysed with 3-Glucuronidase.
Several Fast Blue B positive compounds were observed,, one
component having the characteristics of cannabidiol. Kanter
et al. (1971) also examined the urine of subjects who received 
aA -THC by this method, but failed to obtain a positive reaction. 
Andersen et al. (1971) reported a further method for cannabinoid
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detection. Urine samples, obtained from subjects who had 
taken cannabis resin orally, were extracted with petroleum 
ether and treated with p-toluene sulphonic acid to dehydrate 
any mono-hydroxylated metabolites to CBN. CBN was then 
identified by TLC. Urine analysed by this method showed the 
presence of CBN for 6 hours after ingestion of cannabis resin. 
Salaschek et al. (1973) reviewed these TLC methods for
cannabinoid detection. Fifty samples of human urine obtained 
after ingestion of cannabis resin were compared with twenty 
two control samples. Positive results were obtained with 
only four of the urine samples and with these there was still 
a possibility of misinterpretation. It was concluded that 
reliable, routine detection of cannabis ingestion was not 
provided with the existing TLC methods.
Another TLC method for the detection of THC in blood 
has been described recently by Vinson et al. (1977). Blood 
was extracted, treated with 2-p-chlorosulfophenyl-3-phenylindone 
(DIS-C1) and the reaction product investigated by TLC. The 
derivatised THC was visualised with an alkoxide spray which 
produced a, fluorescent spot visible under ultraviolet light.
The method was claimed to be sensitive to 0.2ng/ml of THC in 
a 5ml serum sample.
TLC has advantages in the speed and low cost of analysis, 
but early methods were not successful, and many workers turned 
to other techniques. Several methods based upon gas 
chromatography (GC) employing specific detectors have been 
devised. Garrett and Hunt (1973) described a GC method with
9electron capture detection (ECD) for the analysis of A -THC 
in blood. The method consisted of an initial plasma extraction
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followed by GC-ECD of the fluorinated THC derivative. The
method was claimed to be capable of detecting THC levels of
40-125ng/ml in plasma. Its use was only described for the
quantification of THC in dog plasma and a clean-up stage was not
included in the method. Routine analysis of human plasma using
this procedure would probably involve considerable problems
of interference from the endogenous substances present in plasma.
Fenimore et al. (1973) described a GC-ECD method which
employed a clean-up stage. An internal standard
hexahydrocannabinol was added to the plasma sample which was
then extracted with an organic solvent. The extract was
treated with heptafluorobutyric anhydride and the derivatised
products injected onto a dual oven GC. This was constructed
so that when the derivatised cannabinoids eluted from the first
column they were directed onto a second capillary column
where they were chromatographed with only small quantities of
interfering compounds. The capillary column eluent was
monitored with ECD. The method was claimed to be capable of
9detecting O.lng/ml of A -THC in plasma. The use of this
9procedure for the quantification of A -THC in human plasma after
9a subject had smoked a A -THC-impregnated cigarette was 
described by Fenimore et al. (1976). The method has the 
disadvantage that a suitable dual oven chromatograph would 
have to be constructed before analysis. McCallum (1973) 
described a GC method employing flame photometric detection.
This consisted of extracting a plasma sample with an organic 
solvent and treating this with diethyl phosphorochloridate to
9produce a A -THC phosphate ester. This was then injected onto
and d e r i v a t i v e  fo rm a tio n  w ith  p e n ta f lu o r o b e n z o y l  c h lo r i d e
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a GC equipped with a flame photometric detector. The 
method was claimed to have a limit of sensitivity of 2ng/ml 
and was able to detect both THC and CBN in human plasma.
McCallum et al. (1974 and 1975) described further use of the 
method for cannabinoid quantitation in human plasma.
Agurell et al. (1973) reported another successful GC
9method for A -THC quantification in which a mass spectrometer 
(MS) was employed as a specific detector. A quantity of
9internal standard,di-deuterated A -THC,was added to the plasma 
sample, which was then extracted with an organic solvent.
Many of the endogenous interfering compounds present in the 
extract were removed by chromatography on a Sephadex LH-20 
column. The refined extract was injected onto a GC with a
9mass spectrometer tuned to monitor ions 299 and 314 for A -THC
and 301 and 316 for 1(1 ,2 -^H^THcl The A9-THC plasma
concentration was calculated from the ratio of peak heights
9obtained from the deuterated and non-deuterated A -THC. This 
procedure was suitable for the detection of less than lng/ml
9of A -THC in plasma and was used to measure plasma concentrations
9in subjects who had smoked A -THC.
Several other procedures have been described in which a
mass spectrometer was used as a GC detector. Hosenfeld et al.
9(1974 ) reported a method for A -THC quantification in which a
9deuterated methyl ether of A -THC was used as internal standard
and in which an extraction procedure was used in place of a
chromatographic clean-up stage. An organic solvent extract
of the plasma sample to be assayed was treated with a potassium
9hydroxide solution (0.1M) in order to extract A -THC by way of
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its phenolic properties, The extract, together with an
9 2internal standard A -THC-OC H^, was injected onto a GC in a
solution of N,N,N,-trimethylanilinium hydroxide in methanol.
A9-THC was converted on column to its methyl ether and peak
heights from the mass spectrometer tuned to record ions 328
for A9-THC-OCHg and 331 for A^-THC-OCDg were used to calculate 
9the plasma A -THC concentration. The assay was used to 
9measure A -THC concentrations in the range l-200ng/ml for 
plasma samples obtained from subjects who had previously
9smoked A -THC-impregnated cigarettes.
9A GC method for A -THC quantification in plasma employing 
chemical.ionisation-mass spectrometry (CI-MS) was described 
by Detrich and Foltz (1976). The use of chemical ionisation 
in place of electron impact mass spectrometry resulted in a 
reduction of background interference from endogenous material 
present in plasma and allowed the use of a simple extraction
9procedure prior to chromatography. Deuterated A -THC was used 
as the internal standard, and both the deuterated and non-
9deuterated A -THC were chromatographed as TMS derivatives.
9The method was claimed to be sensitive to 0.5ng/ml of A -THC 
and was used with spiked plasma samples.
9GC-MS has also been used for the quantification of A -THC 
metabolites in biological fluids. Rosenfeld and Taguchi (1976)
9reported a modification of their GC-MS method for A -THC 
quantitation which could be used for the measurement of
911-hydroxy-A -THC. The procedure was, however, only capable 
of measurement down to 3ng/ml and quantitation of the.
9metabolite in human plasma after the administration of A -THC 
was not reported.
Wall et al. (1976) used GC-MS for quantification of
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Q 9A -THC, CBN and ll-hydroxy^-A -THC in human plasma samples 
obtained after the intravenous administration of 4-5 mg of 
A^-THC. The method employed a Sephadex LH-20 column for the 
removal of interfering plasma constituents prior to GC-MS. 
Deuterated cannabinoids were used as internal standards.
The method was able to measure down to 0.2ng/ml and levels of 
these cannabinoids were determined in plasma over the 24 hour
9period after A -THC administration,
Nordqvist et al. (1976) modified the GC-MS method 
described by Agurell et al. (1973) for the analysis of 
A9-THC-ll-oic acid in plasma and urine. The metabolite was 
chromatographed as its methyl ester and TMS derivative. The 
sensitivity of the method was claimed to be in the range of 
a few ng/ml but the quantitation of the metabolite in human 
body fluids was not described.
The methods described above all utilise a chromatographic 
separation prior to detection. A further form of detection 
involving the immune reaction, radioimmunoassay (RIA) has 
sufficient specificity to allow it to be used as the basis 
of a non-chromatographic assay. Several RTA procedures have 
been developed for the detection of cannabinoids in body 
fluids. Teale et al. (1974a , 1974b , 1974° and 1975) described
the production of an antiserum which would cross-react with 
9A -THC and the use of this for cannabinofd detection in body
9fluids. The assay could measure quantities of A -THC as small 
as 50pg and levels of cross-reaction of Ing/ml in urine and 
7.5ng/ml in plasma. The assay was used to measure cross­
reaction in plasma and urine samples obtained from subjects 
after they had smoked cigarettes impregnated with 5mg of
9A -THC. Levels of cross-reaction were between 0~70ng/ml for
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the urine and plasma samples obtained from four subjects.
9Antibodies to A -THC conjugated to bovine serum albumin via
the phenolic group were raised in sheep. The specificity of
the antiserum was investigated and twenty four non-cannabinoid
drugs were found to give no cross-reaction, suggesting that
the assay was specific for cannabinoid compounds. As weil 
9as ' A -THC the antiserum was found to cross-react with other
9cannabinoids and A -THC metabolites. Marks et al. (1975) 
reported results which were obtained after the application of 
this assay to the analysis of urine obtained from hospital 
patients suspected of taking drugs. Several of the urine 
samples examined were found to contain cannabinoid material and 
gave levels of cross-reaction >100ng/ml. The high levels of 
cross-reaction which have been found in urine suggests that 
the assay is measuring cannabinoid metabolites rather than
9A -THC which has never been detected in urine.
Grant et al. (1972) and Gross et al. (1974) also described
the use of an RIA procedure for cannabinoid detection. The anti-
9serum was raised in rabbits after the administration of a A -THC- 
azobenzoyl-keyhole limpet haemocyanin conjugate. The assay 
was used to measure levels of cross-reaction in plasma samples 
obtained from chronic users of cannabis and these were found 
to give levels of cross-reaction between 200-250ng/ml. The 
sensitivity of the method was limited to 25-50ng/ml which was 
sufficient to confirm the presence of cannabinoid material in 
all but weakly positive samples. Gross and Soares (1976) also
9described the use of RIA procedures specific for A -THC and 
9the A -THC-ll-oic acid metabolite and the measurement of 
concentrations of these metabolites in human plasma and urine
9samples. The A -THC plasma concentrations obtained with 
the RIA were compared with results obtained for the same
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two sets of results were found to give good agreement. The 
9A -THC-ll-oic acid RTA gave results which were higher than
would be expected for concentrations of this metabolite in
body fluids, suggesting that this assay may not be totally
specific for the one metabolite.
Chase et al. (1976) described a cannabinoid RIA
procedure for which antisera were raised in rabbits after
9the administration of A -THC conjugated by its phenolic 
hydroxyl group to bovine serum albumin. The assay was used 
to measure levels of cross-reaction in human urine samples
9obtained after the oral administration of A -THC and cannabis 
extracts.
Cook et al. (1976) described a RIA procedure in which
9antisera were raised after A -THC,bound to bovine serum albumin 
by the pentyl side'chain of THC,was intravenously administered 
to rabbits. The use of this type of conjugate for raising 
antibodies was designed to provide antiserum specific for 
THC measurement. The assay was used with plasma samples 
spiked with 5-100ng/ml of A9-THC.
A free radical immunoassay has been described for 
cannabinoid measurement by Cais et al. (1975). Antiserum was
9raised in rabbits by administering a A -THC-bovine serum
9albumin or ovalbumin conjugate. A -THC was conjugated with
the protein at several points of the molecule in order to
provide antisera of varying specificities. Spin labelled
9antigen was synthesised by coupling A -THC to 3-amino-2,2,5,5 
tetramethyl pyrrolidine-l-oxyl. The proportion of unbound
9spin labelled A -THC in the immunoassay and equilibrium 
mixture was measured using electron spin resonance. The assay
9sam ples u s in g  a GC-MS method f o r  A -THC q u a n tif ic a tio n  and th e
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was capable of -detecting cross-reacting compounds in urine 
from 5-72 hours after subjects had smoked quantities of 
cannabis resin.
The methods described in this section do not provide 
a complete answer to the problem of the detection and quantifica 
tion of cannabinoids in body fluids. The chromatographic 
methods are at present capable of detecting only a few 
cannabinoids and are time consuming. RIA does not provide 
information concerning the concentration of the individual 
cannabinoids in body fluids. This thesis will describe some 
further contributions to the problem of detecting cannabinoids 
in plasma and urine.
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SECTION 2 
PLASMA ANALYSIS
(A) RADIOIMMUNOASSAY (RIA)
RIA is a technique well suited to the detection of 
cannabinoids in body fluids. It has sufficient sensitivity 
for the measurement of the low concentrations of cannabinoids 
present in body fluids and the specific nature of the imraune- 
reaction involved in the assay avoids interference from 
endogenous compounds present in body fluids.
Some of the advantages of this technique compared with 
the chromatographic methods for cannabinoid analysis described 
in the previous section are; only a small sample volume is 
required, minimal sample preparation is needed, analysis 
time is usually short, and many samples may be analysed at 
the same time. RIA does have the disadvantage that whereas 
the chromatographic methods usually provide measurement of a 
specific cannabinoid, RIA may give a result which represents 
the sum of contributions from several cross-reacting 
cannabinoids or their metabolites.
RIA represents one of the more viable methods for
cannabinoid analysis and as part of an investigation into
methods for cannabinoid detection in body fluids, antiserum
was obtained for the assay procedure described by Teale et al.
(1974), and this method was then evaluated. The objectives
of this evaluation of RIA for the analysis of cannabinoids
in plasma were: (a) obtaining an indication of the levels of
cross-reaction in human plasma after the administration of
ga known quantity of A -THC (b) determining how well the 
assay would distinguish between positive and negative samples 
and (c) obtaining a measure of the specificity of the assay
INTRODUCTION
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with both cannabinoid and non-cannabinoid compounds.
EXPERIMENTAL
Materials and Equipment
Antiserum (133Y/22/5) for the assay was obtained from
Dr J D Teale, Department of Biochemistry, University of 
9Surrey and A -THC and other cannabinoid compounds were
generously provided by the National Institute on Drug Abuse,
9 3Rockville, USA, A -(G- H)«-tetrahydrocannabinol was purchased 
from the Radiochemical Centre, Amersham, Bucks, polyvinyl­
pyrrolidone-40 and charcoal (Norit A) from Sigma Chemicals 
Ltd., Dextran T70 from Pharmacia, and methanol (Analar) 
and all other chemicals and solvents were obtained from BDH 
Chemicals Ltd. An Intertechnique SL30 was used for liquid 
scintillation counting.
Method
The RIA method was based upon that described by Teale
et al. (1975), but was modified by the replacement of the THC
solubilising agent Triton X-405 with methanol and with the
replacement of bovine Y-globulin in the assay buffer with
polyvinylpyrrolidone-40. Antiserum (133Y/22/5) was stored
as aliquots in buffer (0.1M phosphate buffer pH 7.5 containing
0.2% polyvinylpyrrolidone-40) at -20°C and diluted to 1:300 
9before use. A -THC solutions used to calibrate the assay were 
made up in aqueous methanol (50% v/v, pH 7.5) at concentrations 
ranging from 500pg/ml to 50ng/ml and stored at -20°C. A9-(^H)- 
THC was also stored at -20°C at a concentration of 0.25pCi7ml 
(12Ci/mmol) in aqueous methanol (50% v/v, pH 7.5) ready for use.
The plasma sample to be assayed was mixed with three 
volumes of methanol, vortexed and allowed to stand for 30
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minutes. It was then centrifuged and the supernatant added
directly to the assay tubes. Normal human plasma similarly
treated was used in the total, non-specific binding and
zero tubes and for assay dilutions. Using the protocol in
Table 1, reagents were added to a series of assay tubes
(duplicated); the antiserum was added last. These were then
allowed to stand at room temperature for 1 hour. Dextran-
coated charcoal (Teale et al. 1975, pH 9.5) was added, the
tubes were centrifuged after 2 minutes contact time and
500yl of the supernatant from each tube was counted. The
results obtained from serial dilutions of a sample were 
averaged to obtain a mean value.
9Plasma samples taken after A -THC were obtained from 
three volunteers who smoked tobacco cigarettes impregnated 
with lOmg (subject 1 and 2) and 8mg (subject 3) of A9-THC
TABLE 1 
RADIOIMMUNOASSAY PROTOCOL
Reagent Yolume (y l)
/
Total counts Non-specific Zero Standard Sanple
tube binding tube tube tube tube
^ U IC  (50% MeCH) 50 50 50 50 50
THC standard (50% MeOH) - - - 100 -
50% MeCH 100 100 100 - 100
Plasma sanple extract - - - - 100
Normal plasma extract 100 100 100 100 -
Diluent buffer 250 350 250 250 250
Antiserum 100 - 100 100 100
Incubated fo r 1 hour at room tenperature
Diluent bu ffe r 200 —
Dextran-coated charcoal
(2.5%) - 200 200 200 200
Centrifuged and 500yl of supem itan t count ed
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over a 10 minute period. Blood samples (10ml) were taken 
at timed intervals after the subjects had finished smoking. 
Blank plasma samples were also obtained from twelve volunteers 
with no history of cannabis use.
Anticoagulant (K^EDTA, lOmg) was added to the blood 
which was centrifuged to separate the plasma. This was 
stored at -20°C until analysis.
The cross-reactivity of the cannabinoids were assessed 
by determining the quantity required to give a 50% depression
9of binding of the radiolabelled A -THC with the normal assay 
conditions. The measurement was made by assaying each 
cannabinoid over a range of concentrations.
The non-cannabinoid drugs were assessed for any cross­
reactivity by assaying each compound using the normal RIA 
conditions.
RESULTS AND DISCUSSION
The assay methodology was similar to that described 
by Teale et al. (1975), except that methanol replaced 
Triton X-405 as the THC solubilising agent. This modification 
increased the solubility of THC and reduced non-specific 
binding in the assay, A reduction of blank levels was 
obtained with normal plasma samples together with improved 
assay sensitivity.
Blank plasma levels for the twelve samples examined all 
gave a level of cross-reaction less than 2ng/ml (Table 2).
The l e v e l s  o f  c r o s s - r e a c t i o n  in  p lasm a sam ples o b ta in e d
from th e  th r e e  s u b j e c t s  who smoked THC im pregnated  c i g a r e t t e s
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TABLE 2
LEVELS OF RIA CROSS-REACTION OBTAINED 
WITH BLANK PLASMA SAMPLES
Sample
number
Cross-reaction for 
25yl of plasma (ng/ml)
1 0
2 0
3 0
4 1.4
5 0
6 1.6
7 0
8 0
9 0
10 1.2
11 1.4
12 0
9are given in Table 3. The samples taken after A -THC gave 
levels of cross-reaction between 5 and 67ng/mT. These were 
significantly greater than the results obtained with blank 
plasma samples.
Subject 1 was a regular user of cannabis and the 
control sample contained cross-reacting material. This was 
probably due to the consumption of cannabinoid material at 
some time before the experiment. Subject 3 was not a cannabis 
user and his control sample contained no indication of cross­
reacting material. Levels of cross-reaction were highest for 
those samples obtained immediately after smoking while values 
obtained for subsequent samples fell to a constant level for 
the remainder of the two hour experiment. The absence of a 
continuing decline of plasma cross-reacting cannabinoids over
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TABLE 3
THE PLASMA CONCENTRATION OF A -THC IN VOLUNTEERS WHO HAD SMOKED 
A9-THC DETERMINED BY RADIOIMMUNOASSAY, HIGH PRESSURE LIQUID 
CHROMATOGRAPHY AND GAS CHROMATOGRAPHY - MASS SPECTROMETRY
Subject
Tine after 
smoking 
(min)
Plasma concentration of A9-THC (ng/ml)
Direct RIAa RIA after separation by HPLC G C - M S
1 Control 23b 0 0
2 67 47 55
12 48 15 18
24 47 7 9
34 48 5 8
64 47 3 5
126 | 48 1 2
1 2 Control0 NDb ND ND
3 63 45 58
13 44 20 30
24 53 9 16
34 47 6 9
64 58 4 5
124 50 2 1
3 Control 0 0 0
2 37 26 26
22 7 4 3
31 5 1.1 ND
60 9 0.9 ND
120 6 0.8 ND
a These values include a contribution from THC metabolites
b Subjects 1 and 2 were both cannabis users and cannabinoid
material may have been present in the plasma before the 
experiment
c A control sample was taken for subject 2 but this was lost
during centrifugation
ND Not determined
the course of the experiment could not be fully explained 
without a greater understanding of the changes of plasma 
cannabinoid concentrations.
Teale etal. (1975) investigated antiserum specificity
42
and found no cross-reaction with twenty four non-cannabinoid 
drugs. Forty three non-cannabinoid drugs chosen as 
representative of a wide range of drugs were examined in this 
study (Table 4) at a concentration equivalent to 400yg/ml 
plasma and again no cross-reaction was observed with any of 
the compounds. Antiserum specificity to cannabinoid 
compounds using the modified RIA procedure was examined 
(Table 5). Results were similar to those obtained by Teale 
et al. (1975) in that the antiserum cross-reacted with the 
same avidity to THC as it did to some of the closely related 
THC met abo1i t es.
TABLE 4
MISCELLANEOUS DRUGS TESTED FOR CROSS-REACTIVITY 
IN THE RADIOIMMUNOASSAY
Adrenaline Methaqualone hydrochloride
Amitriptyline hydrochloride Morphine sulphate
Amphetamine sulphate Nicotine hydrogen tartrate
Ascorbic acid Nitrazepam
Aspirin Oestradiol
Barbitone Papaverine hydrochloride
Bromodiphenhydramine Paracetamol
hydrochloride Pentobarbitone
Caffeine Phenobarbitone
Codeine phosphate Phenmetrazine theoclate
Cocaine hydrochloride Phenylbutazone
Chlordiazepoxide Progesterone
Chlorpromazine hydrochloride Promazine hydrochloride
N,N-Dimethyltryptamine Spironolactone
Diphenhydramine hydrochloride Stilboestrol
Doxepin Sulphadimidine
Ephedrine hydrochloride Sulphamethoxypyridazine
Ergometrine maieate Tetracycline hydrochloride
Ethylenediamine tetraacetic acid Thiopentone sodium
Imipramine Trifluoperazine
Lignocaine Tryptamine hydrochloride
Mescaline sulphate Tyramine hydrochloride
Methadone hydrochloride
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CROSS-REACTIVITY OF A 9-THC METABOLITES AND 
RELATED COMPOUNDS IN THE RADIOIMMUNOASSAY
TABLE 5
Compounds Amount required for 50% depression of binding (ng)
A9-yhc 0.6
a8-ihc 0.6
CBN q 
11-hydroxy-A -THC
0.6
0.6
A9-THC-ll-oic acid 0.6
11-hydroxy-CBN 0.6
CBN-ll-oic acid 0.6
Hexahy dro- CBN 
A9,1~1-THC (Exo-cyclic
0.6
compound) q 0.6
8a - hydroxy-A -1HC 
88 - hydroxy-A -THCq
0,6
3.0
8 a , 11-dihydroxy-Aq-THC 
8 8 ,11- dihydroxy-A -1HC
2.0
9.0
11-oxo-CBN 3.0
1'-hydroxy-CBN 10.0
5’-hydroxy-A9-lHC 30.0
CBD >50.0
Cannabicyclol >50.0
Cannabichiomene >50.0
Cannabigerol >50.0
i- • - - - . ... ■ -- -.. - - - - - -
The above results demonstrate that the assay is able
to distinguish samples obtained after a moderate dose of 
9A -THC from blank samples and some indication that the assay 
is specific for cannabinoid compounds is provided by the 
absence of reaction with non-cannabinoid drugs. The results 
therefore substantiate the view that the assay provides a 
viable means of detecting the presence of cannabinoid material 
in plasma.
44
(B) HIGH PRESSURE LIUQID CHROM ATOGR AP HY - RAD IOIMMUN OAS S A Y
(HPLC-RIA)
INTRODUCTION
The Assay antiserum was shown in part A of this section
9to cross-react with some of the metabolites of A -THC as
9well as the parent compound. This suggests that A -THC 
metabolites provide some contribution to the level of cross­
reaction given by a plasma sample and this may explain why
the level of cross-reaction in plasma decreases very slowly
9over a two hour period after A -THC smoking ( Table 3).
Because of this slow elimination of cross-reacting 
material,plasma RIA data gives no information concerning the
9time the sample was taken after A -THC smoking unless 
further data concerning the levels of the individual cross­
reacting components are also available. Such information is 
often important in forensic science where a knowledge of 
whether a person was experiencing the effects of a drug may 
be significant. This disadvantage of the RIA technique for 
cannabinoid analysis may however be removed by combining the 
assay with a chromatographic technique such as HPLC so that 
the RIA acts as a selective detector for the liquid 
chromatograph. The individual cross-reacting cannabinoid 
components in a plasma sample may then be separated by HPLC 
and quantified . with the RIA. The identity of each component 
would be indicated by its HPLC retention volume.
The objectives of the work described here are
concerned with obtaining an assessment of the viability of
9an HPLC-RIA method as a means of quantifying A -THC and some 
of its metabolites in plasma.
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EXPERIMENTAL 
Materials and Equipment
A constant flow pump (Waters Assoc. M-6000A) was used 
to deliver a methanol/water eluent to a stainless steel 
HPLC column (10cm length x 4.6mm id) slurry-packed with 
Spherisorb-5-0DS (Phase Separations). Samples were 
introduced onto the HPLC column with a six port injection 
valve (Specac) fitted with a 10ml injection loop. Column 
eluate was either monitored with an ultraviolet detector 
at 280'nfm (Cecil CB212) or collected with a Struers Samplomat 
fraction collector (Camlab). A freeze drier (Chemlab 
Instruments, model SB4) was used to remove solvents.
Method
Plasma (0.2-lml) was mixed with three volumes of 
methanol, vortexed, left to stand for 30 minutes and 
centrifuged. The supernatant was removed, the residue mixed 
with methanol and the sample again centrifuged. Water was 
added to the combined supernatants to give a methanol 
concentration of 50% v/v. The HPLC pump, sample loop and 
column were flushed with aqueous methanol (50% v/v) and the 
sample solution injected onto the ODS column. A stepped 
solvent elution programme was used: 10ml of 50% methanol/50% 
water, 10ml of 62.5% methanol/37.5% water, 20ml of 72.5% 
methanol/27.5% water (lml/min) and eluent fractions were 
taken every 30 seconds. Solutions containing the appropriate 
THC standards and the HPLC fractions were freeze dried. The 
freeze drier was flushed with argon before and after drying 
to prevent atmospheric oxidation of sensitive metabolites.
A solution of A9-(3H)-THC (0.025yCi in 500pl of 30% methanol/ 
70% diluent buffer) was added to each of the dried tubes
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with a solution of antiserum in diluent buffer (lOOpl of 
1:300 antiserum solution). The non-specific binding tubes 
received diluent buffer in place of antiserum solution. 
Subsequent RIA procedure was the same as that described 
above.
Cannabinoid retention volumes were determined using 
the pure compounds by monitoring the eluate with either RIA, 
for cross-reacting compounds, or UV absorption (280nm), for 
non-cross-reacting compounds. UV detection required pg 
quantities compared with the ng quantities used with RIA 
detection.
RESULTS AND DISCUSSION
9The plasma samples taken during the A -THC smoking
experiments and assayed for RIA cross-reactivity as described
in part A of this section, were all examined using the
HPLC-RIA system. Chromatograms representing the elution of
cross-reacting compounds from the HPLC column were constructed
for each plasma sample (figures 20 to 36 ) by plotting the
RIA results obtained for consecutive HPLC eluent fractions
against their retention volumes.
A comparison of cannabinoid retention volumes (Table 6)
with the HPLC-RIA chromatograms for plasma samples obtained
after A9-THC smoking showed the presence of cross-reacting
compounds in the plasma samples with retention volumes
9corresponding to those of A -THC, CBN, mono-hydroxylated
9 a*metabolites (11-hydroxy-A -THC, 8a-hydroxy-A -THC and
11-hydroxy CBN all have the same retention volume) and
di-hydroxylated metabolites (8a,ll-dihydroxy-A9-THC and
986,11-dihydroxy-A -THC have similar retention volumes).
Control plasma samples were found to contain none of
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Retention volume (ml)
Figure 20 The HPLC-RIA chromatogram of a plasma sample from
subject 1 taken 2 minutes after smoking- "A^-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
Retention volume (ml)
Figure 21 The HPLC-RIA chromatogram of a plasma sample from
subject 1 taken 12 minutes after smoking A 9-THC 
(lOmg)' The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and dihydroxylated 
metabolites are marked.
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reaction 
(n g /m l)
Retention volume (ml)
Figure 22 The HPLC-RIA chromatogram of a plasma sample from 
subject 1 taken 24 minutes after smoking A 9-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
C ross-  
reaction 
(ng /m l)
Retention volume (ml)
Figure- 23 The HPLC-RIA chromatogram of a plasma sample from 
subject 1 taken 34 minutes after smoking A 9-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
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Retention volume (ml)
Figure 24 The HPLC-RIA chromatogram of a plasma sample from
subject 1 taken 64 minutes after smoking A^-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
Cross -
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The HPLC-RIA chromatogram of a plasma sample from 
subject 1 taken 126 minutes after smoking A9-THC 
(lOmg). The retention volumes of THC. CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
50
Retention volume (ml)
Figure 26 The HPLC-RIA chromatogram of a plasma sample from
snbject 2 taken 3 minutes after smoking A9-THG 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
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Figure 27 The HPLC-RIA chromatogram of a plasma sample from
subject 2 taken 13 minutes after smoking A9-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
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Retention volume (ml)
Figure 28 The HPLC-RIA chromatogram of a plasma sample from
subject 2 taken 24 minutes after smoking A^-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
Retention volume (ml)
Figure 29 The HPLC-RIA chromatogram of a plasma sample from
subject 2 taken 34 minutes after smoking A^-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
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Figure 30 The HPLC-RIA chromatogram of a plasma sample from
subject 2 taken 64 minutes after smoking A9-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
Retention volume (m l)
Figure 31 The HPLC-RIA chromatogram of a plasma sample from
subject 2 taken 124 minutes after smoking A9-THC 
(lOmg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
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The HPLC-RIA-chromatogram of a plasma sample from 
subject 3 taken 2 minutes after smoking A9-THC 
(8mg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are mairked.
THC
/
d i-
hydroxylated
m etabolites
A n .t
1 0 2 0
CBN
m ono- A 
hydroxylated 1 \ 
m etabolites I i
. . . . . t .y v . i . j
30
Retention volume (m l)
Figure 33 The HPLC-RIA chromatogram of a plasma sample from
subject 3 taken 22 minutes after smoking A9-THC 
(8mg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
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Figure 34 The HPLC-RIA chromatogram of a plasma sample from
subject 3 taken 31 minutes after smoking A^-THC 
(8mg). The retention volumes of THC, CBN, the 
' mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
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F igu re  35
Retention volume (m l)
The HPLC-RIA chromatogram-of a plasma sample from 
subject 3 taken 60 minutes after smoking A^-THC 
(8mg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
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Figure 36 The HPLC-RIA chromatogram of a plasma sample from
subject 3 taken 120 minutes after smoking A9-THC 
(8mg). The retention volumes of THC, CBN, the 
mono-hydroxylated metabolites and di-hydroxylated 
metabolites are marked.
TABLE 6
CANNABINOID HPLC RETENTION VOLUMES
Oonpounds Retention volume (ml)a
A9-THC 
A -THC
31.5
31.0
CBN
11-hydroxy-A -TEC
30.0
25.5
A9-'IHC-ll-oic acid 10.0
11-hydroxy-CBN 25.5
CBNFll-oic acid 
8a-hydroxy-A -THC
10.0
25.5
83~hydroxy~A9~THCp 20.5
8a,ll-dihydroxy-Ap~THC 17.0
83,11-dihydroxy-A -THC 16.5
11-oxo-CBN 29. Of !
11 -hydroxy-CEN 22.5
a For the system described in the text
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these cannabinoids. In d iv id u a l components were
q u a n tif ie d  by summing the data p o in ts  fo r  each area o f
c r o s s -r e a c t io n  ( in  the chromatograms Figures 2 0 -3 6 )  and
r e la t in g  th e se  to  the o r i g i n a l  volume o f  plasma used.
The con cen tra tion  o f  a c r o s s -r e a c t in g  component w ith
9
re te n tio n  volume eq u iv a le n t to  A -THC was determined by 
t h i s  method fo r  each plasma sample (Table 3) and p lo t t e d
9
again st the time the sample was taken to  o b ta in  a A -THC 
e lim in a tio n  curve fo r  each su b je ct  ( f ig u r e s  3 7 , 38 and 3 9 ) 
These in d ic a te d  a b iph asic  e lim in a tio n  curve fo r  t h i s  
compound with the th ree  s u b je c t s .  The r e s u l t s  fo r  s u b je c ts
1 and 2 , th e  re g u la r  u sers  o f  cannabis who each smoked lOmgs
9 9o f  A -T H C ,in d ica ted  an i n i t i a l  A -THC plasma con cen tra tion
Time (min)
Figure 37 The e lim in a tio n  from plasma o f  cannabinoids w ith  
re te n tio n  volumes equ ivalen t to  A9-THC ( □ —□ ) ,
CBN (A — A) and mono-hydroxylated m e ta b o lite s  (O— O) 
fo r  su b je c t  1 .
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Time (min)
Figure 38 The elimination from plasma of cannabinoids with 
retention volumes equivalent to A9-THC (□— □),
CBN (A— a ) and mono-hydroxylated metabolites (O— O) 
for subject 2.
of approximately 50ng/ml descreasing rapidly during the
first 30min (the distribution phase) to approximately
5ng/ml. Results for subsequent samples indicated a slower
9rafe of decrease of the A -THC concentration (the elimination
phase) falling to 1 or 2 ng/ml at the conclusion of the
experiment two hours after smoking. The results for subject
93, the non-cannabis user who smoked 8mg of A -THC indicated
9a similar elimination pattern but lower A -THC plasma
9concentrations. The initial A -THC concentration was found 
to be 37ng/ml decreasing to less than lng/ml at the end of 
the two hour smoking experiment. These results are consistent
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Tim e (min)
Figure 39 The elimination from plasma of cannabinoids with 
retention volumes equivalent to A9-THC (□— a),
CBN (A— A) and mono-hydroxylated metabolites (O— O) 
for subject 3.
9with the A -THC plasma concentrations measured after the
9administration of A -THC to human subjects by Agurell et al.
(1973) and Wall et al. (1976).
Plasma concentrations of the cross-reacting compound
with retention volume equivalent to CBN were also found
to follow a biphasic elimination pattern for the three
subjects (Figures 37, 38 and 39). The levels for samples
9taken immediately after smoking A -THC were between 5 and 9ng/ml 
(Table 7) falling to concentrations well below lng/ral two 
hours later. CBN has been reported present in plasma samples
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TABLE 7
THE PLASMA CONCENTRATIONS OF CROSS-REACTING CANNABINOIDS OTHER 
THAN A9-THC IN VOLUNTEERS WHO HAD SMOKED A9-THC- DETERMINED BY 
HIGH PRESSURE LIQUID CHROMATOGRAPHY - RADIOIMMUNOASSAY
Subject
.Time after 
smoking 
(mins)
Plasma concentration as determined by 
radioiimiunoassay and expressed as ng/ml of 
cross-reacting cannabinoid
Peak elution at the 
position of 
mono-hydroxylated 
metabolites
Peak elution at the 
position of 
CBN
1 Control 0 0
2 0.6 9.0
12 1,2 2.1
24 0.6 1.4
34 0.5 0.5
64 0,2 0.2
126 0.1 0.1
2 ’ 3 1.0 5.0
13 1.0 2.5
24 1.4 1.7
34 0.5 0.7
64 0.3 0.2
124 0.4 0.1
3 Control 0 0
2 0.3 9.0
22 0.3 1.2
31 0.1 0.4
60 0.1 0.3
120 0.1 0.2
9after A -THC administration by McCallum et al, (1975) who
suggested that CBN was a metabolic product of A9-THC. However
Wall et al. (1976) found almost no CBN in plasma after the
9intravenous administration df A -THC to human subjects and
9concluded that CBN was not a A -THC metabolite. Because the 
elimination mode of the compound with the retention volume 
equivalent to CBN was biphasic, these results suggest that a 
metabolic explanation for the presence of CBN in the samples 
is unlikely.
One of the other areas of cross-reaction observed with
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metabolites 11-hydroxy-A9-THC, 8a~hydroxy-A9-THC and 11-hydroxy-
CBN all have this retention volume with the HPLC system used and it
is possible that the observed level of cross-reaction may
represent a contribution from any of these metabolites. Levels
of cross-reaction at this retention volume reached a maximum 
« 9shortly after A -THC smoking for the three subjects, falling
slowly over the remainder of the experiment (Figures 37, 38
and 39). The concentrations and elimination curves for this
9area of cross-reaction are similar to those of 11-hydroxy-A - 
THC measured by Wall et al. (1976) in plasma samples obtained
9from subjects receiving intravenously administered A -THC.
An area of cross-reaction at the retention volumes
corresponding to the di-hydroxylated metabolites 83,11-
9 9dihydroxy- A -THC and 8a,11-dihydroxy A -THC was also observed
with the HPLC-RIA data (Figures 20 to 36). These metabolites
were not well resolved with the chromatographic system used
(Table 6) and do not cross-react in the RIA to the same
9extent as each other or to A -THC (Table 5). Quantitative 
results for these compounds were not therefore, obtained 
from the HPLC-RIA data.
A further feature of the HPLC-RIA data was the presence 
of an area of cross-reaction eluting from the HPLC column 
at a retention volume of 10ml (Figures 20 to 36). This 
corresponds to the retention volume of metabolite conjugates
9observed in human urine samples obtained after A -THC 
administration as well as to the mono-carboxylated metabolites 
A9-THC-ll-oic acid and CBN-ll-oic acid (Table 6). This
th e  HPLC-RIA d a ta  had a r e t e n t i o n  volume o f  2 5 .5 m l .  The
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cross-reacting metabolite conjugates and the mano-
carboxylated metabolites. The contribution of this area of
cross-reaction to the total RIA result increased as the THC
concentration decreased so that the total RIA result
remained approximately constant for the two hour period after
THC administration (Table 3). The absolute identification
of the structure of cross-reacting compounds would require
the isolation of sufficient quantities of material to obtain
mass spectral data.
HPLC-RIA has been found to provide a convenient method
for separating, presumptively identifying and quantifying
THC and some of its metabolites in plasma. It has the
advantage over the previously reported methods of using a
small volume of sample to simultaneously quantify THC and some
of its metabolites. The provision of this additional data
has the advantage that they may be used to justify a greater
confidence in the validity of a result than RIA alone.
Some additional conclusions may also be made from a knowledge 
9of the A -THC plasma concentration. The psychoactive 
9effects of A -THC usually continue for several hours after
taking the drug (Wootton Committee,1968) while the plasma
concentration has been found to decrease rapidly to a level
of the order of. one ng/ml several hours after smoking. The
9presence of ng/ml concentrations of A -THC in a plasma
9sample would therefore suggest that A -THC had been taken 
within a period of a few hours before the sample was taken 
and this could help to substantiate other evidence suggesting 
cannabis intoxication.
are a  o f  c r o s s  r e a c t i o n  may t h e r e f o r e  r e p r e s e n t  a m ix tu re  o f
(C) HIGH PRESSURE LIQUID CHROMATOGRAPHY — GAS CHROMATOGRAPHY -
MASS SPECTROMETRY (HPLC-GC-MS)
INTRODUCTION
The GC-MS technique has been one of the more successful
methods for cannabinoid analysis in plasma. Its application
9to the quantification of A-THC in plasma was first described
by Agurell et al. (1973), The method consisted of adding 
9deuterated A-THC as internal standard to a plasma sample, 
extracting this, removing interfering material from the 
extract with column chromatography and analysing the refined 
extract with GC-MS. The mass spectrometer was used as a 
sensitive and selective detector by tuning the instrument
to record the intensities of two of the electron impact
9 9fragmentation ions of both A -THC and the deuterated A -THC.
The method was capable of measuring ng/ml concentrations of 
9A -THC in plasma.
9The measurement of A ~THC in plasma is one of the more 
important aspects of cannabinoid analysis and a method 
modified in the isolation stage by the replacement of liquid 
chromatography with HPLC was investigated using the plasma 
samples described previously. The results obtained with
9this method for a -THC measurement were then compared
with those obtained using the HPLC-RIA method.
EXPERIMENTAL
Materials and Equipment
HPLC equipment was the same as that described in
part B of this section. GC-MS was conducted using a Pye 104
GC equipped with an 0V17 column (Gas Chrom Q, 80-100 mesh)
interfaced to a VG Micromass 16E Mass Spectrometer. The
2 9internal standard (5'- H^)-a -THC was kindly supplied by 
Dr S Agurell, Stockholm.
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The GC-MS method used was similar to that described 
by Agurell et al. (1973). (5*-2H3)-A9-THC (lOng) in methanol
was added to the plasma sample (1ml) and the mixture extracted 
with methanol as described previously. The plasma extract 
was chromatographed using a 10cm ODS column(4.6mm id) and 
67.5% methanol/32.5% water eluent. The A9-THC fraction 
(retention volume approximately 20ml) was collected, freeze 
dried and the residue dissolved in hexane. This was gas 
chromatographed with a mass spectrometer in the MID mode
\ tuned to ions of m/e 299 and 314 for A^-THC and 302 and
q q317 for deuterated A -THC, The A -THC retention time was 
4 minutes with a helium flow of 20ml/min at 190°. The
9A -THC plasma concentration was calculated from the ratio
9 9of ion intensities for A -THC and deuterated A -THC using
a previously prepared calibration graph.
RESULTS AND DISCUSSION
9The A -THC concentrations obtained by this method 
(Table 3) were found to be similar to, but consistently 
higher than those obtained by the HPLC-RIA method. The 
results from both methods showed similar biphasic elimination 
curves. The accuracy of the GC-MS method which incorporates 
an internal standard would be expected to be greater than 
that of the HPLC-RIA method in which no account of possible 
losses was made. The discrepancy between results could not 
however be fully explained by losses occurring during the 
plasma extraction and chromatography stages of the HPLC-RIA 
procedure which were found to be approximately 10%. The 
HPLC-RIA results for subjects 1 and 2 were obtained 
approximately six months after the GC-MS analyses were
Method
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performed. It is possible that decomposition of the
9 ^ ___^  _   . •A -THC had occurred during this period.*
The GC-MS method was found to be a viable method
9for the measurement of A -THC concentrations in plasma.
Its accuracy was probably greater than that obtained using 
HPLC-RIA, The method did have the disadvantages relative 
to HPLC-RIA that the analysis time was longer and that 
measurement of the concentration of only one cannabinoid 
component in a plasma sample was obtained.
t
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An ideal analytical method for cannabinoid detection in 
plasma,suitable for use in a forensic science laboratory 
would have the following features
(a) a low operational cost,
(b) a short analysis time,
(c) provide quantitative results preferably for 
several of the cannabinoid components,
(d) require a small sample volume,
(e) provide an unequivocal result.
The methods described in section 1 are able to satisfy 
some but not all of these conditions.
The thin-layer chromatography method described by 
Vinson et al. (1976) provides a qualitative result for one 
cannabinoid (THC) at low cost with moderate analysis time 
but uses a relatively large sample volume (5ml), This method 
does have the serious limitation that non-cannabinoid 
material present in plasma may be labelled with the fluorescent
9reagent as well as A -THC and this might lead to an erroneous 
result.
The GC methods employing electron capture or flame 
photometric detection provide a quantitative result for THC 
and sometimes CBN at moderate cost with a moderate analysis 
time using different sample volumes (l-10ml). The major 
limitation of these methods again results from the possibility 
of error due to the presence of interfering material in 
plasma.
Most of the GC methods employing a mass spectrometer 
as detector provide results which are derived from both the
(D) CONCLUSION
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A -THC chromatographic retention time and the ratio of intensities 
9of two A -THC EI fragmentation ions. These methods therefore 
give a higher specificity of detection that the other 
chromatographic procedures and also provide an accurate 
quantitative result. They are however costly, time consuming 
and require a relatively large plasma sample volume (5ml).
The RIA procedure involves moderate cost, relatively 
short analysis time, especially where a large number of samples 
are to be analysed and requires a small sample volume. The 
method does not however provide a totally unequivocal result 
since thi£ is derived from the measurement of only one 
parameter, ie the proportion of radioactive label bound to 
the antiserum. The result could be affected by simple error, 
or the presence in a sample of an unknown non-cannabinoid 
compound capable of influencing antiserum binding.
In order to obtain a high degree of confidence in the 
validity of a result with the methods described above, a sample 
would have to be assayed either by using two of the 
described methods for the analysis or by using a single 
method capable of quantifying at least two of the cannabinoids 
present in plasma after cannabis smoking. The'former 
alternative though quite feasible has the disadvantage that 
the total analysis time required for two different procedures 
would.be large and this might affect the practicality of this 
approach for its use on a routine basis. The latter- alternative 
however might offer a possibility of reducing analysis time.
This could be achieved by using either RIA or one of 
the chromatographic methods. Two or more RIA procedures 
specific for different cannabinoids could be used to provide 
this, though the production of suitable antisera with the
9
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required specificities would probably involve some
difficulties. Most of the chromatographic methods may be
modified to procedures capable of the detection of different
cannabinoids, though the majority of these would probably
fail to provide the sensitivity required for the detection
of metabolite concentrations of lng/ml and below. Of the
chromatographic methods GC/MS is the only technique reported
9capable of the measurement of levels of a A -THC metabolite
9(11-hydroxy-A -THC) in plasma (Wall et al., ,1976) . Measurement
q 9of A -THC and 11-hydroxy-A -THC by this method might require
several days work and would therefore be unsuitable for use’
in routine analysis. The published methods described above,
therefore have the main disadvantage, that they are unable
to give an unequivocal result in a time suitable for routine
analysis.
The work described in the experimental part of this 
section has affected this situation. The development of 
the HPLC-RIA method has provided a means of quantifying
9A -THC and other cross-reacting cannabinoids in a plasma 
sample in one analysis with moderate analysis time and cost , 
and with a relatively small plasma sample volume (< 1ml). 
Retention volumes for as many as five cross-reacting 
components are obtained from an analysis using this method , 
as well as the quantitative data. A high degree of 
confidence may therefore be placed in the validity of a 
result obtained by this method. HPLC-RIA therefore
appears at present to be the most suitable method for routine
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cannabinoid analysis in plasma for use in a forensic science context 
where a high degree of confidence in the validity of a result 
is required, RIA alone is a valuable method for screening 
plasma to identify positive samples for subsequent analysis 
with HPLC-RIA.
SECTION 3 
URINE ANALYSIS
RIA is at present the only technique reported capable
of providing a successful method for the routine analysis
of cannabinoids in urine. The application of several thin-
layer chromatography methods to the analysis of cannabinoids
in urine have been described in the literature but these were
all found to be unreliable and the results obtained capable of
misinterpretation (Salaschek et al., 1973), A GC-MS
qmethod for the measurement of A -THC-ll-oic acid was 
described by Nordqvist et.al. (1976) but the application of 
the method to the measurement of this metabolite in urine 
has not yet been reported (see Section 1).
Though methods other than RIA may be developed for 
cannabinoid analysis in urine this technique would probably 
still provide the most useful means of screening samples for 
cannabinoid content because of its short analysis time and 
moderate cost. Because of the advantages of RIA the procedure 
described previously for the analysis of plasma was adapted 
for use in the analysis of urine samples. This modified 
method was then evaluated, with the objectives of determining 
what magnitude the levels of cross-reaction would be in urine 
samples obtained from subjects after they had smoked A9-THC 
and whether these samples could be distinguished from blank 
urine samples.
EXPERIMENTAL 
Materials and Equipment
The equipment and most of the materials were the same 
as those used for plasma analysis (see section 2A). Urine
( A ) RADIOIMMUNOASSAY
INTRODUCTION
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samples taken over a 24 hour period after A -THC smoking 
(lOmg for subjects 1 and 2 and 8mg for subject 3) were taken 
during the same experiment in which the plasma samples were 
obtained. These were received from Professor J W Thompson 
(University of Newcastle Upon Tyne), Blank urine samples 
were obtained from twenty five volunteers with no experience 
of cannabis use.
Method
The RIA method used for the analysis of urine was similar 
to that described for plasma analysis (see section 2A). The 
only modifications of the assay protocol (Table 8) were 
adjustment of the solution volumes added to the assay 
equilibrium mixture. This allowed for the methanol which had 
been added to the assay solutions as part of the plasma
9
TABLE 8
RADIOIMMUNOASSAY PROTOCOL FOR URINE ANALYSIS
Reagent Volume (pi)
Total counts Non-specific Zero Standard Sample
tube binding tube tube tube tube
3H-THC (50% MeCH) 200 200 200. 200 200
THC standard - - — 100 —
50% MeCH 100 100 100 — 100Urine sample 
extract _ 100
Diluent buffer 200 300 200 200 100
Antiserum 100 - 100 100 100
■ Incubated for 1 hour at room tenperature
Diluent buffer 200 — — — —
Dext ran-coated 
charcoal (2.5%) - 200 200 200 200
Centrifuged and 500pl of supernatant counted
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extraction. The same methanol concentration (25%) in the 
assay was thus used for both plasma and urine analysis.
RESULTS AND DISCUSSION
The urine samples from subjects 1 and 2, the regular 
users of cannabis, gave levels of cross-reaction between 15 
add 145ng/ml with the RIA (Table 9). Levels obtained from 
the urine samples of subject 3, the non-cannabis user, were 
lower than for these two subjects and were between 3 and 7.3ng/ml. 
Control urine samples from subjects 1 and 2 also contained
TABLE 9
LEVELS OF RIA CROSS-REACTION IN URINE SAMPLES OBTAINED 
FROM VOLUNTEERS WHO HAD SMOKED A9~THC
Subject
Time sample was 
taken after 
smoking(h)
Level of cross- 
reaction (ng/ml)
Urine
Volume
(ml)
Total cross­
reacting material 
(pg/h)
1 Control 35 132 4.6
1 117 111 13.0
2 142 34 4.8
3 125 56 7.0
4 145 44 6.3
6 135 38 2.6
8 78 113 4.4
24 49 600 2.0
2 Control 113 95 10.7
1 120 92 11.0
2 67 51 3.4
3 42 110 4.5
4 68 66 4.5
8 15 206 0.8
24 56 109 0.4
3 Control 0 15 0
1 3.2 82 0.26
2 7.3 45 0.33
3 6.6 50 0.33
4 . 3.8 110 0.42
6 6.2 65 0.20
8 I 3.0 166 0.2524 3.4 673 0.14
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cross-reacting material which was most probably due to the
consumption of cannabinoid material at some time prior to the
experiment. The presence of this additional cannabinoid
material contributed to the levels of cross-reaction
“ 9observed in the samples taken after A -THC smoking from subjects 
1 and 2. The quantities of cross-reacting material excreted 
in the urine (Table 9) by subjects 1 and 2, without this 
contribution, might have been closer to that observed in the 
urine samples from subject 3, The rate of excretion of cross­
reacting material for the three subjects was higher at the 
beginning of the experiment than towards its end. A totally 
consistent trend in the excretion rate was not observed 
between these times and the point at which the excretion rate 
was at a maximum could not be accurately determined from these 
data. Levels obtained from the urines of subject 3 suggest 
that the RIA is capable of detecting cross-reacting material
^ABLE 10
LEVELS OF RIA CEOSS-REACTION IN NORMAL 
CONTROL URINE SAMPLES
Subject Level of cross-reaction ng/ml Subject
Level of cross-reaction 
ng/ml
1 0 13 0
! 2 0 14 03 0 15 0
4 0 16 0
5 0.1 17 0
6 0 18 0
7 0.3 19 0
8 0 20 0
9 0 21 0
10 0.2 22 0.2
11 0 23 0
12 0 24 0
25 0.1
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in urine samples which have been taken during a period of at
9least 1 hour and up to 8 hours after A -THC smoking. Levels 
of cross-reaction for the normal control urine samples 
(Table 10) were all less than lng/ml, which demonstrates that 
the RIA is capable of distinguishing these samples from those 
obtained during a period after the consumption of a moderate 
quantity of A9-THC.
75
(B) HIGH PRESSURE LIQUID CHROMATOGRAPHY - RADIOIMMUNOASSAY OF
URINE SAMPLES
INTRODUCTION
HPLC-RIA is a method potentially capable of measuring
the individual cannabinoid metabolites in urine. There is
however a problem associated with cannabinoid analysis in
urine which does not exist with plasma analysis. This is, that the 
9type of A -THC metabolites present in urine differ from those 
in plasma. Wall et al. (1974) found that the majority of 
cannabinoid metabolites in urine were present as water 
soluble conjugates. It is therefore probable that a 
proportion of the RIA cross-reacting compounds present in urine 
are metabolite conjugates. For the identical HPLC-RIA system 
used for plasma analysis to be applied to urine a suitable 
hydrolysis procedure capable of liberating metabolites from 
their polar conjugates might therefore be required.
The experimental objectives of the work described in 
this section are concerned with the development of a suitable 
procedure for the analysis of urine samples by the HPLC-RIA 
method and obtaining an indication of the suitability of the 
method for use in routine analysis.
EXPERIMENTAL 
Materials and Equipment
These were the same as those described in Section 2B.
(3*,5'-44C)A9-THC was purchased from the Radiochemical Centre, 
Amersham, and 3-glucuronidase and sulphatase were purchased 
from Sigma Chemicals Ltd.
Method
Initial experiments designed to investigate the HPLC 
retention characteristics of urinary metabolites and devise a
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suitable procedure for conjugate hydrolysis were conducted
9using rabbit urine containing radiolabelled A -THC metabolites.
A New Zealand white rabbit (4kg), from which a control urine 
sample had been taken, was injected with 9yCi(90yg) of 
(3! , 5'-44C)A9-THC (in 0.1ml ethanol and 0.4ml of saline 
containing 2%v/v Tween 80) into one of its ear veins. Urine 
samples were collected from the rabbit after 10 minutes, 5 
hours, 48 hours and 72 hours. The radioactivity of each 
urine sample was measured by liquid scintillation counting 
and corrected for quenching by the channels ratio method.
The molar concentrations of radiolabelled metabolites were 
subsequently calculated from the specific activity of the 
(3*,5'-14C)A9-THC.
The HPLC system used in the investigation of hydrolysis 
conditions differed from that described previously. It 
consisted of two 10cm ODS columns in series, eluted with 20ml of 
50% methanol/50% water, 20ml of 65% methanol/35% water and 
20ml of 80% methanol/20% water. Eluate fractions (1ml) were 
taken at one minute intervals and mixed with scintillation 
fluid (4ml) for counting. The HPLC conditions for all the 
work employing HPLC-RIA were the same as those described for 
plasma analysis.
The treatment of urine samples with enzymes was 
investigated as a potential method for conjugate hydrolysis. 
Urine samples (1ml) were incubated with 8-glucuronidase 
(2000 units of Sigma Type Bl) and sulphatase (1000 units of 
Sigma Type HI) at pH5 and at 37° over a 24 hour period. Three 
volumes of methanol were added and the samples were 
centrifuged. The supernatant was diluted to a 50% aqueous
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methanol solution and chromatographed. Alkaline conditions 
(0.5M sodium hydroxide) were also used in an attempt to 
hydrolyse metabolite conjugates, The effect of different 
incubation temperatures (4°-37°C) and incubation times 
(4^30 min.) were examined in order to identify the optimum 
hydrolysis conditions.
The procedure finally chosen and subsequently used 
for the hydrolysis of human urine samples was as follows: 
an equal volume of methanolic sodium hydroxide (IM) was 
added to the urine; the sample vessel was evacuated in order 
to exclude oxygen and left at room temperature for 30 minutes.
The pH of each sample was then adjusted with acetic acid.
For the initial investigation of basic hydrolysis conditions 
the rabbit urine samples were adjusted after hydrolysis to 
pH4 and for the later work involving the RIA of HPLC eluate 
fractions the samples were adjusted to pH 5.5.
The stability of cannabinoids to acidic and basic
9conditions was investigated by incubating the compounds A -THC,
CBN, ll-hydroxy-A9-THC, 8a-hydroxy~A9-THC, 83-hydroxy-A9-THC,
9 983,11-dihydroxy-A -THC and A -THC-ll-oic acid at approximately 
5yg/ral concentrations in solutions of either sodium hydroxide 
(0.5M', 50% aqueous methanol) or hydrochloric acid (0.1M, 50% 
aqueous methanol) for two hours at temperatures between 
20°C and 80°C. Changes in metabolite concentrations were 
measured using HPLC with 80% MeOH/20% water eluent and a 10cm 
ODS column. The column eluate was monitored using ultra-violet 
detection (280nm).
RESULTS AND DISCUSSION
The r a b b it  [treated; w ith  r a d i o l a b e l l e d  A9-THC e x c r e te d
48% o f  th e  i n j e c t e d  dose, b ased  on r a d i o a c t i v i t y  and a q u a n t i t y
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equivalent to 6 f5yg of THC cross-reacting material in the
urine, over the 72 hour period after administration (Table 11).
TABLE 11
LEVELS OF 14C RADIOACTIVITY AND CROSS-REACTION IN RABBIT URINE
OBTAINED AFTER INTRA-VENOUS ADMINISTRATION OF 9pCi
44C-A9-THC (90pg)
Urine sample
Urine
Volume
(ml)
DPM/ml TotalDPM
RIA cross­
reaction 
(ng/ml)
Total cross­
reaction (ng)
0 - 10 min 23 42,300 973,000 0 0
10 min - 24' hr 20 220,000 4,400,000 25 496
24 hr - 48 hr 75 42,000 3,157,000 77 5,790
48 hr - 72hr 410 2,840 934,000 0.4 164
Total 9,500,000* 6,450
Equivalent to 48% of the administered dose.
The urine was used to investigate the retention characteristics
of urinary cannabinoid metabolites. Urine samples (adjusted
\
to pH7) were chromatographed with the described HPLC system.
The radioactivity present in the urine was found to elute
as a single peak from the ODS column at a low retention volume.
Urine samples acidified with acetic acid (pH4) produced a
similar elution pattern except that several components eluted
at longer retention volumes (Figure 40a). These results
9suggested that the A -THC metabolites present in the rabbit
urine were relatively polar, since compounds are eluted from
/
the ODS column used in this study in order of decreasing
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<*> U n h y d r o l y s e d
radioactivity
Retention volum e
Figure 40 The HPLC elution patterns of radiolabelled
A9-THC metabolites present in rabbit urine (a) 
for the acidified urine (b) for enzymically 
hydrolysed and then acidified urine (c) for 
urine hydrolysed with methanolic sodium hydroxide 
and then acidified.
polarity. The metabolites whose HPLC retention characteristics 
were affected by the addition of acetic acid to the sample are 
possibly weak acids.
Urine samples were hydrolysed enzymically as previously 
described in order to attempt the conversion of the polar 
conjugated metabolites into less polar compounds. Enzymically
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treated rabbit urine samples were found to give HPLC elution
patterns in which several components were present with greater
retention volumes than those observed with the untreated samples
(Figure 40b), suggesting that some hydrolysis of metabolite
conjugates had occurred. It was considered that the total
hydrolysis of conjugates had not been achieved since no
radioactive peak was present at a retention volume corresponding
9to that of the expected major A -THC metabolite,
911-hydroxy-A -THC. The basic hydrolysis of metabolite
conjugates was therefore examined.
The HPLC elution pattern constructed after chromatographing
rabbit urine treated with sodium hydroxide (Figure 40c)
demonstrated that material of low polarity was present.
This had not been found in the enzymically hydrolysed sample
and it was concluded that basic conditions provided a more
effective means of conjugate hydrolysis. The conditions
necessary for optimum conjugate hydrolysis were investigated.
Variations of reaction temperature produced no differences
in the chromatographic elution patterns but the reduction of
incubation time to 4 minutes did reduce the amount of low
polarity material observed. It was concluded from these
results that the reaction was essentially complete after
incubation for 30 min. at room temperature and these hydrolysis
conditions were subsequently used.
The effect of sodium hydroxide on metabolite stability
was also considered. No significant losses of the cannabinoids
were observed over the temperature range 20°-80°C provided
that oxygen was excluded from the reaction by evacuating the
9
sam ple v e s s e l .  L o sse s  o f  th e  c a n n a b in o id s ,  A -THC, 1 1 -h y d r o x y -
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9 9A -THC and 88,11-dihydroxy-A -THC (5ng of each) were measured
for the complete hydrolysis and HPLC-RIA procedure and were
found to be no more than 10% when oxygen was excluded from
the HPLC solvents. The pH of the cannabinoid solutions was
adjusted to pH5.5 after treatment with sodium hydroxide,
unlike the rabbit urine experiment where it was adjusted to
pH4. These less acidic sample conditions were used to reduce the
possibility of. a pH change occurring in the. assay buffer solution which might
adversely affect the RIA result. These pH conditions were
used subsequently for all the urine analyses involving the RIA of HPLC
eluate fractions. The weak acidity of the sample solution
(6ml of 50% aqueous methanol) did however affect the retention
9volumes of the acid metabolites A -THC-ll-oic acid and CBN-11- 
oic acid. These metabolites were eluted together at retention 
volume 10ml with the sample conditions used for plasma analysis 
(Section 2B, the pH of the plasma sample extract was normally 
between pH 7.5 to 8) but at increased retention volumes with 
the conditions used for urine analysis.. The two metabolites 
were now well separated (Table 12). The combined hydrolysis
TABLE 12
THE MONO-CARBOXYLATED METABOLITE RETENTION 
VOLUMES WITH THE CONDITIONS USED FOR URINE ANALYSIS
Canpound 2L 'Retention Volume (ml)
•A9-lHC-ll-oic' acid 
CEN-ll-oic acid
16.5
15.0
a For the system described in the text
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and HPLC-RIA procedure had now been developed to the stage 
that was considered suitable for the quantification of cross­
reacting cannabinoid metabolites in urine.
The use of acidic conditions for metabolite conjugate
9hydrolysis was also considered, but the 11-hydroxy-A -THC 
metabolite was found to be unstable in a dilute hydrochloric 
acid solution and this approach was not pjuprsued further.
The HPLC elution pattern of radiolabelled A9-THC 
metabolites in rabbit urine had now been established but 
the extent to which these metabolites cross-reacted in the 
RIA was not known. A sample of the rabbit urine was therefore 
hydrolysed and chromatographed and the eluate fractions 
monitored for both radioactivity and RIA cross-reactivity.
Two chromatograms were constructed from the experimental data 
(Figure 41), one representing the total metabolite elution 
pattern and the other the elution pattern of cross-reacting 
metabolites. The chromatograms both showed similar concentrations 
of metabolites eluting at the retention volumes 16.5ml and 
30ml. The equivalent quantitative result obtained by the two 
methods suggested that these metabolites cross-reacted in the
9RIA with the same avidity as the A -THC used to calibrate the 
assay. The differences between the two chromatograms, were the 
presence of metabolite peaks with the chromatogram representing 
the elution of radioactive compounds (at retention volumes of 
19.5ml and less than 15.ml) which were not present in the 
chromatogram of cross-reacting metabolites. These compounds 
appear to be metabolites which do not cross-react in the RIA.
This experiment has provided an indication of the proportion 
and retention volumes of cannabinoid metabolites in the rabbit 
urine samples which are able to cross-react in the RIA.
83
* 40-
Urine 
concentration 
(pmol/ml)
2 0
I I 1<C Radioactivity
RIA Cross-reaction
Retention volume (ml)
Figure 41 The HPLC elution patterns of radiol'abelled
A9-THC metabolites and cross-reacting A -THC 
metabolites present in a hydrolysed rabbit urine 
sample.
The combined hydrolysis and HPLC-RIA procedure had now 
been developed to the stage where it could be applied to the 
analysis of human urine. The human urine samples described 
in part A of this section were examined by this method and 
the chromatograms of eluting cross-reactivity constructed.
A representative sample of those chromatograms is given in 
Figures 42-47. All the samples which had given a positive 
RIA result with direct analysis of urine gave chromatograms 
which had areas of cross-reaction at the retention volumes 
16.5ml and 30ml observed with the rabbit urine sample. The 
identification of these cross-reacting components required
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Retention volume (ml)
Figure 42 The HPLC-RIA chromatogram of a urine sample
from subject 1 for the period between 1 and 2 
hours after smoking A9-THC 0-Omg).
Retention volume (ml)
F igu re  43 The HPLC-RIA chromatogram o f  a u r in e  sample
from s u b j e c t  1 f o r  th e  p e r io d  between 8 and 24
hours a f t e r  smoking A -THC (lO m g ).
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20-
C ro ss -  
reaction 
(n g /m l)
Retention volume (ml)
Figure 44 The HPLC-RIA chromatogram of a urine sample
from subject 2 for the period between 1 and 2 
hours after smoking A9-THC (lOmg).
Retention volume (ml)
F ig u re  45 The HPLC-RIA chromatogram o f  a u r in e  sam ple
from s u b j e c t  2 f o r  the  p e r io d  between 8 and 24
hours a f t e r  smoking A -THC (lO m g).
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Retention volume (ml)
Figure 46 The HPLC-RIA chromatogram of a urine sample
from subject 3 for the period between 1 and 2 
hours after smoking A -THC (8mg).
Retention volume (ml)
F ig u re  47 The HPLC-RIA chromatogram o f  a u r in e  sample
from s u b j e c t  3 f o r  th e  p e r i o d  between 8 and 24
hours a f t e r  smoking A9 -THC (8 m g ) .
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t h e i r  m a s s - s p e c t r a l  a n a ly s e s  ( s e e  s e c t i o n  3 C ). Two o f  th e  
com pon en ts  do h ow ever  h ave r e t e n t i o n  vo lu m es  e q u iv a le n t  t o  
A9- T H C - l l - o i c  a c i d  ( 1 6 .5 m l )  and CBN (3 0 m l) .
9Human u r in e  sa m p le s  o b t a in e d  a f t e r  A -THC sm ok in g  
h ave been  a n a ly s e d  by  t h e  d e s c r i b e d  m ethod  and c r o s s - r e a c t i n g  
com pon en ts  have b e e n  o b s e r v e d  in  t h e s e  sa m p les  w ith  r e t e n t i o n  
vo lu m es  c o r r e s p o n d in g  t o  t h o s e  o f  r a d i o l a b e l l e d  m e t a b o l i t e s  
p r e s e n t  in  r a b b i t  u r in e .  The m ethod  can  b e  u se d  f o r  th e  
r o u t in e  a n a ly s i s  o f  u r in e  sa m p le s  and s h o u ld  p r o v id e  a h ig h e r  
d e g r e e  o f  c o n f id e n c e  in  th e  v a l i d i t y  o f  a r e s u l t  than  w ith  
RIA a lo n e .
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(C )  THE IDENTIFICATION OF URINARY RIA CROSS-REACTING COMPOUNDS
INTRODUCTION
The HPLC-RIA p r o c e d u r e  d e s c r ib e d  in  S e c t i o n  3B was 
u s e d  t o  d e t e c t  c r o s s - r e a c t i n g  c a n n a b in o id s  in  u r i n e .  A r e s u l t  
o b t a in e d  by  t h i s  m ethod  w o u ld  h ow ever  h ave  a g r e a t e r  s i g n i f i c a n c e  
i f  th e  s t r u c t u r e s  o f  t h e s e  com pounds w ere  know n. The w ork  
d e s c r i b e d  h e r e  was c o n c e r n e d  w ith  th e  i s o l a t i o n  and m ass 
s p e c t r a l  i d e n t i f i c a t i o n  o f  tw o o f  t h e s e  u r in a r y  c r o s s - r e a c t i n g  
co m p o n e n ts .
EXPERIMENTAL 
M a t e r ia ls  and E quipm ent
The RIA and HPLC equ ip m en t was t h e  same as t h a t  
d e s c r i b e d  in  S e c t io n  2 . GC-MS was c o n d u c te d  w ith  a 3%OV17 
colum n (2mm i d . ,  0 .3m  l e n g t h )  i n t e r f a c e d  b y  a j e t  s e p a r a t o r  t o  
a VG M icrom ass 16F mass s p e c t r o m e t e r .  A u r in e  sam p le  (C a s e  2 , 
s e e  S e c t io n  4 )  fo u n d  t o  c o n t a in  a h ig h  l e v e l  o f  c r o s s - r e a c t i n g  
m a t e r ia l  (6 8 0 n g /m l)  was u s e d  as th e  s o u r c e  o f  c a n n a b in o id  
m e t a b o l i t e s .  N , 0 - b i s - ( t r i m e t h y l s i l y l ) - t r i f l u o r o a c e t a m i d e  
(BSTFA ) w ith  1% t r i m e t h y l c h l o r o s i l a n e  was p u r c h a s e d  fro m  
P h ase  S e p a r a t io n s  L td .
M ethod
The u r in e  sam p le  (3 m l)  was h y d r o ly s e d  and ch ro m a to g ra p h e d  
w ith  t h e  HPLC s y s te m  d e s c r i b e d  in  S e c t io n  2B . A l iq u o t s  ( 5 y l )  
o f  th e  e l u a t e  f r a c t i o n s  w ere  a s s a y e d  by RIA t o  i d e n t i f y  t h o s e  
f r a c t i o n s  c o n t a in in g  c r o s s - r e a c t i n g  m a t e r i a l .  Two m e t a b o l i t e s  
d e s ig n a t e d  A and B ( F ig u r e  5 6 ) , h a v in g  re ten tion  volumes o f  30ml and 16.5m] 
r e s p e c t i v e l y , w ere  i s o l a t e d  by  t h i s  m ethod  and r e -c h r o m a to g r a p h e d  
u s in g  an ODS colum n (1 0 cm ) and 67 .5%  m e th a n o l /3 2 .5 %  w a te r  
s o l v e n t .  The HPLC e l u a t e  was a g a in  m o n ito r e d  w ith  RIA ( 5 y l
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a l i q u o t s )  and t h e  s o l v e n t  fro m  th e  f r a c t i o n s  c o n t a in in g  c r o s s ­
r e a c t i n g  com pounds A and B ( r e t e n t i o n  v o lu m es  28ml and 8ml 
r e s p e c t i v e l y )  rem oved  b y  f r e e z e  d r y in g .  A p a r t  o f  e a ch  o f  
th e  m e t a b o l i t e  sa m p le s  w as s i l a n i s e d  w ith  BSTFA ( 1 0 y l )  in  
d ry  p y r i d i n e  ( 3 0 y l )  a t  8 0 °C , A f u r t h e r  p o r t i o n  o f  th e  m ore 
p o l a r  m e t a b o l i t e  B was m e th y la te d  w ith  an e t h e r e a l  d ia zo m e th a n e  
s o l u t i o n  ( lO O y l)  a t  room  t e m p e r a tu r e . The m e t a b o l i t e  o r  
m e t a b o l i t e  d e r i v a t i v e  s o l u t i o n s  ( lO y l  o f  an a p p r o x im a te ly  
5 n g /y l  m eth a n o l s o l u t i o n ,  o r  f o r  TMS d e r i v a t i v e s ,  p y r i d i n e  
s o l u t i o n )  w ere  ga s  ch ro m a to g ra p h e d  a t  2 2 0 °  w ith  a h e liu m  f l o w  
r a t e  o f  2 0 m l/m in . The m ass s p e c t r o m e t e r  s o u r c e  te m p e ra tu re  
was a d ju s t e d  t o  2 5 0 °  and th e  a c c e l e r a t i n g  v o l t a g e  t o  4 k v .
Mass s p e c t r a  w ere r e c o r d e d  when com pounds w ere e lu t e d  from  
t h e  GC co lu m n .
RESULTS AND DISCUSSION
The mass s p e c tr u m  o f  th e  TMS d e r i v a t i v e  o f  th e  m ore 
p o l a r  m e t a b o l i t e  B (GC r e t e n t i o n  t im e  -  2 .5 m in )  ga ve  m a jo r  
io n  p ea k s  a t  m /e  4 8 8 , 473 ( l o s s  o f  -C H g) and 371 ( l o s s  o f  
-COOTMS) and th e  m e th y la te d  d e r i v a t i v e  o f  B, (GC r e t e n t i o n  t im e  
= 5 m in ) a t  m /e , 3 5 8 , 343 ( l o s s  o f  -CH3 ) and 299 ( l o s s  o f  
-COOCHg ) .  I t  was c o n c lu d e d  fro m  th e s e  d a ta  t h a t  th e  m e t a b o l i t e  
B r e a c t e d  w ith  d ia zo m e th a n e  t o  g i v e  a d e r i v a t i v e  w ith  one 
m e th y l g ro u p  (CH3 = 1 5 )  and w ith  BSTFA t o  g i v e  a d e r i v a t i v e  
w ith  tw o TMS g ro u p s  (2xTMS = 1 4 6 ) s u g g e s t in g  a m o le c u la r  w e ig h t  
f o r  th e  u n d e r iv a t i s e d  com pound o f  3 4 4 . T h is  c o r r e s p o n d s  t o  
th e  m o le c u la r  w e ig h t  o f  A9- T H C - l l - o i c  a c i d ,  th e  m e t a b o l i t e  
w h ich  h a s  th e  same HPLC r e t e n t i o n  vo lu m e (1 6 .5 m l )  as
m e t a b o l i t e  B. The m ass s p e c t r a  o £  t h e  m e th y l e s t e r  and TMS
g
d e r i v a t i v e s  o f  A - T H C - l l - o i c  a c i d  w ere  fo u n d  t o  be  i d e n t i c a l  t o
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com pound. I t  was c o n c lu d e d  t h a t  th e  u r in a r y  c a n n a b in o id
9
m e t a b o l i t e  B., w ith  HPLC r e t e n t i o n  volu m e 1 6 .5 m l,  was A -  
T H C - l l - o i c  a c i d .
The m ass s p e c tru m  o f  t h e  l e s s  p o l a r ,  u n d e r i v a t i s e d ,  RIA 
c r o s s - r e a c t i n g  com pound (GC r e t e n t i o n  t im e  = 5 m in ) ga ve  m a jo r  
io n s  a t  m /e  358 , 343 ( l o s s  o f  -CH ^) and 299 ( l o s s  o f  -COOCH^)
9
i d e n t i c a l  t o  t h a t  o f  m e th y la te d  A - T H C - l l - o i c  a c i d .  The m ass
sp e c tru m  o f  th e  TMS d e r i v a t i v e  (GC r e t e n t i o n  t im e  = 2 m in )
had m a jo r  i o n s  a t  m /e  4 3 0 , 415 ( l o s s  o f  -CH3 ) and 371 ( l o s s
o f  - C00CH3 ) and was fo u n d  t o  b e  i d e n t i c a l  t o  t h a t  o f  th e  TMS
9d e r i v a t i v e  o f  t h e  m e th y l e s t e r  o f  A - T H C - l l - o i c  a c i d .  I t  was
9
c o n c lu d e d  t h a t  com pound A was th e  m e th y l e s t e r  o f  A - T H C - l l -
o i c  a c i d .  ,
T h is  was an u n e x p e c te d  s t r u c t u r e  f o r  a n a t u r a l l y
o c c u r r i n g  c a n n a b in o id  m e t a b o l i t e  and th e  p o s s i b i l i t y  t h a t
m e t h y la t io n  m igh t h ave  o c c u r r e d  d u r in g  h y d r o l y s i s  was
9i n v e s t i g a t e d .  A s o l u t i o n  o f  A - T H C - l l - o i c  a c i d  ( 5 y g /m l )  was 
s u b je c t e d  t o  th e  u r in e  h y d r o l y s i s  c o n d i t i o n s  and p o s s i b l e  
c o n v e r s io n  o f  th e  a c i d  m e t a b o l i t e  t o  i t s  m e th y l e s t e r  was 
m easu red  w ith  HPLC (10cm  ODS co lu m n , 80% m e th a n o l/2 0 %  w a te r  
s o l v e n t ,  UV d e t e c t i o n  a t  2 8 0 nm). No e s t e r i f i c a t i o n  o f  t h e
9
A - T H C - l l - o i c  a c i d  was o b s e r v e d .
The p o s s i b i l i t y  t h a t  u r in a r y  m e t a b o l i t e  c o n ju g a t e s  had 
b een  c o n v e r t e d  t o  th e  m e th y l e s t e r  was i n v e s t i g a t e d  and a 
sam p le  o f  t h e  u r in e  was h y d r o ly s e d  u s in g  e t h a n o l i c  sod iu m  
h y d r o x id e  s o l u t i o n  (1M ) in  p l a c e  o f  th e  m e t h a n o l ic  s o l u t i o n  
u se d  p r e v i o u s l y .  A com pound was i s o l a t e d  as  d e s c r i b e d  p r e v i o u s l y  
and th e  mass s p e c t r a l  d a ta  o b t a in e d .  T h is  w as fo u n d  t o  h ave 
m a jo r  io n s  a t m /e  3 7 2 , 357 ( l o s s  o f  -CH3 ) and 299 ( l o s s  o f
th o se  o b ta in e d  w ith  th e  c o rre sp o n d in g  d e r i v a t i v e  o f  t h i s
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-COOC2H5 ) ,  a s p e c tru m  e x p e c t e d  t o  b e  g iv e n  by th e  e t h y l  e s t e r  
q
o f  A - T H C - l l - o i c  a c i d .  I t  was c o n c lu d e d  t h a t  t h e  h y d r o l y s i s  
c o n d i t i o n s  u s e d  w ere  r e s p o n s i b l e  f o r  th e  fo r m a t io n  o f  th e  m e th y l
Q
( o r  e t h y l )  e s t e r  o f  th e  A - T H C - l l - o i c  a c i d  m e t a b o l i t e .  The
tw o a p p a r e n t ly  c o n f l i c t i n g  e x p e r im e n t a l  r e s u l t s  m igh t b e
e x p la in e d  i f  th e  b a s i c  m e t h a n o l ic  h y d r o l y s i s  c o n d i t i o n s  u se d
w ere  u n a b le  t o  e s t e r i f y  t h e  f r e e  a c i d ,b u t  w ere  a b le  t o  e f f e c t  a
9
t r a n s e s t e r i f i c a t i o n  o f  a A ^ -T H C -l l -o ic  a c i d  c o n ju g a t e .  The
a b i l i t y  o f  th e  b a s i c  m e t h a n o l ic  c o n d i t i o n s  t o  e f f e c t  su ch  a
t r a n s e s t e r i f i c a t i o n  r e a c t i o n  c o u ld  b e  d e p e n d e n t on th e  t y p e  o f
m e t a b o l i t e  c o n ju g a t e .  I f  a u r in e  sam p le  c o n t a in e d  m ore th a n
on e  t y p e  o f  c o n ju g a t e  ( p o s s i b l y  a s u lp h a t e  c o n ju g a t e  o f  t h e
p h e n o l g ro u p  o r  g l u c u r o n i c  a c i d  c o n ju g a t e s )  b o t h  th e  f r e e  and 
9m e th y la te d  A - T H C - l l - o i c  a c i d  com pounds m igh t b e  o b s e r v e d .
9The w ork  in  t h i s  s e c t i o n  h a s  i d e n t i f i e d  A - T H C - l l - o i c  
a c i d  and i t s  m e th y l e s t e r  a s  c r o s s - r e a c t i n g  com p on en ts  in  th e  
h y d r o ly s e d  u r in e .  The a c i d  m e t a b o l i t e  may now b e  q u a n t i f i e d  in  
u r in e  by  th e  HPLC-RIA m eth od .
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(D) THE DETECTION OF CANNABINOIDS IN BODY FLUIDS BY THEIR 
PHOTOCHEMICAL CONVERSION- TO FLUORESCENT PRODUCTS
INTRODUCTION
Q
Bowd e t  a l . (1 9 7 1 )  o b s e r v e d  t h a t  a lth o u g h  A -THC and 
CBN had o n ly  a weak i n t r i n s i c  f l u o r e s c e n c e  th e y  c o u ld  b e  
c o n v e r t e d  t o  a h ig h ly  f l u o r e s c e n t  com pound by i r r a d i a t i n g  a 
c a n n a b in o id  s o l u t i o n  w ith  UV l i g h t  a t  280nm. The CBN 
p h o t o p r o d u c t  p r o d u c e d  by  t h i s  m eth od  was p o s t u l a t e d  t o  b e  a 
s u b s t i t u t e d  p h e n a n th re n e  ( F ig u r e  4 8 )  b y  Bowd e t  a l . ( 1 9 7 5 ) .
F ig u r e  48 C o n v e r s io n  o f  CBN t o  a f l u o r e s c e n t  p h o t o ­
p r o d u c t
I t  was c o n s id e r e d  t h a t  th e  a b o v e  r e a c t i o n  c o u ld  b e  u s e d  
in  a p r o c e d u r e  f o r  d e t e c t i n g  th e  lo w  l e v e l s  o f  c a n n a b in o id s  
p r e s e n t  in  b od y  f l u i d s .  A s u i t a b l e  m ethod w o u ld  r e q u i r e  a 
c h r o m a to g r a p h ic  s e p a r a t i o n  s t a g e  in  o r d e r  t o  a v o id  i n t e r f e r e n c e  
fro m  en d o g e n o u s  f l u o r e s c e n t  m a t e r ia l  p r e s e n t  in  b od y  f l u i d s  and 
in  o r d e r  t o  s e p a r a t e  th e  c a n n a b in o id s  from  e a ch  o t h e r .
Such a p r o c e d u r e  m igh t p r o v id e  an a d d i t i o n a l  m eth od  f o r  
d e t e c t i n g  c a n n a b in o id  com pounds in  b od y  f l u i d s .  I t  c o u ld  h av e  
th e  a d v a n ta g e s  o f  h ig h  s p e c i f i c i t y  o f  d e t e c t i o n ,  low  a n a l y s i s  
t im e  and m o d e ra te  a n a l y s i s  c o s t .  The o b j e c t i v e s  o f  th e  w ork  
d e s c r ib e d  in  t h i s  s e c t i o n  w ere  t h e r e f o r e  t o  exam in e th e
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EXPERIMENTAL 
M a t e r ia ls  and Equipm ent
The f i n a l  d e s ig n  o f  a p h o t o c h e m ic a l  r e a c t o r ,  i n c o r p o r a t i n g  
a medium p r e s s u r e  m ercu ry  a r c  lam p, i s  i l l u s t r a t e d  in  F ig u r e  49 .
f e a s i b i l i t y  o f  such  a sy s te m .
F ig u r e  49 A s e c t i o n a l  d ra w in g  o f  t h e  p h o t o c h e m ic a l
r e a c t o r  f o r  HPLC. A -  lam p , B -  fu s e d  
s i l i c a  t u b e ,  C -  c o o l a n t  j a c k e t ,  D -  end 
p l a t e s ,  E -  c o o l a n t  c o n n e c t i o n s ,  F -  fu s e d  
s i l i c a  i r r a d i a t i o n  c o i l ,  G -  1 /1 6 "  S w a ge lok  
c o n n e c t i o n s .
The m ercu ry  a r c  lamp (A ) was m ounted  c o - a x i a l l y  w it h in  a 
f u s e d - s i l i c a  tu b e  ( B ) ,  (8 .5 c m  x  2 .1 cm  o d . , 1 .8 cm  i d ) .  T h is  
was e n c lo s e d  by an a lu m in iu m  a l l o y  c y l i n d r i c a l  c o o la n t  j a c k e t
(C ) (6 .5 c m  x  4 .7 cm  o d )  f i t t e d  w ith  s t a i n l e s s  s t e e l  e n d - p l a t e s
(D ) w h ich  w ere  s e a l e d  t o  t h e  tu b e  (B ) w ith  r u b b e r  O - r in g s .
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The i n s i d e  s u r f a c e  o f  th e  c o o la jn t  j a c k e t  was p o l i s h e d  t o  form  
a r e f l e c t i v e  s u r f a c e .  I n l e t  and o u t l e t  c o n n e c t i o n s  f o r  c o o la n t  
w ere  p r o v id e d  ( E ) .  I n s id e  th e  c o o la n t  s p a c e  was p la c e d  th e  
q u a r t z  i r r a d i a t i o n  tu b e  (F )  ( o d  2mm, i d  0.25mm and le n g t h  7 0 cm ). 
The en d s o f  t h i s  tu b e  w ere  s e c u r e d  w ith  e p o x y  r e s i n  t o  1 /1 6 "  
S w agelok  f i t t i n g s  (G ) (1 0 0 -C  P h a se  S e p a r a t io n s )  b r a z e d  o n t o  
t h e  end p l a t e  (D ) .
The p h o t o c h e m ic a l  r e a c t o r  i s  t h e  s u b je c t  o f  B r i t i s h  
P a te n ts  A p p l i c a t i o n s  ( T w it c h e t t  and W il l ia m s ,  1 9 7 7 a , 1 9 7 7 b ) .
The q u a r t z  t u b in g  u s e d  in  th e  c o n s t r u c t i o n  o f  th e  
p h o t o c h e m ic a l  r e a c t o r  was p u r c h a s e d  from  H era eu s  Q u a rtz  F u sed  
P r o d u c t s  L t d . ,  and th e  medium p r e s s u r e  m ercu ry  a r c  lam p (lOO w) 
and p ow er s o u r c e  fro m  E n g e lh a rd  H a n ov ia  Lamps L td .
S am ples w ere  i n j e c t e d  o n t o  th e  HPLC colum n w ith  a U6K 
v a lv e  i n j e c t o r  (W a ters  A s s o c ) .  A W aters  M -6000 HPLC pump 
was u s e d  t o  d e l i v e r  e lu e n t  t o  a colum n (10cm  x  4.6mm i d )  
s lu r r y -p a c k e d  w ith  S p h e r is o r b -5 -0 D S .
The e lu a t e  was m o n ito r e d  w ith  e i t h e r  a v a r ia b le -w a v e le n g t h  
UV d e t e c t o r  (CE -  2 1 2 , C e c i l  In s t r u m e n ts )  o r  a f l u o r i m e t e r  
(MPF 2A, P e r k in  E lm er) e q u ip p e d  w ith  a f l o w  c e l l .
M ethod
The c o n v e r s io n  o f  c a n n a b in o id s  t o  f l u o r e s c e n t  p h o t o ­
p r o d u c t  was i n i t i a l l y  i n v e s t i g a t e d  by  i r r a d i a t i n g  m e th a n o l 
s o l u t i o n s  o f  A9-THC (5 y g /m l )  and CBN ( 0 .5 y g /m l )  w ith  UV l i g h t  
(280nm ) in  th e  MPF 2A f l u o r i m e t e r  f o r  a p e r i o d  o f  on e  h o u r . 
C hanges in  t h e  c o m p o s it io n  d f  t h e s e  s o l u t i o n s  w ere  o b s e r v e d  
u s in g  HPLC w ith  ODS colum n and an 80% m e th a n o l/2 0 %  w a te r  
e lu e n t  , m o n ito r e d  f o r  b o t h  UV a b s o r b a n c e  and 
f l u o r e s c e n c e .
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The r a t e  o f  f o r m a t io n  o f  th e  p h o t o p r o d u c t  in  m e th a n o l and 
80% m e th a n o l/2 0 %  w a te r  w h ich  w ere  e i t h e r  a c i d i c  (0 .1 M , s u l p h u r i c  
a c i d ) ,  b a s i c  ammonium h y d r o x id e )  o r  n e u t r a l ,  was
i n v e s t i g a t e d  by  i r r a d i a t i n g  t h e  a p p r o p r ia t e  c a n n a b in o id  
s o l u t i o n  ( lO y g /m l )  w ith  UV l i g h t  (280nm ) and r e c o r d in g  th e  
i n t e n s i t y  o f  f l u o r e s c e n t  e m is s io n  a t 365nm.
The p h o t o c h e m ic a l  r e a c t o r  was c o u p le d  b e tw een  th e  HPLC 
colum n and f l u o r e s c e n c e  d e t e c t o r  (F ig u r e  5 0 )  by  s t a i n l e s s  s t e e l
PUMP COLUMN PHOTOCHEMICAL DETECTOR
REACTOR
F ig u r e  50 An HPLC sy s te m  f o r  c a n n a b in o id  d e t e c t i o n
u s in g  o n - l i n e  c o n v e r s io n  t o  th e  f l u o r e s c e n t  
p h o t o p r o d u c t
t u b in g  ( 0 . 0 1 ” i d )  u s in g  th e  c o n n e c t o r s  (Q ) .  The HPLC f l o w  
r a t e  f o r  optim um  s e n s i t i v i t y  was d e te rm in e d  by  r e p e a t e d ly  
c h r o m a to g r a p h in g  20n g o f  CBN a t d i f f e r e n t  f l o w  r a t e s  w ith  80% 
m e th a n o l/2 0 %  w a te r  e lu e n t  and r e c o r d i n g  t h e  p h o t o p r o d u c t  p e a k  
h e i g h t .
The a b i l i t y  o f  t h e  t e c h n iq u e  t o  d e t e c t  CBN in  u r in e  was 
i n v e s t i g a t e d  by h y d r o ly s in g  a u r in e  sam p le  c o n t a in in g  CBN 
(2 0 n g /m l)  w ith  an e q u a l  vo lu m e o f  m e t h a n o l ic  sod iu m  h y d r o x id e ,  
as  d e s c r i b e d  in  s e c t i o n  3B, The h y d r o ly s e d  u r in e  was d i l u t e d  
w ith  an e q u a l vo lu m e o f  w a te r  and. th e  CBN e x t r a c t e d  w ith  h e x a n e . 
The CBN was b a ck  e x t r a c t e d  i n t o  80% m e th a n o l/2 0 %  w a te r ,  d i l u t e d
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t o  50% a q u eou s  m e th a n o l s o l u t i o n  and i n j e c t e d  o n t o  th e  HPLC-
p h o t o c h e m ic a l  r e a c t o r .  A s i m i l a r  volu m e o f  c o n t r o l  u r in e  was
s i m i l a r l y  e x t r a c t e d  and ch ro m a to g ra p h e d .
RESULTS AND DISCUSSION
C o n v e r s io n  o f  A 9-THC and CBN t o  th e  f l u o r e s c e n t
p h o t o p r o d u c t  was p e r fo r m e d  as d e s c r ib e d  a b o v e  and th e  e x t e n t
o f  r e a c t i o n  o b s e r v e d  w ith  HPLC u s in g  b o th  UV and f l u o r e s c e n t
d e t e c t i o n .  A f t e r  i r r a d i a t i o n  f o r  one h ou r a s m a ll  p r o p o r t i o n  
9
o f  th e  A -THC and most o f  th e  CBN w ere  c o n v e r t e d  t o  a p r o d u c t  
h ig h ly  s e n s i t i v e  t o  f l u o r e s c e n c e  d e t e c t i o n  ( F ig u r e  5 1 ) .  T h is
ml rnl
F ig u r e  51 HPLC ch rom atogram s o f  (a )A 9-THC and ( b )  CBN, a f t e r
i r r a d i a t i o n  o f  th e  c a n n a b in o id  s o l u t i o n s  w ith  
UV l i g h t  (280nm ) f o r  1 h ou r  i n  an MPF-2A 
f l u o r i m e t e r  ( e x c i t a t i o n  s l i t  4 0 n m ). The HPLC 
colum n e l u a t e  was m o n ito r e d  f o r  UV a b s o r b a n c e  
(280nm ) and f l u o r e s c e n c e  (A e x  258nm, Aern 362nm, 
s l i t s  lOnm, s e n s i t i v i t y  x 4 ) .
Colum n: S -5 -0 D S , E lu e n t :  m e th a n o l ( 8 0 % ) /  
w a te r  (2 0 % ).
ga v e  a f l u o r e s c e n t  s p e c tr u m  (F ig u r e  5 2 ) .  S in c e  CBN was m ore 
e f f e c t i v e l y  c o n v e r t e d  t o  th e  p h o t o p r o d u c t  t h i s  com pound was 
u se d  f o r  s u b s e q u e n t  e x p e r im e n t s .
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F ig u r e  52 The f l u o r e s c e n c e  sp e ctru m  o f  t h e  c a n n a b in o id
p h o t o p r o d u c t  in  m eth a n o l (A ex  280nm ).
The r a t e  o f  p h o t o p r o d u c t  fo r m a t io n  was exa m in ed  u s in g  
CBN in  d i f f e r e n t  s o l v e n t s  and a t  d i f f e r e n t  pH c o n d i t i o n s .
The f a s t e s t  r e a c t i o n  r a t e  was fo u n d  t o  ta k e  p l a c e  in  n e u t r a l  
m e th a n o l /w a te r  s o l v e n t ,  th e  r e a c t i o n  b e in g  c o m p le te  in  l e s s  
th an  one m in u te .
The c o n v e r s io n  o f  a c a n n a b in o id  t o  th e  p h o t o p r o d u c t  
c o u ld  b e  c o n d u c te d  e i t h e r  b e f o r e  ch ro m a to g ra p h y  as a s e p a r a t e  
d e r i v a t i v e  f o r m a t io n  s t a g e ,  o r  a f t e r  c h ro m a to g ra p h y ,w h e re  
d e r i v a t i v e  fo r m a t io n  c o u ld  b e  a c h ie v e d  by c o n t in u o u s ly  
i r r a d i a t i n g  th e  HPLC colum n e lu a t e  b e f o r e  i t  p a s s e d  i n t o  t h e  
f l u o r e s c e n c e  d e t e c t o r .
T h is  a p p ro a ch  has th e  a d v a n ta g e s  t h a t  d e r i v a t i v e  
fo r m a t io n  and d e t e c t i o n  a r e  a c h ie v e d  in  on e  p r o c e s s  and t h a t  
th e  r e t e n t i o n  v o lu m es  o f  t h e  c a n n a b in o id s  th e m s e lv e s , n o t  t h a t  
o f  th e  p h o to p r o d u c t ,  a re  m e a su red . Such a p r o c e d u r e  c o u ld  a l s o  
p r o v id e  a d d i t i o n a l  c o n f i r m a t io n  o f  c a n n a b in o id  d e t e c t i o n  ( a )  
by r e -c h r o m a t o g r a p h in g  th e  c a n n a b in o id  w ith o u t  UV i r r a d i a t i o n ,
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in  w h ich  c a s e  th e  p h o t o p r o d u c t  w o u ld  n o t  b e  o b s e r v e d  and ( b )  by 
t r a p p in g  th e  p h o t o p r o d u c t  in  t h e  f l u o r o m e t r i c  d e t e c t o r  and 
r e c o r d in g  th e  t o t a l  f l u o r e s c e n t  s p e c tru m  c h a r a c t e r i s t i c  o f  
t h i s  com pound (F ig u r e  5 2 ) .
I n i t i a l  a t te m p ts  t o  p r o d u c e  o n - l i n e  p h o t o c h e m ic a l  
r e a c t i o n  w ere  c o n d u c te d  by  w in d in g  a q u a r t z  i r r a d i a t i o n  c o i l  
( th r o u g h  w h ich  th e  s o l v e n t  fro m  th e  HPLC colu m n  w ou ld  p a s s )  
rou n d  th e  f l u o r i m e t e r  UV s o u r c e  (h ig h  p r e s s u r e  X en on ) s o  t h a t  
t h e  t r a n s m is s io n  o f  r a d i a t i o n  i n t o  th e  f l u o r i m e t e r  was n o t  
a f f e c t e d .  W ith  a v e r y  lo w  HPLC s o l v e n t  f l o w  r a t e  ( 0 .2 m l /m in )  
th e  d w e l l  t im e  in  th e  i r r a d i a t i o n  c o i l  was fo u n d  t o  be  
s u f f i c i e n t  f o r  a lm o s t  t o t a l  c o n v e r s io n  t o  t h e  p h o t o p r o d u c t  and 
th e  c o m p le te  s y s te m  was c a p a b le  o f  d e t e c t i n g  ln g  o f  CBN. I t  
was c o n s id e r e d  h ow ever  t h a t  th e  p r o c e d u r e  w o u ld  b e  m ore 
p r a c t i c a l  i f  a h ig h e r  HPLC s o l v e n t  f l o w  r a t e  c o u ld  be  u s e d  in  o r d e r  
t o  r e d u c e  th e  a n a ly s i s  t im e .  The r a t e  o f  t h e  p h o t o r e a c t i o n  was 
in c r e a s e d  by u s in g  a 100W medium p r e s s u r e  m e rcu ry  a r c  UV 
s o u r c e  w h ich  had s e v e r a l  t im e s  g r e a t e r  p h o to n  f l u x  a t  280nm 
and th e  p h o t o c h e m ic a l  r e a c t o r  (F ig u r e  49) d e s ig n e d  f o r  maximum 
i r r a d i a t i o n  o f  th e  HPLC s o l v e n t  c o i l ,  w ith  c o o l i n g ,  was 
c o n s t r u c t e d .  T h is  s u p p l i e d  s u f f i c i e n t  r a d i a t i o n  s o  t h a t  th e  
optim um  HPLC s o l v e n t  f l o w  r a t e  f o r  maximum c o n v e r s io n  o f  CBN 
t o  th e  p h o t o p r o d u c t  was b e tw e e n  1 .5  and 2 m l /m in ,e q u iv a le n t  t o  
a d w e ll  t im e  in  th e  r e a c t o r  o f  l e s s  th a n  tw o s e c o n d s .  The 
c o m p le te  H P L C -r e a c t o r - f lu o r im e t e r  s y s te m  was c a p a b le  o f  
d e t e c t i n g  l e s s  th a n  ln g  o f  CBN (F ig u r e  5 3 ) .  The s y s te m  was 
a l s o  c a p a b le  o f  d e t e c t i n g  CBN, in  a sam p le  o f  h y d r o ly s e d  
c o n t r o l  u r in e  t o  w h ich  2 0 n g /m l o f  CBN had b e e n  added  and
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F ig u r e  53 The d e t e c t i o n  o f  ln g  CBN u s in g  th e  p h o t o c h e m ic a l  
r e a c t o r  ( a )  w ith  r e a c t o r  UV lam p on ( b )  w ith  
r e a c t o r  UV lamp o f f .
Colum n: S -5 -0 D S , E lu e n t :  m e th a n o l (8 0 % ) /
w a te r  (2 0 % ): D e t e c t o r  MPF-2 f l u o r i m e t e r
Aex 258nm, Aem 362nm, s l i t s  lOnm, s e n s i t i v i t y  x6
d i s t i n g u i s h i n g  t h i s  fro m  th e  e n d o g e n o u s  f l u o r e s c e n t  m a t e r ia l  
in  t h e  u r in e  (F ig u r e  5 4 ) .
9 9The sy s te m  was n o t  a b le  t o  d e t e c t  A -THC, 1 1 -h y d r o x y -A  -
9
THC o r  A - T H C - l l - o i c  a c i d ,  CBN has n o t  b een  d e t e c t e d  in  u r in e
9o b t a in e d  a f t e r  A -THC sm ok in g  and th e  c o n c e n t r a t i o n s  o f  t h i s  
c a n n a b in o id  in  p la sm a  a r e  e x t r e m e ly  lo w  ( F ig u r e s  37 , 38 and 
3 9 ) .  I t  i s  p r o b a b le  t h e r e f o r e  t h a t  t h e  s y s te m  d o e s  n o t  have 
a p r a c t i c a l  v a lu e  as  a m eans o f  d e t e c t i n g  CBN a lo n e .  The 
d e v e lo p m e n t o f  th e  m ethod  i s  h ow ev er  a t  an e a r l y  s t a g e  and
9
a d a p t a t io n  o f  th e  t e c h n iq u e  f o r  th e  m easurem ent o f  A -THC
9and p o s s i b l y  i t s  m e t a b o l i t e s  m ig h t b e  p r a c t i c a l .  A “ THC ca n  
be  c o n v e r t e d  t o  CBN w ith  d e h y d r o g e n a t in g  a g e n ts  su ch  as
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F ig u r e  54 HPLC ch rom atogram s o b t a in e d  u s in g  th e
p h o t o c h e m ic a l  r e a c t o r  and f l u o r e s c e n c e  
d e t e c t i o n  (A ex  258nm, Aem 362nm ) from  u r in e  
e x t r a c t s  ( e q u iv a le n t  t o  1ml o f  u r i n e )  o f  
( a )  a n orm al c o n t r o l  u r in e  sa m p le  c o n t a in in g  
2 0 n g /m l o f  CBN and ( b )  a n orm al c o n t r o l  
u r in e  s a m p le .
c h l o r a n i l  (W o lln e r  e t  a l . 1 9 4 2 ) 2 , 3 - d i c h l o r o - 5 , 6 - d i c y a n o b e n z o -  
q u in o n e  (D D Q ,C a rd illo  e t  a l 1968 )  and p o s s i b l y  t h i s  r e a c t i o n  
c o u ld  be  em p loy ed  s o  t h a t  c a n n a b in o id s  o t h e r  th an  CBN c o u ld  
b e  d e t e c t e d  in  b o d y  f l u i d s  w ith  th e  h ig h  s e n s i t i v i t y  and 
s p e c i f i c i t y  p r o v id e d  by th e  d e s c r ib e d  s y s te m .
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The RIA i s  c a p a b le  o f  d i s t i n g u i s h i n g  b la n k  u r in e  sa m p le s
9
from  t h o s e  o b t a in e d  a f t e r  A -THC sm ok in g  and i s  c o n s id e r e d  t o
b e  a u s e f u l  m ethod f o r  s c r e e n i n g  u r in e  sa m p les  f o r  c a n n a b in o id
c o n t e n t ,  In  c o m b in a t io n  w ith  HPLC, i t  w i l l  q u a n t i fy  some o f
th e  i n d iv id u a l  c a n n a b in o id  m e t a b o l i t e s  in  u r in e  w ith  h ig h
9
s e n s i t i v i t y  and s p e c i f i c i t y .  The A - T H C - l l - o i c  a c id  m e t a b o l i t e
h as b een  i d e n t i f i e d  as  on e  o f  t h e  u r in a r y  com pon en ts d e t e c t e d
by t h i s  p r o c e d u r e  and t h i s  m e t a b o l i t e  may now b e  q u a n t i f i e d
u s in g  th e  m ethod .
The w ork d e s c r i b e d  in  t h i s  s e c t i o n  a l s o  c o n t a in e d  an
a c c o u n t  o f  th e  d e v e lo p m e n t o f  a p h o t o c h e m ic a l  m ethod  f o r
d e t e c t i n g  low  c o n c e n t r a t i o n s  o f  CBN, T h is  p r o c e d u r e  i s  a t  an
e a r l y  s t a g e  o f  d e v e lo p m e n t and may h ave a p o t e n t i a l  a p p l i c a t i o n
9
as a means o f  d e t e c t i n g  lo w  c o n c e n t r a t i o n s  o f  A -THC o r  i t s  
m e t a b o l i t e s  in  b od y  f l u i d s  w ith  h ig h  s e n s i t i v i t y  and s p e c i f i c i t y .
( E ) CONCLUSION
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SECTION 4
THE ANALYSES OF SAMPLES SUBMITTED FOR 
FORENSIC EXAMINATION
( A) INTRODUCTION 
I t  was n o t e d  in  t h e  p r e v io u s  s e c t i o n s  t h a t  o f  th e  
m eth ods a v a i l a b l e  f o r  c a n n a b in o id  a n a ly s i s  in  b od y  f l u i d s ,  
RIA was a g o o d  s c r e e n in g  p r o c e d u r e  and HPLC-RIA a s u i t a b l e  
h ig h ly  s p e c i f i c  m ethod  f o r  r o u t i n e  a n a l y s i s .  T h ese  m eth od s 
and th e  GC-MS m ethod  h ave  b e e n  a p p l ie d  t o  sa m p le s  s u b m it te d  
f o r  f o r e n s i c  a n a l y s i s .  A n a ly s is  o f  sa m p le s  f o r  c a n n a b in o id  
c o n t e n t  may b e  r e q u i r e d  e i t h e r  b y  th e  p o l i c e ,  in  o r d e r  t o  
h e lp  s u b s t a n t i a t e  a p o s s i b l e  c h a r g e  o f  c a n n a b is  p o s s e s s io n  
o r  t o  h e lp  them w ith  o t h e r  e n q u i r i e s  ( s e e  c a s e  9 ) , o r  t o  
a s s i s t  a C o ro n e r  in  d e te r m in in g  th e  c a u s e  o f  d e a th  in  c a s e s  
w h ere  t h e r e  i s  e v id e n c e  t o  s u g g e s t  t h a t  u se  o f  c a n n a b is  may 
b e  in v o lv e d  in  a f a t a l  r o a d  a c c i d e n t  o r  su dden  d e a th . Some 
exa m p les  o f  t h e s e  a n a ly s e s  a r e  d e s c r ib e d  in  t h i s  s e c t i o n .
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C ase H is t o r y
A 20 y e a r  o l d  m ale who f e l l  from  h i s  m o t o r - c y c l e  was run 
o v e r  by a f o l l o w i n g  c a r  and d ie d  in  h o s p i t a l  3 h o u r s  l a t e r .  
C a n n ab is  was fo u n d  in  t h e  s u b j e c t s  p o c k e t .  A n a ly s is  f o r  
c a n n a b in o id  m a t e r ia l  was r e q u ir e d  in  o r d e r  t o  d e te rm in e  i f  
th e  d ru g  was a c o n t r i b u t i n g  f a c t o r  t o  th e  a c c i d e n t .
Sam ples
W ith in  30 m in u te s  o f  th e  a c c id e n t  a b l o o d  sam p le  was 
t a k e n . A s e c o n d  b l o o d  sam p le  was ta k e n  a f t e r  a b l o o d  
t r a n s f u s i o n  (1 0  u n i t s )  and a sam p le  o f  l i v e r  was ta k e n  d u r in g  
th e  p o s t  m ortem  e x a m in a t io n .
RIA
P lasm a fro m  th e  p r e - t r a n s f u s i o n  b l o o d  ga ve  c r o s s ­
r e a c t i o n  e q u iv a le n t  t o  l i n g  THC/m l, th e  p o s t - t r a n s f u s i o n  
b l o o d ,  6 n g /m l and th e  l i v e r  7 2 n g /g  ( t h e  l i v e r  was m a c e r a te d  
w ith  m e th a n o l, th e  m ix tu r e  c e n t r i f u g e d  and t h e  m e t h a n o l ic  
s u p e r n a ta n t  added  d i r e c t l y  t o  th e  a s s a y ) .
HPLC-RIA
P lasm a from  th e  p r e - t r a n s f u s i o n  b l o o d  was a n a ly s e d  
u s in g  th e  m ethod  d e s c r i b e d  in  s e c t i o n  2B. A ch rom atogram  
was o b t a in e d  (F ig u r e  5 5 )  w h ich  had s i m i l a r i t i e s  t o  t h o s e  
o b t a in e d  from  th e  p la sm a  sa m p le s  o f  s u b j e c t s  1 , 2 , and 3 
(F ig u r e s  2 0 - 3 6) and w h ich  d e m o n stra te d  t h a t  A9-THC ( 4 .4 n g /m l )  and 
i t s  m e t a b o l i t e s  w ere  p r e s e n t  in  t h e  sa m p le .
C o n c lu s io n
The sa m p le s  w ere  fo u n d  t o  c o n t a in  c a n n a b in o id  m a t e r i a l .
The HPLC-RIA p r o c e d u r e  show ed t h a t  th e  p r e - t r a n s f u s i o n  sam p le
(B ) CASE EXAMPLES
C ase  1
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Cross -  
reaction 
(ng/ml)
F ig u r e  55
Retention volume (ml)
The HPLC-RIA ch rom atogram  o f  th e  p r e ­
t r a n s f u s i o n  p la sm a  sam p le  from  Case 1
9
c o n t a in e d  A -THC and t h i s  i n d i c a t e d  t h a t  th e  d ru g  had
b een  ta k e n  w it h in  a p e r i o d  o f  a fe w  h o u rs  b e f o r e  t h e  a c c i d e n t
( s e c t i o n  2 B ).
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C ase H is t o r y
A you n g  m ale  was o b s e r v e d  by  th e  p o l i c e  t o  b e  in  a s t a t e  
o f  i n t o x i c a t i o n  and a d m it te d  sm ok in g  c a n n a b is  th e  p r e v io u s  
d a y .
Sam ple
A sa m p le  o f  u r in e  was o b t a in e d .
RIA
The u r in e  g a v e  6 8 0 n g /m l c r o s s - r e a c t i o n  a v e r y  h ig h  
l e v e l  com pared  w ith  p r e v io u s  r e s u l t s  ( s e c t i o n  3 A ) .
HPLC-RIA
The u r in e  sam p le  was a n a ly s e d  by th e  m ethod  d e s c r ib e d  
in  S e c t i o n  3B. The ch rom atogram  (F ig u r e  5 6 )  had
C ase  2
Retention volume (ml)
F ig u r e  56 The HPLC-RIA ch rom atogram  o f  t h e  u r in e  sa m p le
fro m  C ase 2 .
I
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s i m i l a r i t i e s  t o  t h o s e  o b t a in e d  fro m  th e  u r in e  sa m p le s  o f  
s u b j e c t s  1 ,  2 , and 3 ( F ig u r e s  4 2 -4 7  ) .  The a r e a s  o f  c r o s s ­
r e a c t i o n  e lu t in g ,  a t  r e t e n t i o n  v o lu m es  1 6 .5 ra l and 30ml w ere
9
i s o l a t e d  and i d e n t i f i e d  by  m a s s -s p e c t r o m e t r y  as  A -T H C -1 1 -
9
o i c  a c i d  and A - T H C - l l - o i c  a c i d  m e th y l e s t e r  r e s p e c t i v e l y  
( S e c t i o n  3 C ).
C o n c lu s io n
The a b o v e  r e s u l t s  i n d i c a t e d  t h a t  th e  s u b j e c t  had 
sm oked a l a r g e  q u a n t i t y  o f  c a n n a b is .
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C ase H is t o r y
The p o l i c e  w ere  f o l l o w i n g  a c a r  w h ich  was b e in g  d r iv e n  
in  an e r r a t i c  m anner and saw a p a ck a g e  throw n  from  th e  c a r  
o n t o  th e  r o a d . T h is  was l a t e r  fo u n d  t o  c o n t a in  15g o f  
c a n n a b is  r e s i n .  The c a r  d r i v e r  ga v e  a n e g a t iv e  r e s u l t  w ith  
an A l c o t e s t  b r e a t h  t e s t .
Sam ple
A sa m p le  o f  b l o o d  was o b t a in e d  from  th e  c a r  d r i v e r .  
T h is  w as fo u n d  t o  c o n t a in  42 mg o f  e t h a n o l  in  100m l o f  b l o o d .  
RIA
P lasm a fro m  th e  b l o o d  sam p le  ga ve  2 0 n g /m l c r o s s ­
r e a c t i o n .
GC-MS
The p lasm a  sam ple  was a n a ly s e d  by  th e  m ethod  d e s c r i b e d
9
i n  S e c t i o n  2C. A A -THC c o n c e n t r a t i o n  o f  6 n g /m l was fo u n d  
C o n c lu s io n
The a b ov e  r e s u l t s  show t h a t  c a n n a b in o id  m a t e r ia l  was
9
p r e s e n t  in  th e  b l o o d .  The p r e s e n c e  o f  A -THC in  th e  sam p le  
s u g g e s t s  th a t  t h e  d ru g  was ta k e n  w it h in  a few  h o u rs  p r i o r  t o  
t h e  sa m p le  b e in g  ta k e n .
C ase  3
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C ase H is t o r y
A you n g  man d ie d  as  a r e s u l t  o f  i n h a l i n g  v o m it .  T h ere  
was e v id e n c e  t o  s u g g e s t  t h a t  p r i o r  t o  d e a th  he had b een  u s in g  
c a n n a b is  and i t  was c o n s id e r e d  p o s s i b l e  t h a t  t h i s  may h ave 
im p a ir e d  h i s  r e f l e x e s .
Sam ples
S am ples o f  b l o o d  and u r in e  w ere  o b t a in e d  d u r in g  th e  
p o s t  m ortem  e x a m in a t io n . The b l o o d  sam ple  a p p e a re d  t o  h ave  
u n d e rg o n e  d e c o m p o s it io n  and s m e l le d  s t r o n g l y  o f  h y d ro g e n  
s u lp h id e .
RIA •
The p lasm a  was fo u n d  t o  c o n t a in  8 0 n g /m l o f  c r o s s - r e a c t i n g  
m a t e r ia l  and th e  u r in e  2 3 n g /m l.
HPLC-RIA
The p la sm a  sam p le  was a n a ly s e d  by t h i s  m eth od . The 
ch rom atogram  o b t a in e d  (F ig u r e  5 7 )  was c o n s i s t e n t  w ith  th e
C ase  4
Retention volume (ml)
F ig u r e  57 The HPLC-RIA ch rom atogram  o f  th e  p lasm a
sam p le  fro m  C ase 4 .
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p r e s e n c e  o f  c a n n a b in o id  m a t e r ia l  in  th e  s a m p le , b u t  n o A -  
THC was o b s e r v e d .
C o n c lu s io n
The a b ov e  r e s u l t s  show  t h a t  c a n n a b in o id  m a t e r ia l  was 
p r e s e n t  in  th e  b l o o d  and u r in e  sam p les . The a b s e n c e  o f  A9-THC in  
th e  b l o o d  sam ple  d o e s  n o t  p r o v e  c o n c l u s i v e l y  t h a t  th e  d ru g  
had n o t  been  ta k e n  w it h in  a few  h o u rs  o f  d e a th  s i n c e  th e  
sam ple  was in  a s t a t e  o f  d e c o m p o s it io n  and any A9-TKC may 
have  b een  l o s t .
9
I l l
A man was o b s e r v e d  by th e  p o l i c e  t o  b e  sm ok in g  a 
c a n n a b is  c i g a r e t t e .  He d e n ie d  t h i s .
Sam ple
A sam p le  o f  u r in e  was o b t a in e d .
C ase 5
C ase H is to r y
The u r in e  was fo u n d  t o  c o n t a in  1 6 n g /m l o f  c r o s s ­
r e a c t i n g  m a t e r ia l .
HPLC-RIA
The ch rom atogram  (F ig u r e  5 8 ) show ed t h a t  th e  u r in e  
3*
2-
C ross -  
reaction 
(ng/ml)
1-
RIA
10 20 30
Retention volume (ml)
F ig u r e  58 The HPLC-RIA ch rom atogram  o f  th e  u r in e  sam p le  
fro m  C ase 5 .
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c o n t a in e d  ,A9 -THC m e t a b o l i t e s .  As w e l l  as a r e a s  o f  c r o s s -
9
r e a c t i o n  a t  r e t e n t i o n  v o lu m e s  c o r r e s p o n d in g  t o  A - T H C - l l - o i c  
a c id  and A9- T H C - l l - o i c  a c i d  m e th y l e s t e r  th e  ch rom atogram  
a l s o  had a m a jo r  p eak  a t  th e  same r e t e n t i o n  volu m e as t h e  m on o- 
h y d r o x y la t e d  m e t a b o l i t e s .
C o n c lu s io n
The a b o v e  r e s u l t  i n d i c a t e d  t h a t  c a n n a b is  had b een  t a k e n .
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Case H is t o r y
A man was o b s e r v e d  t o  s w a llo w  a p i e c e  o f  c a n n a b is  
r e s i n  when b e in g  q u e s t io n e d  b y  th e  p o l i c e .  S m all q u a n t i t i e s  
o f  c a n n a b is  r e s i n  w ere  fo u n d  on a r in g  w orn b y  th e  s u b j e c t .  
Sam ple
A sa m p le  o f  u r in e  was o b t a in e d .
RIA
The u r in e  was fo u n d  t o  c o n t a in  1 5 n g /m l o f  c r o s s - r e a c t i n g  
m a t e r i a l .
HPLC-RIA
The ch rom atogram  ( F ig u r e  5 9 )  c o n t a in e d  a r e a s  o f  c r o s s -
9 9r e a c t i o n  c o r r e s p o n d in g  t o  A - T H C - l l - o i c  a c i d  and A -T H C -1 1 -
C ase 6
Petention volume (ml)
F ig u r e  59 The HPLC-RIA ch rom atogram  o f  t h e  u r in e  sa m p le
from  C ase 6 .
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C o n c lu s io n
The a b o v e  r e s u l t  i n d i c a t e d  t h a t  c a n n a b is  had b e e n  t a k e n .
o ic  a c id  m ethyl e s t e r .
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C ase H is t o r y
A 19 y e a r  o l d  m a le  m o t o r - c y c l i s t  d ie d  a f t e r  a c o l l i s i o n  
on  a b e n d . No a l c o h o l  was d e t e c t e d .
Sam ple
A b lo o d  sa m p le  was o b t a in e d .
RIA
P lasm a fro m  th e  b l o o d  sam p le  was fo u n d  t o  c o n t a in  
lO n g /m l c r o s s - r e a c t i n g  m a t e r i a l .
HPLC/RIA
The ch rom atogram  ( F ig u r e  6 0 )  show ed t h a t  th e  p lasm a  
c o n t a in e d  A9-THC ( 1 .5 n g /m l )  and A9-THC m e t a b o l i t e s .
2-
C ross-  
reaction 
(ng/ml)
1-
C ase  7
10 20 30
Retention volume (ml)
F ig u r e  60 The HPLC-RIA ch rom atogram  o f  th e  p la sm a  sa m p le
fro m  C ase 7 .
C o n c lu s io n
The a b ov e  r e s u l t  i n d i c a t e d  t h a t  c a n n a b is  had 
b e e n  consum ed w i t h in  a few  h o u rs  p r i o r  t o  t h e  sam p le  b e in g  
ta k e n .
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C ase H is t o r y
A 23 y e a r  o l d  m ale  c a r  d r i v e r  d ie d  a f t e r  an a c c i d e n t .  
The b l o o d  a l c o h o l  l e v e l  was 343 m g/100m l.
Sam ple
A sam p le  o f  b l o o d  was o b t a in e d .
RIA
P lasm a fro m  th e  b l o o d  was fo u n d  t o  c o n t a in  1 9 n g /m l 
c r o s s - r e a c t i n g  m a t e r ia l ,
HPLC-RIA
The ch rom atogram  (F ig u r e  6 1 )  show ed  t h a t  th e  p la sm a  
c o n t a in e d  A9r-THC ( 2 .3 n g /m l )  and A9-THC m e t a b o l i t e s .
4- 
C r o ss -  
reaction 
(ng/ml)
2-
C ase  8
10 20 30
Retention volume (ml)
F ig u r e  61 The HPLC-RIA ch rom atogram  o f  th e  p lasm a  sa m p le
fro m  C ase 8 ,
C o n c lu s io n
The a b o v e  r e s u l t  i n d i c a t e d  t h a t  c a n n a b is  had 
b e e n  consum ed w it h in  a few  h o u r s  p r i o r  t o  d e a th . The b l o o d  
a l c o h o l  l e v e l  h ow ever  w o u ld  p r o b a b ly  b e  th e  m a jo r  f a c t o r  
c o n t r i b u t i n g  t o  th e  a c c i d e n t .
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Case H is t o r y
A fe m a le  m urder v i c t i m  had c a n n a b is  in  h e r  p o s s e s s i o n .  
The p o l i c e  r e q u i r e d  t o  know i f  sh e  had b e e n  u s in g  th e  d ru g  
im m e d ia te ly  p r i o r  t o  d e a th . T h is  c o u ld  h ave  b een  o f  
a s s i s t a n c e  in  d e te r m in in g  th e  c ir c u m s t a n c e s  o f  d e a th .
Sam ples
S am ples o f  b l o o d  and u r in e  w ere  o b t a in e d .
RIA
The b lo o d  was n e g a t iv e  and th e  u r in e  c o n t a in e d  4 n g /m l 
c r o s s - r e a c t i n g  m a t e r i a l .
C o n c lu s io n
The a b o v e  r e s u l t s  a r e  n o t  c o n s i s t e n t  w ith  c a n n a b is  
h a v in g  b een  ta k e n  im m e d ia te ly  p r i o r  t o  d e a th . The p r e s e n c e  
o f  a lo w  l e v e l  o f  c r o s s - r e a c t i n g  m a t e r ia l  in  th e  u r in e  may 
i n d i c a t e  t h a t  th e  d ru g  was p o s s i b l y  ta k e n  a c o n s i d e r a b l e  
t im e  b e f o r e  d e a th .
C ase  9
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Case 10 
C ase H is t o r y
A man was o b s e r v e d  by t h e  p o l i c e  t o  b e  in  a ’ d ru g g e d  
c o n d i t i o n ’ . He had p r e v io u s  c o n v i c t i o n s  f o r  th e  p o s s e s s i o n  
o f  c a n n a b is .
Sam ple
A u r in e  sam p le  was o b t a in e d ,
RIA
The u r in e  was fo u n d  t o  c o n t a in  8 n g /m l c r o s s - r e a c t i n g  
m a t e r ia l .
C o n c lu s io n
The a b o v e  r e s u l t  i n d i c a t e d  t h a t  ca n n a b is - had a t some 
tim e  b een  ta k e n . The l e v e l  o f  c r o s s - r e a c t i o n  was low  
h ow ever  and t h i s  s u g g e s t s  t h a t  c a n n a b is  was p r o b a b ly  n o t  th e  
c a u s e  o f  th e  s t a t e  o f  i n t o x i c a t i o n .
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C ase 11
C ase H is t o r y
A 20 y e a r  o l d  man was in t e r v ie w e d  by  th e  p o l i c e  a f t e r  
c a u s in g  a d i s t u r b a n c e  in  a p u b l i c  h o u s e . D u rin g  th e  i n t e r v i e w  
he a d m it te d  t h a t  he had b een  sm ok in g  c a n n a b is .
Sam ple
A sa m p le  o f  u r in e  was o b t a in e d .
RIA
The u r in e  was fo u n d  t o  c o n t a in  9 n g /m l c r o s s - r e a c t i n g  
m a t e r i a l .
C o n c lu s io n
The a b o v e  r e s u l t  i n d i c a t e d  t h a t  c a n n a b is  had at som e 
tim e  been  t a k e n .
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a p p l ie d  t o  th e  a n a ly s e s  o f  c a n n a b in o id s  in  b o t h  p lasm a and
u r in e  c a s e  s a m p le s . RIA was u s e d  as a s c r e e n in g  p r o c e d u r e
in  o r d e r  t o  s e l e c t  p o s i t i v e  sa m p le s  f o r  s u b s e q u e n t  a n a l y s i s  '
w ith  HPLC-RIA. T h is  l a t t e r  m ethod  ga ve  q u a n t i t a t i v e  d a ta
f o r  i n d i v i d u a l  c a n n a b in o id s  i n  b od y  f l u i d s  and was fo u n d  t o
p r o v id e  a h ig h  d e g r e e  o f  c o n f i d e n c e  in  th e  v a l i d i t y  o f  a
r e s u l t .  The GC-MS m ethod  was fo u n d  t o  b e  l e s s  s u i t a b l e  f o r
r o u t in e  a n a ly s i s  s i n c e  t h e  a n a l y s i s  t im e  was lo n g e r  th a n  f o r
9
HPLC-RIA and i t  o n ly  p r o v id e d  d a ta  f o r  A -THC. I n fo r m a t io n
9c o n c e r n in g  th e  c o n c e n t r a t i o n  o f  A -THC m  p lasm a  has b een  
u se d  t o  o b t a in  some i n d i c a t i o n  o f  t h e  le n g t h  o f  tim e b e tw e e n  
con su m p tio n  o f  th e  d ru g  and t h e  t a k in g  o f  th e  sa m p le .
( C) GENERAL CONCLUSION
The RIA and HPLC-RIA m ethods have been  s u c c e s s f u l l y
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PHOTOCHEM ICAL DETECTION IN HIGH-PERFORM ANCE LIQUID CH RO­
M ATO G RA PH Y AN D  ITS APPLICATION TO CANNABINOID ANALYSIS
P. J. TWITCHETT*, P. L. WILLIAMS and A. C. MOFFAT
Home Office Central Research Establishment, Aldermaston, Reading RG7 4PN ( Great Britain)
SUMMARY
A  novel technique o f  on-line photochemical derivatization is described which 
can enhance considerably both the sensitivity and specificity o f detection in high- 
performance liquid chromatography (HPLC). Material eluting from the column is 
irradiated with a high flux o f  UY light, which may induce a reaction to form 
fluorescent or highly UV-absorbing products. The irradiated eluent then passes into 
a suitable detector. The photochemical reactor has a negligible effect on resolution, 
and reaction is achieved in 1-5 sec.
An example o f  the use o f  this technique is in the detection o f can'nabinol 
(CBN), a component o f  cannabis, which is converted into a highly fluorescent com ­
pound on irradiation with UV light. Thus, if a sample containing CBN is chromato­
graphed and the column eluent irradiated, CBN can be detected (as the fluorescent 
photoproduct) with a sensitivity o f  less than I ng. If the chromatogram is then 
repeated without UV irradiation, only naturally fluorescent products are detected. A  
comparison o f the two chromatograms allows these to be eliminated and leads to a 
very high specificity for the method.
This approach is being developed as the basis o f a rapid, sensitive and specific 
method for the detection o f  cannabinoids in body fluids. It is expected, however, that 
photochemical derivatization will extend the use o f HPLC to many substances that 
cannot be satisfactorily detected at present.
INTRODUCTION
An important requirement in high-performance liquid chromatography 
(HPLC) is for a detector which is both sensitive and specific. Ultraviolet (UV) 
monitors and fluorescence detectors are commonly used, but it frequently happens 
that a substance o f interest does not possess a suitable chromophore or fluorophore. 
This has led to the use o f  derivatization procedures which render the substance more 
readily detectable by chemical reaction either before (pre-column) or after chromato-
* Present address: Home Office Forensic Science Laboratory, Priory House, Gooch Street 
North, Birmingham B5 6QQ, Great Britain.
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TABLE I '
DERIVATIZATION TECHNIQUES IN HPLC
Technique Advantages Disadvantages
Pre-column derivatization Reaction conditions are not 
restricted.
Eluent choice is unrestricted.
Each sample requires individual 
preparation. L ' ‘ 
Reproducibility may be low. In 
quantitative work an internal 
standard is necessary for the 
derivatization.
Post-column derivatization Sample preparation is minimal. 
Derivatization is automated and 
quantitative precision can be 
high.
Eluent must be a suitable solvent 
and reaction medium for the 
derivatization process.
Reaction must be rapid. 
Resolution is usually adversely 
affected.
Mixing and pumping pulses may 
affect sensitivity.
graphy (post-column). Conventional derivatization methods such as these suffer a 
number o f  disadvantages1,2, which are summarized in Table I.
This, paper describes a novel method o f  derivatization which combines many 
o f  the advantages o f conventional methods* but with few o f  the disadvantages. The 
technique involves a photochemical reaction which takes place within a few seconds 
as the eluent leaves the column before passing into the detector.
This method o f derivatization has been applied to the detection o f  cannabinol 
(CBN), a component o f  cannabis, with high sensitivity and specificity. Cannabis is a 
widely used illicit drug and its detection in body fluids is o f  considerable forensic 
importance. The complex metabolism’ o f the drug3 and the low levels found in body 
fluids have meant that no simple, rapid and specific method is yet available to the 
forensic toxicologist. Although a radioimmunoassay4 has been.developed for screening 
purposes and a technique based , on gas chromatography-mass fragmentography5 is 
available, the latter method requires extensive sample preparation and is not suitable 
for the analysis o f  large numbers o f  samples.
The application o f  photochemical detection to cannabinoid analysis is based 
on observations by Bowd et a/.Mhat such substances, while having only a weak intrinsic 
fluorescence can be converted into highly.fluorescent compounds on irradiation with 
UV light at 280 nm for up to 4\ h. For CBN (I), the photoproduct was postulated to 
be the substituted phenanthrene (II)7.
CBN, ‘ -
‘ The present study was intended as an investigation o f the feasibility o f  on-line 
photochemical derivatization in HPLC, primarily for the detection o f  cannabinol in
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body fluids. The use o f  the technique to enhance the specificity o f  detection o f other 
substances is also briefly discussed.
EXPERIMENTAL
High-performance liquid chromatography
A  Waters M-6000 pump (Waters Assoc., Northwich, Great Britain) was used 
to deliver eluent to a column o f dimensions 10 cm x  4.6 mm I.D. slurry-packed with 
Spherisorb 5 ODS (Phase Separations, Queensferry, Great Britain), or 25 cm X 4.6 
mm I.D. packed with Partisil 10 PAC (Whatman Ltd., Maidstone, Great Britain).
Samples were introduced via a U6K valve injector (Waters Assoc.) and eluted 
components were detected by a variable-wavelength UV monitor (CE-212, Cecil 
Instruments, Cambridge, Great Britain) or, for CBN, a fluorimeter (MPF-2A, Perkin- 
Elmer, Beaconsfield, Great Britain) equipped with a home-made flow cell. The eluent 
for the reversed-phase (ODS) column was prepared from methanol and aqueous (0.025 
M ) disodium hydrogen orthophosphate and adjusted to pH 8 before use. For the 
normal-phase column (Partisil PAC), eluents consisting o f iso-octane and dioxane 
were used.
Photochemical reactor
The photochemical reactor (PCR), which was designed and constructed at the 
Home Office Central Research Establishment, is illustrated in Fig. 1. A  100-W 
medium-pressure mercury arc (A) (Engelhard Hanovia Lamps, Slough, Great
Fig. 1. Sectional drawing of the photochemical reactor for HPLC. A =  lamp; B =  fused silica tube; 
C =  coolant jacket; D =  end-plates; E — coolant connections; F =  fused-silica irradiation coil; 
G =  1/16-in. Swagelok connectors.
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Britain) was mounted co-axially within a fused-silica tube (B) (8.5 cm X 2.1 cm O .D ., 
1.8 cm I.D., Heraeus Quartz Fused Products Ltd.-, Byfleet, Great Britain). This tube 
was surrounded by an aluminium alloy cylindrical coolant jacket (C) (6.5 cm x  4.7 
cm O.D.) fitted with alloy or stainless-steel end-plates (D), which sealed to tube (B) 
with O-ring seals. The inside surface o f  the coolant jacket was polished to form a 
reflective surface, and inlet and outlet connections for coolant were provided (E j.‘ 
Immersed in the annular coolant space1’was a convoluted irradiation tube o f  fused 
silica (F)J O.D. 2 mm, I.D. 0.25 mm; length 70 cm (Heraeus Quartz Fused Products). 
The ends o f  the tube were attached by epoxy resin into drilled-out 1/16-in. Swagelok 
fittings (G) (Type I00-G, Phase Separations), which were brazed onto the end-plate (D).
The photochemical reactor was coupled between the HPLC column and de­
tector (Fig. 2) using conventional 1/16-in. O.D. capillary-bore tubing attached to the 
connectors (G). Samples were chromatographed twice, both with and without UV 
irradiation. A single chromatogram would suffice if an additional detector were 
coupled between the column and the photochemical reactor and traces from the two 
detectors were compared.
The photochemical reactor is the subject o f British Patent Applications8,9.
P U M P  C O L U M N  P H O T O C H E M I C A L  DET EC T OR
R E A C T O R
Fig. 2. HPLC with photochemical derivatization.
Extraction o f  urine samples
As no samples were available from subjects who had smoked or ingested 
cannabis or CBN, urines from non-drug users were collected and spiked by addition 
o f 20 ng-m l-1 o f CBN. It was expected that CBN would be present in the urine o f 
cannabis users as a glucuronide or sulphate conjugate, and urines. (10 ml) were 
therefore hydrolysed by treatment with an equal volume o f cold methanolic sodium 
hydroxide (1.0 M ) for 5 min. The urine was then diluted with water (10 ml) and 
extracted into H-hexane (10 ml; BDH, Poole, Great Britain, spectroscopic grade). 
Aliquots o f  the extract were injected directly on to the Partisil PAC column.
RESULTS AND DISCUSSION
Detection o f  cannabinol by photochemical derivatization
The photochemical detection o f  cannabinol is shown in Fig. 3, which illustrates 
the specificity o f  the method: CBN was detected only after irradiation o f the eluent. 
A high sensitivity was achieved and the technique has been found to be suitable for 
the detection and quantitation o f CBN in the range 0.5-500 ng injected on-column.
The value o f  this specificity for the analysis o f  biological samples is shown in 
the chroipatogram o f  urine extracts (Fig. 4). Although several endogenous urinary 
components are naturally fluorescent, only CBN is photolabile and forms a fluorescent
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10ng CBN
(a )
LAMP
OFF
(b)
LAMP
ON
ml ml
Fig. 3. Photochemical detection of 10 ng of CBN: (a) without UV irradiation; (b) with UV irradia­
tion. Column, Partisil PAC; eluent, isooctane-dioxane (3:2); flow-rate, 1 ml/min-1 ; detector, MPF-2 
fluorimeter, Acx =  258 nm, Acm — 362 nm, slits 12 nm, sensitivity x4.
(a) Lamp off (c) Lamp on
Eluent volume (m l) Eluent volume (m l)
Fig. 4. Photochemical detection of CBN in urine extracts, (a) Extract (500 /tl) of urine containing 20 
ng*ml” ‘ of CBN; (b) extract of blank urine; (c) and (d), as (a) and (b), respectively, but chromato­
graphed with UV irradiation. Column, Partisil PAC; eluent, isooctane-dioxane (82.5:17.5); flow- 
rate, 1 ml*min"1; detector, MPF-2A fluorimeter, 2ex =  258 nm, 20n, =  362 nm, slits 12 and 15 nm, 
sensitivity x5.
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product, and it can be readily detected by comparison o f  the chromatograms with and 
without UV irradiation. In contrast, the chromatograms o f blank urine extracts are 
identical, with and without irradiation. Hence, by disconnecting or by-passing the 
photochemical reactor, each sample can be made to serve as its own blank.
Effect o f  the photochemical reactor on resolution
The efficiency o f  the chromatographic system (with the Partisil PAC column) 
was determined by measurement o f  the number o f  theoretical plates using the CBN 
photoproduct (II) as a convenient solute. Samples were chromatographed using the 
eluent and conditions given in Fig. 3 with the PCR connected but with the lamp 
switched off. The measurements were repeated with the column eluent flowing 
directly into the detector in the conventional fashion. The conventional chromato­
graphic system gave an average o f  4710 theoretical plates, which was reduced to 4650 
plates when the PCR was incorporated into the system. Thus, for all practical pur­
poses, the effect o f  the PCR on column resolution is negligible. This is thought to be 
due to the narrow bore o f  the irradiation coil (0.25 mm) and the absence o f  unswept 
dead volumes which would cause eluent mixing. In contrast, most conventional 
methods o f  post-column derivatization involve coils o f  wide (2 mm) bore tubing for 
mixing and reaction to take place before detection.
Effect o f  chromatographic parameters on the derivatization process
Eluent flow-rate. The eluent flow-rate has a fundamental effect on the yield o f  
photoproduct (II), as the flow-rate regulates the dwell time o f  a chromatographic 
peak in the photochemical reactor. Using an irradiation coil o f  length 70 cm, irradia­
tion times o f  0.5-4.1 seconds were achieved by variation o f the flow-rate from 4 to 
0.5 ml-min-1 . The optimal sensitivity o f detection for CBN was achieved at flow- 
rates between 0.5 and 1.0 ml-min-1 . Presumably, at higher flow-rates, the sample 
receives insufficient irradiation, while at flow-rates below 0.5 ml-min-1, the photo­
product itself may undergo photodecomposition to a non-fluorescent product. Thus 
although the PCR can be used at flow-rates above 1 ml-min-1, the sensitivity o f  de­
tection for CBN is reduced unless an irradiation coil longer than 70 cm is fitted. At 
a flow-rate o f  2 ml-min-1 , for example, the sensitivity for CBN was 60% o f  that 
found at 1 ml-min-1 when a 70-cm irradiation coil was used.
Eluent composition The eluent composition had only a small effect on the ef­
ficiency o f  the photochemical derivatization o f  CBN, and both normal- and reversed- 
phase eluents have been used successfully. Some variation in the sensitivity o f  detec­
tion is to be expected, however, as factors such as the eluent polarity, pH, hydrogen 
bonding and proton-donor ability may influence the rate and course o f  the photo­
chemical reaction and the fluorescence quantum efficiency o f  the photoproduct. 
Eluents with a UV absorbance above 250 nm also act as an “ inner filter”  in both the 
derivatization and detection stages o f  the process.
Other applications o f  the photochemical reactor
The PCR can be used to enhance the specificity o f  detection other than by the 
formation o f  fluorescent derivatives. A  shift in the wavelength o f  UV absorbance can 
be advantageous, as interferences due to extraneous UV-absorbing substances are 
generally minimized at longer wavelengths o f  detection. An example o f  this is the use
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Fig. 5. Photochemical detection of CBN (180 ng) by UV absorbance at 360 nm. Conditions as in 
Fig. 3 except: flow-rate, 0,5 ml-min-1 ; detector, Cecil CE-212, 360 nm, 0.02 a.u.f.s.
o f  a UV monitor in place o f a fluorimeter for the detection o f CBN, when the drug 
can be detected by its UV absorbance at 360 nm (Fig. 5).
The specificity o f  detection o f  the hallucinogen LSD may also be enhanced. 
Upon irradiation at 320 nm, the naturally fluorescent LSD is converted into the non- 
fluorescent limn derivative10,11 (Fig. 6), and HPLC with UV irradiation may be 
valuable in distinguishing the drug from other fluorescing material with similar chro­
matographic properties.
Photochemical derivatization may be applicable to the HPLC analysis o f other 
drugs which are at present difficult to detect with the required sensitivity or specificity. 
An example is dextropropoxyphene, a widely prescribed analgesic which has been 
implicated in many drug overdose fatalities12. The drug has only a weak UV 
absorbance, and detection by UV spectroscopy or HPLC is difficult. Irradiation o f 
the drug with UV light leads to the formation o f a photoproduct with an increased 
UV absorbance13, and preliminary results indicate that the use o f  the PCR described 
here leads to a 10-fold increase in the sensitivity o f detection by HPLC using a UV 
monitor. Further work on this aspect is in progress.
It is envisaged that the application o f the technique can be further extended % 
by the use o f  derivatization reagents which photoreact with the substance o f interest. 
Such reagents can conveniently be added to the eluent prior to chromatography.
CONCLUSION
HPLC with photochemical derivatization and fluorimetric detection has been 
shown to provide a highly specific means o f  detection o f nanogram amounts o f
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Fig. 6. Specific detection of LSD (11 ng) using photochemical derivatization (a) without and (b) with 
UV irradiation. Column,-Spherisorb ODS; eluent, methanol-aq. (0.025 M) Na2HP04 (65:35) 
adjusted to pH 8; flow-rate, 0.5 m l'min"1; detector, MPF-2A fluorimeter, Acx =  320 nm, 2em =  400 
nm, slits 10 nm, sensitivity x 5.
cannabinol. A general method based on this principle for the detection o f  
cannabinoids in body fluids is under development. The photochemical technique is 
also applicable to the specific detection o f  several other drug substances, such as 
dextropropoxyphene, for which conventional HPLC with UV detection gives poor 
sensitivity.
Photochemical derivatization offers several advantages over other pre- and 
post-column derivatization techniques. Time-consuming sample preparation proce­
dures associated with pre-column methods are eliminated, and the retention volume 
measured is that o f  the parent substance rather than that o f  a derivative. In contrast 
with conventional post-column derivatization methods, photochemical derivatization 
has a negligible effect on the resolution o f  the chromatographic system and imposes 
few practical restrictions on the eluent composition. As no reagents need to be added 
to the eluent stream, problems o f  mixing and pulsating flow do not arise. The 
principal advantage o f  photochemical derivatization is, however, the specificity o f  
detection that it provides, and the simple means by which the substance o f  interest 
can be differentiated from non-photolabile interfering compounds. It is expected that 
photochemical derivatization will form a valuable addition to available derivatization 
methods owing to its simplicity, speed o f  operation and very high specificity.
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ri jaraey o/' cannabinoid levels in post-mortem blood from 66  fatally injured drivers 
showed, by radioimmunoassay alone, cannabis use in 6  cases. Further examination o f 3 o f 
the specimens by a combined system of high pressure liquid chromatography and radio­
immunoassay showed typical patterns o f separated cross-reacting cannabinoids and gave a 
specific measurement o f THC levels. The total cross-reacting cannabinoid levels in the 
positive samples were low compared with the levels detected in earlier cases o f intoxication 
or in volunteers smoking moderate doses o f pure THC. An assessment o f the effect on 
driving impairment is given.
Introduction
The effects of drugs on driving capability are being examined more closely 
as prescribed drug-taking by the public increases. The involvement of drugs in 
fatal road accidents may be more important than has been realised. In cases 
involving drugs, the substance found most often is alcohol, but it is becoming 
increasingly apparent that medically prescribed drugs can also be effective in 
impairing judgement and co-ordination. Particularly dangerous is the intake 
of drugs in combination with alcohol. Although the blood alcohol level may be 
measured and found to be low, other undetected drugs may be present, resulting 
in serious impairment of driving ability.
The incidence o f involvement o f groups of drugs has been the subject o f a 
recent survey in the U.S.A. (Glauz and Blackburn, 1975). In a comparison of 
the incidence of drugs in living and fatally injured drivers the authors estimated 
that the use o f stimulants for example, increased the risk o f involvement in a 
fatal accident 14 times above control. Other groups of drugs, such as sedatives 
(5 times) and antihistamines (5 times) were less of a risk, whilst tranquillisers 
and nicotine produced no increase in risk. Cannabis increased the risk 3-|- times 
above control.
From experimental studies of driving skills there is evidence that adminis­
tration of tetrahydrocannabinol (THC) causes, for example, impairment of 
tracking ability and perceptual performance and it is concluded that cannabis 
use will increase the probability of driving accidents (Moskowitz, 1976). 
However, direct evidence o f the involvement of cannabis use in accidents is 
needed. Whilst the assessment of cannabis use in the survey by Glauz and 
Blackburn is an attempt to produce such evidence, the results are based on a 
detection system of uncertain reliability involving swab testing o f mouth and 
fingers. A  sensitive technique for the analysis of blood specimens is required 
and a radioimmunoassay (A/ri) method has been developed (Teale et al., 1975)
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permitting the rapid routine screening of samples in this type of epidemiological 
study.
RIA has been used already for the confirmation of the involvement of 
cannabis use in a fatal car accident (Teale and Marks, 1976). With the co­
operation of the coroners and pathologists throughout England and Wales, an 
attempt has been made to assess the incidence o f cannabis involvement in fatal 
road accidents by screening blood samples from fatally injured vehicle drivers.
Methods and Materials
A circular letter was sent to all coroners in England and Wales requesting 
their assistance in a survey of cannabis use in fatally injured drivers. It was 
suggested chat the request, if acceptable, be passed on to the pathologists 
carrying out post-mortem examinations o f such cases and, where appropriate, 
that they send specimens of blood for screening. The use of anticoagulant or 
preservative was not important, since none are known to affect the RIA method. 
On receipt, blood samples were centrifuged and the supernatants separated 
for storage at —20°G. One volume of each blood supernatant was mixed with 
two volumes of methanol. The methanolic supernatant was separated from the 
precipitated proteins and stored at —20°C.
Aliquots (50(jd) o f methanolic supernatant were assayed initially by direct 
addition to the RIA system by a similar method to that previously published 
(Teale et al., 1975). The same volume o f methanolic supernatant extract o f 
normal serum was added to all other assay tubes. Results are expressed in 
TH C cross-reacting cannabinoids (THG-GRGs) since TH C was used as the 
standard and the antiserum cross-reacts with TH C and several o f its metabolites.
Blood samples regarded as positive for the presence of cannabinoids were 
examined further by the use of high pressure liquid chromatography (HPLC) 
combined with the RIA (Williams et al., 1977). Methanolic supernatant 
extracts were subjected to HPLC separation on a reverse-phase column and by 
elution with a step-wise gradient of methanol-water mixtures. Golumn fractions 
were assayed by direct addition of aliquots to the RIA system. THG was 
identified and quantified by this method.
Results
Between July, 1976 and April, 1977, 65 blood specimens from fatally injured 
drivers were received at the Department of Biochemistry, University o f Surrey: 
54 from car drivers and 11 from motor-cyclists. One other specimen (number 
86), a sample from a motor-cyclist suspected of cannabis use prior to his 
accident, was received at the Home Office Central Research Establishment.
Figure 1 shows the ratio (B/Bo) of the amount o f radioactive label bound to 
antibody in the presence o f an aliquot o f each sample extract (B) to the amount 
o f label antibody-bound in the presence of the same volume of normal serum 
extract (Bo). Samples which produced a decrease in binding to below a ratio 
of 0*65 were regarded as positive for cannabinoids. From Figure 1 it can be 
seen that six samples, viz. numbers 8, 15, 21, 42, 53 and 86 were positive for 
THC-CRCs using this criterion. The histories for these cases are given below: 
Sample 8
A 22-year-old male died at 23.05 after being involved in an accident at 
21.30 when his sports car, containing 3 passengers failed to take a corner. No 
alcohol was detected.
Sample 15
A 17-year-old male, with a passenger who was also killed, was involved in an 
accident on his motor cycle at 10.30. Blood alcohol was negative.
Sample 21
A 27-year-old driver died at 23.00, soon after his car had collided with a 
lamp-post whilst overtaking. Alcohol was noc detected.
"V
v
i Bo
Sample number
Figure 1. Antibody-bound 3H-THC in the presence of methanolic supernatant extracts of each of 66 post-mortem “serum" specimens (B) compared with antibody-bound 3H-THC in the presence of methanolic supernatant extract of normal serum (Bo). Specimens producing a decrease in 3H-THC binding greater than 35% (B/Bo < 0*65) were regarded as containingcannabinoids.
Sample 42
A  19-year-old male motor-cyclist died at 18.50 after a head-on collision on 
a bend at 17.00. No alcohol was detected.
Sample 53
A  23-year-old male car driver died at 18.45 after an accident. His blood 
alcohol was 343mg/100ml blood.
Sample 86
A  20-year-old male fell off his motor-cycle and was run over by a following 
car. The accident happened at 20.05 and within 30 minutes a blood sample 
was taken after hospitalisation. The subject died at 23.20. No alcohol or other 
drugs were detected in the blood. Cannabis was found in the subject’s pocket.
Figure 2 shows the samples grouped according to the age of the victim. The 
shaded areas represent the number of samples regarded as positive for THC- 
CRCs, as determined by direct RIA. As might be expected, the incidence of 
cannabis use is apparently confined to the younger drivers.
Samples 8 and 15 were not investigated further. Aliquots of the other 
specimens were re-assayed using different conditions (Williams et al., 1977). 
The level of THC-CRCs in sample 21 was considered to be too low (5ng/ml) 
to attempt an HPLC separation. However, the levels in samples 42, 53 and 86
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Figure 2. Number of post-mortem blood specimens from each age group. The hatched areas represent the positive results.
were 10, 19 and llng/m l respectively and separation of the cannabinoids in 
each sample was performed. Figure 3 shows the resultant radioimmuno- 
chromatograms. By peak area integration the concentration o f TH C in sample 
42 was estimated as l*5ng/ml, in sample 53, 2 ‘3ng/ml and in sample 86, 
4 ring/ml.
D iscussion
The use of RIA, based on anti-THC antibodies, is o f proven value in the 
sensitive and rapid detection o f cannabis use (Marks et a l 1975). When 
coupled to an HPLC separation system, the capacity o f the RIA for the measure­
ment of TH C and its cross-reacting metabolites confers greater specificity on 
the technique, one application o f which is illustrated by the present study.
The patterns o f cross-reacting cannabinoid peaks, observed by HPLCjRIA 
analysis of the post-mortem blood specimens regarded as positive for canna­
binoids by direct RIA, may be compared with the patterns produced by 
similar analyses of samples collected from a volunteer following the smoking of 
a cigarette impregnated with lOmg of pure TH C (Teale et al., 1977). With the 
reverse-phase HPLC system used, the RIA cross-reacting metabolites elute from 
the column in decreasing order of polarity. Major features o f the chromato­
grams include an initial very polar peak (probably due to metabolite conjugates) 
which is followed by peaks due to other metabolites. The last peak is that for 
THC. The current system therefore provides a measurement of THC, confirms 
cannabinoid detection by direct RIA and will ultimately permit identification 
of the other isolated peaks o f cross-reacting metabolites.
From Figure 1 it is apparent that direct addition o f post-mortem serum 
extract to the RIA system often causes marked decrease or increase in 3H-THC 
binding to antibody. For this reason a relatively low cut-off level was selected 
(B/Bo =  0*65). Any sample causing a depression o f label binding below this
180
Sample 42
1
A .
10 15 20 25 30 35
Figure 3. Radioimmunochromatograms produced by HPLC j RIA analysis of 3 post-mortem blood specimens (42, 53 and 86). The elution volume of pure THC is indicated by an arrow.
level was regarded as containing cannabinoids. Under normal conditions 
samples from subjects causing a decrease in binding greater than 10% (B /Bo< 
0*90) would be taken as containing cannabinoids. It is possible, therefore, that 
some of the post-mortem specimens classified as negative for cannabinoids by 
direct RIA but producing a decrease in label binding between 10% and 35%, 
may contain low levels o f cannabinoids. Although, this sensitive detection of 
cannabinoids should be strictly interpreted as further incidence of cannabis 
involvement in fatal accidents, it is unlikely that such very low blood levels of 
TH C-CRC would be associated with a degree o f intoxication likely to cause 
the impairment o f driving ability. The TH C-CRC levels obtained by direct 
j  RIA analysis o f all 6 positive samples may be regarded as moderate compared
% with the limited data previously available. For example, in the first road
accident case examined by RL4 (Teale and Marks, 1976) the blood THC-CRC 
level was found to be 350ng/ml. Cannabis use by the driver had been clearly 
indicated by discovery o f the substance in the car and, similarly, this was the
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situation in one of the present cases (86), although the blood THG-GRG level, 
measured under the same assay conditions, was relatively low. Even though 
cannabis use was virtually certain in both these cases, and samples o f the 
material consumed were available, there was no information on the amount 
consumed or the time of consumption. For this reason it is difficult to relate the 
THC-CRC level with a degree of intoxication. Recently, in a case of cannabis 
intoxication resulting in coma, a blood THG-GRG level of 180ng/ml was 
recorded in a sample taken during the comatose state, approximately 8 hours 
after the smoking of an unknown amount o f material (Garrett et al., 1977). 
Data from volunteers smoking cigarettes impregnated with 5mg pure THG 
showed a maximum blood TH C-CRC level o f 72ng/ml in one volunteer immedi­
ately after smoking and at a time when mild euphoria was experienced (Teale 
et al., 1974).
On the basis o f these findings, the moderate THG-GRG levels (10—30ng/ml) 
in the other road accident cases (8, 15, 21, 42 and 53), in which cannabis use 
was not initially implicated, would not at first sight appear to be the probable 
cause of driving impairment. In one case (53) a high blood alcohol level was 
more likely to be the reason. Nevertheless, the blood level at the time of the 
accident may have been higher than that detected in a sample taken, perhaps, 
several hours afterwards and, for example, after a blood transfusion. The 
picture is further complicated by variation in psychoactive cannabinoid 
composition in similar total THG-GRG levels. Intoxication may be related to 
the THG component o f blood cannabinoids. In sample 86 THG comprised 
40% of the total THG-GRCs detected, whilst in samples 42 and 53 the THG 
fraction was less (15% and 12%) even though the total THG-GRG levels in 
the latter samples were higher than that in sample 86. Therefore, the relatively 
low THG-GRG level may be more intoxicating than a higher level by virtue 
of its higher THG content. The level o f THG may also be a reflection o f the 
time the blood sample was collected. Sample 86 was taken soon after the 
accident, and before death, whereas all the other specimens were collected at 
post-mortem examination.
I f the moderate blood THG-GRG levels detected in the majority o f the 
positive cases are associated with a degree of intoxication likely to be the cause 
o f driving impairment, a much broader survey of cannabis involvement in all 
accidents, or even in all road-users, should be undertaken to ascertain the 
extent o f its use. With more potent preparations of cannabis extract becoming 
popular (Lopez el al., 1974; Garrett et al., 1977), degrees o f intoxication may 
exceed those previously experienced and in an increasing number o f users. 
This development may be reflected in cannabis becoming a more important 
factor in the causation o f road accidents.
The minimum apparent incidence of cannabis involvement in 66 fatal road 
accidents was 9% . The 66 specimens analysed cannot, however, be considered 
a representative group for several reasons. For example, only 8 specimens were 
received from the most highly populated area o f the country— the South East 
o f England, and nearly half came from another— the Midlands. It will also be 
noted (Figure 2) that 70% of the specimens came from subjects under 33 years 
o f age. This suggests that some o f the pathologists involved in sending samples 
selected only subjects most likely to have used cannabis. Since all the positive 
cases fell within this age-group the deliberate selection o f such samples will 
result in a correspondingly higher incidence of cannabis use. The relatively 
high number of samples from motor-cyclists (16%) may be a reflection of age 
selection and also the apparently high incidence o f cannabis use amongst that 
group (18%.)
The present survey constitutes an example of the type o f study which can 
readily be carried out using an RIA as an initial screening method followed by 
closer examination o f drug-containing"samples by a specific HPLCjRIA com­
bined technique.
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